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Abstract 
Changes of histone methylation code, DNA hydroxymethylation and formation of chromatin 
loops are associated with transcription induction by nuclear hormones, but it is not known if 
these events are the consequence or the cause of transcription initiation. We studied the effect 
of activation of the retinoic acid receptor, at the RARE–promoter chromatin of CASP9 and 
CYP26A1 genes, and estrogen receptor !, at ERE and Poly_A of PS2, CAV1 and BCL2 
genes. We found that histone H3 lysines 4 and 9 are demethylated by the lysine-speci"c 
demethylase, LSD1 and by the JMJ-domain containing demethylase, D2A. The action of the 
oxidase (LSD1) and a dioxygenase (JMJD2A) in the presence of Fe++ elicits an oxidation 
wave that locally oxidate the DNA, recruits the enzymes involved in base and nucleotide 
excision repair (BER and NER) and bring to formation of chromatin loops that juxtapose the 
5' and 3' ends of induced genes. In addition we evaluated the crucial role of DNA 
methyltransferase 3a that work closely to OGG1 and APE1, favoring strand specific repair of 
oxo-dG and methylation of the complementary C preventing the accumulation of G to T 
mutations at regulative regions of studied genes. We suggest that coupling transcription with 
methylation and repair enzymes is an evolutionary strategy to reduce the mutational burden 
induced by DNA oxidation necessary for chromatin looping. We characterized the changes in 
chromatin structure, DNA methylation, the recruitment of Base Excision Repair during and 
after homologous DNA repair (HR) in HeLa DR-GFP cells. Repaired genes display stable but 
different methylation profiles. These profiles manage the levels of expression in generated 
recombinant populations. Our data argue that DNA methylation and chromatin remodelling 
induced by HR may be a source of permanent variation of gene expression in somatic cells. 
Finally we studied the relationship between chromatin remodeling of FOXP3 gene and 
immunophenotypic differentiation of human primary CD4+ T lymphocytes moreover the 
alterated immunosuppressive activity in autoimmune desease. We found that the induction 
and suppressive function of iTreg cells (induced Treg cells) tightly depended on glycolysis, 
which controlled FOXP3 splicing variants containing exon 2 ( FOXP3-E2) through the 
glycolytic enzyme enolase-1. The  FOXP3-E2–related suppressive activity of iTreg cells was 
altered in human autoimmune diseases, including multiple sclerosis and type 1 diabetes, and 
was associated with impaired glycolysis and signaling via interleukin 2. This link between 
glycolysis and  FOXP3-E2 variants via enolase-1 shows a previously unknown mechanism 
for controlling the induction and function of Treg cells in health and in autoimmunity. 
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Riassunto 
 
I cambiamenti del codice istonico, l’idrossimetilazione del DNA e la formazione di loops 
cromatinici sono associati alla trascrizione dipendente da ormoni nucleari; non è ben chiaro se 
questi eventi siano la conseguenza o la causa dell’inizio del processo trascrizionale. Abbiamo 
studiato gli effetti dell’attivazione trascrizionale dipendente dal recettore dell’acido retinoico 
sulle regioni RARE-promotore dei geni CASP9 e CYP26A1, e del recettore degli estrogeni ! 
sulle regioni ERE e Poly_A dei geni PS2, CAV1 and BCL2. I risultati ottenuti hanno 
evidenziato che dopo stimolazione ormonale la lisina 4 e 9 dell’istone H3 sono demetilate 
dalla demetilasi lisina specifica LSD1 e dalla demetilasi contenente il dominio JMJ: JMJD2A. 
L’azione dell’ossidasi (LSD1) e della diossigenasi (JMJD2A) genera specie reattive 
dell’ossigeno che ossidano localmente il DNA, reclutano gli enzimi dei complessi di riparo 
per escissione di base e nucleotidica (BER e NER) e portano alla formazione di loops 
cromatinici che giustappongono l’estremità 5' e 3' dei geni indotti. Abbiamo inoltre valutato il 
ruolo cruciale della DNA metiltransferasi 3A (DNMT3A) che, lavorando a stretto contatto 
con OGG1 ed APE1 favorisce il riparo filamento specifico dell’8-oxoG e la metilazione della 
C complementare prevenendo così la transversione della G in T quindi, all’accumulo di 
mutazioni nelle regioni regolative dei geni attivi. In seconda analisi abbiamo valutato i 
cambiamenti della struttura cromatinica, della metilazione del DNA e del reclutamento degli 
enzimi di riparo (BER) conseguenti la rottura a doppio filamento del DNA nel sistema 
pioniere DR-GFP (cellule HeLa DR-GFP) in due popolazioni ricombinanti (cloni Rec H e 
Rec L) generate in seguito ad homologous recombination (HR). I dati ottenuti evidenziano 
che la metilazione del DNA ed rimodellamento della cromatina indotta da HR possono essere 
una fonte permanente della variazione dell’espressione genica nelle cellule somatiche. Infine 
abbiamo studiato la relazione tra rimodellamento cromatinico del gene  FOXP3 e 
differenziazione immunofenotipica di cellule primarie umane (linfociti T CD4+) e l’alterata 
attività immunosoppressiva in individui affetti da patologie autoimmuni come la sclerosi 
multipla. I risultati ottenuti mostrano che la funzione immunosoppressiva delle iTreg (cellule 
Treg indotte) dipende dalla glicolisi, che controlla attraverso l’enzima enolasi-1 l’espressione 
delle varianti di splicing contenenti l’esone 2 ( FOXP3-E2). Il legame tra la glicolisi e 
trascritti  FOXP3-E2 dipendente da enolasi-1 mostra un meccanismo sconosciuto che 
controlla l'induzione e la funzione delle cellule Treg nella autoimmunità. 
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Chapter 1: Introduction 
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The chromatin structure 
DNA, deoxyribonucleic acid, is a long linear polymer in which the genetic information is 
contained. It consists of four monomeric units: the deoxyribonucleotides, composed by 
nucleotide bases, a sugar with five carbon atoms (2-deoxyribose) and a phosphate group 
(PO42-). The nucleotide base is linked through a glycosidic bond to the C1 position of sugar, 
while the phosphate group (PO42-) is bound through phosphodiester bond to the C5 position of 
2-deoxyribose. There are two different types of nucleobases: the purine bases [adenine (A) 
and guanine (G)], and the pyrimidine bases [cytosine (C) and guanine (G)]; that are paired 
together (A-T and C-G) to give DNA its double helical shape. 
Eukaryotic cells package their genetic information into chromatin, a nucleoprotein complex 
composed of the primary genetic information, the DNA, and a mix of structural and 
regulatory proteins; the complex is tightly bound by attraction of the negatively charged DNA 
to the positively charged histones 
(Nick Gilbert et al., 2005). In 
mammalian cells we can distinguish 
three levels of chromatin 
organization: the nucleosome, the 30 
nm chromatin fiber and the 
chromosomes (the highest level of 
DNA compaction) (Fig.1). 
Chromatin is a dynamically entity 
that contains the regulatory signals 
necessary to program appropriate 
cellular pathways and it is believed to 
contribute to the control of genes 
expression. Genetic information 
encoded in DNA is largely identical in 
every cell of a eukaryote. However, 
cells in different tissues and organs can have widely different gene expression patterns and 
can exhibit specialized functions. Gene expression in different cell types needs to be 
appropriately induced and maintained; inappropriate expression patterns lead to disease 
(Greer E. L. & Shi Y., 2012). 
Figura 1 Schematic representation of chromatin structure. 
The chromatin fiber presents in nucleo is composed by 
nucleosome units, each consisting of DNA wrapped around 
histone proteins proteins. 
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 Epigenetics 
Epigenetics is defined as the study of alteration in gene expression without any changes in 
DNA sequence that are transmitted through both mitotis and meiosis (Wu C. & Morris J. R., 
2001). The term is made of two parts: Greek prefix “epi”, which means “above” or “over” and 
“genetics”, which is the science of genes. The word “epigenetics” was coined by Waddington 
to define the changes in phenotype without involve change in genotype. Epigenetic regulation 
in mammals includes three major 
mechanisms: DNA methylation, histone 
variants and histone posttranslational 
modification (PTMs), and noncoding 
RNAs (Xu W. et al., 2016) (Fig.2). 
DNA methylation plays an important 
role in genomic imprinting, X-
chromosome inactivation during 
embryonic development in a several 
diseases such as cancer; Histone 
modification and variant histones 
influence gene regulation through 
changes in nuclear chromatin structure; 
noncoding RNAs knock down gene 
expression through different mechanisms such as microRNA, siRNA pathway, RNA-
mediated interference (RNAi) or post-trascriptional gene silencing (PTGS). Epigenetic 
mechanisms work in addition to the DNA template to stabilize gene expression programmes 
defining cell-type identity (Allis C. D. & Jenuwein T., 2016) and the interaction between 
different mechanisms controls the accessibility of genes by the transcriptional machinery. 
 
Histone proteins 
Histones are the most abundant proteins associated with DNA. They are small basic proteins, 
whose side chains are rich in positive charged basic amino acids, in particular lysine and 
arginine; this positive charge allows the histones to interact in a firm and non-specific with 
the negative charges of the DNA phosphate groups. 
Figura 2 Mechanisms of epigenetic modification. Cell 
transduces the environmental changes (e.g., nutrients, 
toxins, etc.) into epigenetic modifications including DNA 
methylation, histone PTMs, and noncoding RNAs 
(especially the microRNAs), which eventually turn certain 
genes on or off and regulate the transcription process 
without changing DNA sequence. Xu W. et al., 2016)  
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In eukaryotes we can identify five types of histones denominated H1, H2A, H2B, H3 and H4, 
which differ in molecular weight and content in lysine and arginine. Histones are associated 
with DNA to form nucleosomes, the fundamental units of compaction of chromatin, which 
give it an appearance of "pearl necklace" (Alberts et al., 2004). Each nucleosome consists of a 
protein octamer defined histone core, around which DNA is wrapped for one turn and 3/4; the 
quantity of DNA associated with the histone octamer is standard and consists of 147 base 
pairs (bp). The histone octamer is formed by a 
central H3/H4 tetramer (associated to 60 pairs of 
central bases of nucleosomal DNA) sandwiched 
between two H2A/H2B dimers. (Fig. 3). 
Each nucleosome is separated from the adjacent 
one by a region of "linker DNA", which length is 
highly variable among species and can go from 10 
to 90 bp. This DNA sequence is linked to H1 
histone; this histone consists of a central globular 
region linked to amino and carboxy terms. Each molecule H1 binds a single site on a 
nucleosome with its globular domain and its terms is in connection with adjacent 
nucleosomes sites, allowing the transition to a next level of organization called "the 30-nm 
fiber" or "solenoid structure ". DNA can be further compacted by the formation of loops 
locked to the base by a protein structure known as "nuclear scaffolds" which form the highest 
level of condensation of chromatin: the chromosome. 
Histones are tripartite proteins that are composed of a globular domain (histone fold) and 
unstructured N- or C-terminal tails that are subjected to several covalent modifications such as 
methylation, acetylation, phosphorylation as well as addition of large groups like ubiquitin 
and ADP-ribose (Kouzarides T., 2007). These modifications work acting in a combinatorial 
or sequential manner on one or multiple histone tails, to build a real code known as “histone 
code” (Fig. 4), that contribute to the control of genes expression and influence chromatin 
compaction or signaling to other protein complexes (Strahl & Allis, 2000). Therefore, an 
appropriate balance of stability and dynamics in histone post-translational modifications 
(PMTs) is necessary for accurate gene expression. Chromatin structure or landscape is a 
composite of various domains characterized by the local enrichment of a specific combination 
Figura 3 Schematic representation of 
nucleosome structure. 
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of histone post-translational modifications (PMTs), histone variants, nucleosome occupancy, 
DNA methylation patterns and nuclear localization. 
 
 
Figura 4 Histone posttranslational modifications. Histone modifications are covalent post-translational 
modifications that take place on histone tails. They operate in combined manner to generate a code (histone 
code) and influence either 'active' or 'inactive' chromatin states 
The distributions of histone PTMs form a indicative signature of the chromatin state of a 
given loci (Turner B.M., 1993) Euchromatin is generally associated with high levels of 
histone acetylation. H3K9ac and H4K16ac are found at the promoters of actively transcribed 
genes while H3K27ac is enriched at enhancers together with another histone modification 
H3K4me1 (Wang Z. et al., 2008; Pasini D. et al., 2010). Di- and tri-methylations of histone 
H3 at K4 are modifications which are found in close proximity to active promoters (Santos-
Rosa H et al., 2002). 
On the other hand, constitutive heterochromatin is enriched in repressive marks such as 
H3K9me3 and H4K20me3 which are deposited in mammals by Suv39-H1/2 and Suv4-
20H1/2 respectively (Rice J.C. et al., 2002). The characteristic mark of facultative 
heterochromatin is H3K27me3. Polycomb repressive complex 2 (PRC2) methylates histone 
H3 at K27, both at promoters and gene bodies, via its catalytic subunit EZH1/2. 
 
Histone methylation 
Methylation is a post-translational modification of histone tails which occurs on all basic 
residues: lysine, arginine and histidines. It is catalyzed by enzymes (histone 
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methyltransferases) that use S-adenosyl-L-methionine (SAM) as the methyl group donor. 
Lysines can be monomethylated (me1), dimethylated (me2), or trimethylated (me3) on their 
#-amine group; arginines can be mono or while histidines can be only monomethylated. The 
most studied histone methylation sites include histone H3 lysine 4 (H3K4), K9 , K36, K79 
and H4K20. Sites of arginine (R) methylation include H3R2, H3R8, H3R17, H3R26 and 
H4R3. 
The level of histone methylation is essential for regulation of transcriptional activity, in fact 
methylation can influence gene expression in both positive and negative way. Repressive 
marks include di- and trimethylation of lysine 9 on histone H3 (H3K9 me2/me3), 
trimethylation of lysine 27 on histone H3 (H3K27me3) and trimethylation of lysine 20 on 
histone H4 (H4K20me3). Conversely, activation is associated with histone H3 di- and 
trimethylation of lysine 4 (H3K4me2/me3) and trimethylation of lysines 36 and 79 
(H3K36me3, H3K79me3). 
Methyl groups can be removed from histone lysine residues by the action of histone lysine 
demethylases. Two families of these enzymes have been identified that remove methyl groups 
from different lysine residues on histones. These are the amine oxidases (LSD1) (Shi et al., 
2004) and jumonji C (JmjC)-domain-containing, iron-dependent dioxygenases (Tsukada Y. et 
al., 2006; Whetstine J. R. et al., 2006). Methylated histones are recognized by chromatin 
effector molecules (‘readers’), causing the recruitment of other molecules to alter the 
chromatin and/or transcription states (Taverna S. D. et al., 2007). These chromatin-regulating 
complexes include histone acetyltransferases (HATs), DNA methyltransferases (DNMTs), 
histone deacetylases (HDACs), histone methyl-transferases (HMTs) and histone demethylases 
(HDMs) that act in a stepwise and/or combinatorial manner and engage in extensive cross 
talk. 
 
DNA methylation and hydroxymethylation 
DNA methylation is a covalent postreplicative modification of genomic DNA. The process 
consists in the addition of the methyl group at the 5-carbon of the cytosine ring resulting in 5-
methylcytosine (5-mC), also known as the “fifth base” of DNA in the context of CpG 
dinucleotide, in which a cytosine nucleotide is located next to a guanidine nucleotide. 
In the mammalian genome, the CpG dinucleotides occur in CG dense regions termed "CpG 
islands", whose length is generally between 300 and 3,000 bp; these are prevalent at 
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transcription start sites of housekeeping and developmental regulator genes (Deaton et al., 
2011), where they are ipomethylated. The degree DNA methylation of CpG Island regulates 
genes expression; in fact DNA can directly interfere with transcription by preventing binding 
of basal transcriptional machinery or ubiquitous trancription factors that require contact with 
cytosine in the major groove of the double helix (Cuozzo C. et al., 2007). This covalent 
modification regulates different 
biological process such as development 
and differentiation (Li E. et al., 1992), 
imprinting (Li E. et al., 1993), X 
chromosome inactivation (Panning B. & 
Jaenisch R., 1998), and cancer (Laird 
P.W. et al., 1995; Baylin S.B. & Ohm 
J.E., 2006). Aberrant methylation has 
been found in cancer cells (Cho Y.H. et 
al., 2010) and it was shown that DNA 
methylation is associated with DNA 
damage and repair (Cuozzo C. et al., 
2007) and that methylation is reduced by 
transcription of the repaired regions as a mechanism of adaptation to environmental 
perturbations (Morano A. et al., 2014). 
DNA methylation is catalyzed by a family of DNA methyltransferases (DNMTs): DNMT1, 
DNMT2, DNMT3A, DNMT3B, and DNMT3L (Bestor T. H. et al., 2000). DNMT1 is highly 
expressed in mammalian tissues including the brain (Goto K. et al., 1994) it preferentially 
methylates hemimethylated DNA (Pradhan S. et al., 1999; Ramsahoye B. H. et al., 2000). 
During DNA replication, DNMT1 is localized near the replication fork where newly 
synthesized hemimethylated DNA is formed (Leonhardt H. et al., 1992). DNMT1 binds the 
newly synthesized DNA and methylates it to mimic the original methylation pattern present 
before DNA replication (Hermann A. et al., 2004) (Fig. 5). For this reason, DNMT1 is called 
the maintenance DNMT because it maintains the original pattern of DNA methylation in a 
cell lineage. DNMT3A and DNMT3B, in contrast to DNMT1, have preference for 
unmethylated CpG dinucleotides and perform de novo methylation during development. The 
difference between DNMT3a and DNMT3b is DNMT3a gene expression pattern, in fact it is 
Figura 5 DNA methylation pathways. A family of DNA 
methyltransferases (DNMTs) catalyzes the transfer of a 
methyl group from S-adenyl methionine (SAM) to the fifth 
carbon of cytosine residue to form 5-methylcytosine (5mC). 
DNMT1 is the maintenance DNMT and maintains DNA 
methylation pattern during replication. (Moore D. 2013) 
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expressed relatively ubiquitously, 
DNMT3b is poorly expressed by 
the majority of differentiated 
tissues. However, mounting 
evidence indicates that DNMT1 
may also be required for de novo 
methylation of genomic DNA 
(Egger G. et al., 2006) and that 
DNMT3A and DNMT3B 
contribute to maintenance 
methylation during replication. 
(Riggs A. D. et al., 2004). 
DNMT3L has no catalytic 
function, it assists de novo 
methyltransferases by increasing 
their ability to bind to the methyl 
group donor, S-adenosyl-
Lmethionine (SAM), and stimulating 
their activity in vivo (Kareta M. S. et 
al., 2006).  
DNA methylation works with 
histone modifications and 
microRNA (miRNA) to regulate transcription (Fig. 6). These modifications influence not only 
DNA packaging, but also their transcriptional activity, in fact DNMTs interact with enzymes 
that regulate histone modification involved in gene repression. 
Methylation inhibits transcription through the action of a protein, methyl-CpG-binding 
protein 2 (MECP2), that specifically binds methylated DNA and represses transcription 
(Lewis J. D. et al., 1992). Interestingly, MeCP2 functions as a complex with histone 
deacetylase, linking DNA methylation to alterations in histone acetylation and nucleosome 
structure. DNA methylation is directly connected with histone methylation, it is inversely 
correlated with H3K4 trimethylation, in fact this histone modification impairs the binding of 
DNMT3a, DNMT3b and DNMT3L to H3 histone tails and prevents methylation (Zhang Y. et 
Figura 6 Epigenetic crosstalk. Transcription is regulated by the 
interaction of multiple epigenetic mechanisms that cooperate to 
activate or silence gene expression. To suppress gene expression, 
DNMTs target CpG sites and actively methylate DNA. Their 
catalytic activity is enhanced by association with with 
DNMT3L. DNA methylation is recognized by methyl-binding 
proteins such as MBDs that recruit enzymes that modify the 
histone tails such as histone deacetylases (HDACs), which 
remove acetylation, and histone methyltransferases (HMTs), 
which methylate histones and in conjunction with DNA 
methylation repress gene expression. In regions of DNA with 
activate transcription, Tet removes DNA methylation, and 
histone tails in this region often contain H3K4me3 that inhibits 
DNMT binding to unmethylated CpG sites and maintains a 
permissive environment for transcription. (Moore D. 2013) 
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al., 2010); but it is directly correlated with repressive histone mark, in fact DNMT1 and 
DNMT3a bind the histone methyltransferase SUV39H1 that restricts gene expression by 
methylation on H3K9 (Fuks F. et al., 2003). In addition, DNMT1 and DNMT3b can bind to 
histone deacetylases that remove acetylation from histones to compact DNA and restrict 
access for transcription (Fuks F. et al., 2000; Geiman T. M. et al., 2004). 
DNA methylation was assumed to be a stable, irreversible epigenetic modification associated 
with gene repression¸ but the discovery of TET proteins shows that DNA can be 
hydroxymethylated and demethylated. The DNA demethylation process is important for 
epigenetic reprogramming of genes and is also directly involved in many important disease 
mechanisms such as tumor progression. It can either be passive or active, or a combination of 
both. Passive DNA demethylation occurs during DNA replication in dividing cells, when 
maintenance of DNA methylation is abrogated through down regulation of DNMT1 because 
this DNA methyltransferase protein methylate DNA emi-methylated not emi-
hidroxymethylated, (Takahashia S. et al., 2015), it involves a gradual loss of 5mC in a 
dilution manner. As an alternative mechanism, active DNA demethylation removes 5mC in a 
replication-independent manner, in particular the ten eleven translocation protein family 
(TETs) catalize the oxidation of 5-methylcytosine in 5-hydroxymethilcytosine. This proteins 
family includes TET1, TET2 
and TET3. These proteins may 
promote DNA demethylation 
by binding CpG rich regions to 
prevent unwanted DNA 
methyltransferase activity, and 
by converting 5-mC to 5-hmC 
(5- hydroxymethylcytosine), 
5-hmC to 5-fC (5-
formylcytosine), and 5-fC to 5-
caC (5-carboxylcytosine) 
through hydroxylase activity 
(Ito S. et al., 2011). The TET 
proteins have been shown to 
Figura 7 Pathways of DNA demethylation mediated by TET enzymes. 
Model of active DNA demethylation by a TET/TDG-dependent 
pathway. A cytosine base can be methylated by the DNA methylation 
machinery(DNMT1or DNMT3A/B) to form 5mC, which in turn can be 
oxidized by TET enzymes to produce 5hmC, 5fC, and 5caC. TDG then 
recognizes 5fC and 5caC, and the oxidized cytosine base is excised. 
The site is repaired by BER enzymes that restored the unmodified 
cytosine state. (Rasmussen K. D. and Helin K. 2016) 
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function in transcriptional activation and repression (TET1), tumor suppression (TET2), and 
DNA methylation reprogramming processes (TET3).  
The oxidative cytosine derivates from 5-fC and 5-caC are recognized and excised by thymine 
DNA glycosylase (TDG) to allow subsequent base excision repair (BER) processing which 
converts modified cytosine back to its unmodified state (Yamaguchi S. et al., 2013) (Fig. 7) 
 
DNA damage 
DNA is the holder of all the genetic information contained in every living cell, so it is 
essential that the integrity and stability are constantly safeguarded to allow cells to survive. 
However, DNA is not an inert chemical molecular entity but it is subject to a variety of 
aggressions responsable of many damages. The latter may involve directly or indirectly 
causing a break in the DNA or mutations which, if not repaired, can be transmitted to the next 
cellular generation, with a consequent accumulation of damage. The process of replication of 
DNA during cell division, is subject to numerous errors caused essentially by the speed of 
DNA polymerase which incorporates incorrect nucleotides during synthesis of the new strand. 
Most of these errors is repaired by a repair system of its own DNA polymerase which has 
proof reading activity because it is equipped with exonuclease 3'-5 'able to recognize and 
remove nucleotides wrongly matched. Some of these errors may, however, escape the control 
of exonuclease, causing a incorrect pairing between the two strands that if not identified 
induces, in the next cycle of replication, a permanent change in the DNA sequence, 
determining the onset of a mutation. 
Maintaining the integrity of genetic information is critical both for normal cellular functions 
and for suppressing mutagenic events that can lead to cancer. DNA damage can arise from 
external sources such as exposure to ionizing radiation, ultraviolet radiation (UV), or 
environmental toxins, or for endogenous sources, such as reactive oxygen species or errors 
during DNA replication. These events can generate DNA lesions, including modified bases, 
abasic sites, the formation of DNA adducts, the production of single- (SSBs) and double-
strand breaks (DSBs) (Lindahl T. et al., 1993). Persistent DNA damage can induce 
mutagenesis, such as base substitutions and small insertions/deletions, as well as 
chromosomal rearrangements. Thus, constant genome maintenance is essential for the 
viability and longevity of a healthy organism. Cells have therefore evolved multiple DNA 
repair pathways to preserve genome integrity when damage arises. 
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 Oxidative damage 
DNA is constantly attacked by reactive oxygen species generated during normal cellular 
metabolism and exposure to ionizing or ultraviolet radiation (1-3 borh). The oxidative stress is 
the physiological disturbance between the reactive oxygen species (ROS), such as hydrogen 
peroxide (H2O2), superoxide (O2-) and hydroxyl radicals (OH-) ( and the ability to remove 
them it can also be defined as the disordered redox signaling and control (Jones, 2006). The 
reactive oxygen species play an important role in cell signaling and regulation of cytokine, 
growth factor and hormone action, transcription, ion transport, neuromodulation, 
immunemodulation, and apoptosis (Gloire G. et al., 2006; Mittler R. et al., 2011); and also 
play a fundamental role in normal functioning of immune system, proliferation of T cells, and 
immunological defence (Devadas S. et al., 2002; Hildeman D. A. et al., 2004). The formation 
of ROS is prevented, by an effective system of 
antioxidants such as ascorbic acid, glutathione, 
enzymes such as superoxide dismutase (SOD), 
catalase and peroxidase that interacts directly 
with ROS, neutralizing them. One of the most 
deleterious consequences of oxidative stress is 
the formation of DNA lesions as bases oxidation. 
Both purine and pyrimidine bases are subject to 
oxidation. The most common mutation is 
guanine oxidized to 8-oxo-7,8-dihydroguanine, 
resulting in the nucleotide 8-oxo-deoxy-
guanosine (8-oxo-dG). When 8-oxo-dG assumes 
its syn conformation is able to bind 
deoxyadenosine, instead of pairing with 
deoxycytotidine as expected, because it can mimic 
thymine (Fig. 8). 
If this error is not detected and corrected by 
mismatch repair enzymes, the DNA subsequently replicated will contain a C$A point 
mutation. When 8-oxoG is inserted during DNA replication, it can generate double-strand 
breaks, very deleterious lesion (Cheng K. C. et al., 1992). The mutagenic and genotoxic 
Figura 8 The base pairing possibilities of 
8-oxoG (8oG). In an anti conformation it 
forms a Watson-Crick base pair with dCTP 
(a); by assuming a syn conformation, it can 
form a Hoogsteen base pair with dATP (b). 
(Wang Y. and Schlick T., 2006) 
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lesions are removed from DNA by mechanisms such as the base excision DNA repair (BER) 
and nucleotide excision repair (NER).  
 
Base excision repair (BER) 
Base excision repair (BER) is a highly conserved pathway from bacteria to humans and it is 
responsable of repairing the vast majority of endogenous DNA damage including alkylations, 
oxidations, deaminations and depurinations, as well as single-strand breaks (SSBs) (Krokan 
H. E. et al., 2013). Thus, the primary function of BER is to remove these frequently produced 
lesions and maintain genomic integrity. Oxygen radicals generate mostly non-bulky DNA 
lesions, most of them are substrates for Base Excision Repair (BER). The BER pathway 
engages various enzymes and proteins and involves the following major steps: (i) recognition 
and excision of an inappropriate base, (ii) incision at the resulting abasic site, (iii) replacement 
of the excised nucleotide, (iv) processing of the terminal end(s), and (v) sealing of the final 
nick (Wilson III D. M. et al., 2007). This repair system is iniziated by a lesion-specific DNA 
glycosylase (mono or bi-functional), which recognizes and hydrolyzes N-glycosidic bond 
(bond between the nucleotide base and ribose) of a substrate base, creating an apurinic or 
apyrimidinic (AP) site intermediate. DNA-glycosylases are the key enzymes of the BER 
pathway. We can distinguish monofunctional DNA glycosylases, such as uracil-DNA 
glycosylase (UNG) (it excises the uracil that is the product of cytosine deamination, thereby 
preventing the subsequent C$T point mutation) and N-methylpurine-DNA glycosylase 
(MPG) that possess only glycosylase activity, and bifunctional DNA glycosylases, such as 8-
oxoguanine DNA glycosylase (OGG1), mutY homolog (MUTYH), endonuclease III-like 1 
(NTH1) and NEIL1, exhibits both glycosylase activity and an intrinsic 3' AP lyase activity. 
This repair system may take place by “shortpatch” BER (also called “single-nucleotide 
BER”), in which a single nucleotide gap is generated and subsequently filled and ligated, or 
by long-patch BER in which a gap of 2–10 nucleotides is generated and filled. The short-
patch BER is generally the dominant pathway, long-patch BER may be the dominant 
mechanism of postreplicative BER initiated by UNG2 (Otterlei M. et al. 1999) or NEIL1 
(Hegde M. 5L. et al. 2008b), both expressed at highest levels during S phase. 
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In the short-patch BER AP sites in the DNA are repaired by the action of AP-endonuclease 1 
(APE1). APE1 cleaves the phosphodiester chain 5’ to the AP site. Then DNA strand contains 
a 3’-hydroxyl group and a 5’-abasic 
deoxyribose phosphate. DNA polymerase % 
(Pol%) fills in the gap with correct 
nucleotide and removes the deoxyribose 
phosphate through its associated AP-lyase 
activity. The presence of X-ray repair cross-
complementing group 1 (XRCC1) is 
necessary to form a heterodimer with DNA 
ligase III (LIG3). XRCC1 acts as a scaffold 
protein to present a non-reactive binding 
site for Pol%, and brings the Pol% and LIG3 
enzymes together at the site of repair 
(Lindahl T. and Wood R. D., 1999). 
Poly(ADP-ribose) polymerase (PARP-1) 
interacts with XRCC1 and Pol% and is a 
necessary component of the BER pathway 
(Caldecott K.W. et al., 1996; Dantzer F. et 
al., 2000). The final step of repairing is 
performed by LIG3, which connects the 
deoxyribose of the replacement nucleotide 
to the deoxyribosylphosphate backbone.In 
long-patch BER, APEX1 catalyzes the 
formation of a nick 5’ to the AP site, 
PCNA (proliferation cell nuclear antigen) 
acts as a scaffold protein for the 
recruitment of Pol& and Pol# that generate an oligonucleotide flap. The existing nucleotide 
sequence is removed by flap endonuclease-1 (FEN1). Then oligonucleotide is ligated to the 
DNA by DNA ligase I (LIG1), sealing the break and completing the repair (Fig. 9).!
The decision to proceed via the long-patch or shortpatch BER mechanism is poorly 
understood. Different hypotheses exist for the switch between long-patch and short-patch 
Figure 9 Scheme of base excision repair showing the 
two subpathways: (A) the 'short-patch' or single-
nucleotide pathway, and (B) the 'long-patch' pathway. 
Crossing over of the pathways can occur at points (3) and 
(9). There are essentially four steps in the base excision 
repair pathway. First, when an altered base is detected (1) 
the surveillance glycosylases remove that base (2). Next, 
the endonuclease that is specific for an apurinic or 
apyrimidinic site cleaves the strand on the 5' side of the 
abasic site (3). This is followed by filling in of the gap 
with a correct nucleotide by DNA pol %, and at the same 
time releasing the dRP (4). Finally, DNA ligase III 
ligates the newly introduced nucleotide with the 
downstream sequence (5), thereby restoring the repaired 
DNA (6). Sometimes, other DNA polymerases such as 
DNA polymerase & or #, along with PCNA, are involved 
in filling larger sized gaps, also in a strand-displacement 
manner (long-patch repair [B]; steps 7–12). (Rao K. S., 
2007). 
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BER. One hypothesis suggests that the switch from short-patch to longpatch BER depends on 
the relative ATP concentration near the AP site, which is modulated by LIG3 and X-ray 
cross-complementing protein 1 (XRCC1) (Petermann E. et al., 2003). It was shown that long-
patch BER neads low ATP concentrations, whereas short-patch BER prefers mechanism with 
elevated ATP concentrations. A second study has shown that the decision to proceed via long-
patch BER or short-patch BER can be traced by the 5’-dRP intermediate produced by AP 
endonuclease activity. It was shown that if this dRP can be efficiently removed by dRP lyase 
activity of POL%, BER proceeds by the short-patch mechanism. However, if the dRP can not 
be effectively removed BER pathway proceeds by the long-patch mechanism, not to generate 
a nick that is refractory to the action of a DNA ligase (Klungland, A. Et al., 1993). 
 
Nucleotide excision repair (NER) 
The nucleotide excision repair (NER) is the most flexible of all DNA repair mechanisms for 
its ability to resolve numerous DNA lesions, particularly base modifications that distort the 
normal helical structure of duplex DNA (Gillet L. C. et al., 2006). Examples of NER 
substrates include: cyclobutane pyrimidine dimers (CPDs) and pyrimidine-(6,4)-pyrimidone 
photoproducts (6-4PPs) generated by UV radiation; base adducts created by exogenous 
chemical agents such as cisplatin and benzopyrene; and reactive oxygen species (ROS)-
induced base modifications such as the 
cyclopurines (Fig. 10). These “bulky” 
DNA alterations arrest progression of 
replication and transcription, resulting 
replication fork collapse or stalled 
transcription, but in some 
circumstances can be bypassed in an 
error-prone manner. The NER response 
involves four primary steps: (i) 
recognition of the damage, (ii) incision 
on both sides of the lesion and removal 
of the damage-containing oligonucleotide 
fragment, (iii) gap-filling synthesis to 
restore a DNA duplex, and (iv) ligation 
Figura 10 Structure of NER substrates. Structures of the 
main NER substrate cyclobutane pyrimidine dimer and 
the more peculiar dG-acetylaminofluorene, (1,2)-dGG-
cisplatin and dG-benzopyrene adduct. (Alekseev S. 2014) 
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of the nick. The NER pathway involves the action of about 20-30 proteins operating in a 
coordinated manner. NER can recognize and remove the lesion through two sub-pathways 
mechanistically conserved from prokaryotic to eukaryotic cells: global genome repair (GG-
NER) removes lesions anywhere in the genome (Fagbemi A. F. et al., 2011) and transcription-
coupled NER (TC-NER), which removes lesions on the transcribed strand of DNA that block 
RNA polymerase (RNAP) progression (Diderich K. et al., 2011). These two pathways differ 
only at the step of recognition, but utilize common machinery to execute the final steps of the 
repair response (Fig. 11). Defects in NER are linked to genetic disorders characterized by 
extreme UV radiation sensitivity such as xeroderma pigmentosum (XP), Cockayne syndrome 
(CS) and a photosensitive form of trichothiodystrophy (TTD) (Kraemer K.H. et al., 2007). 
!
Figura 11 Nucleotide excision repair pathways. Two subpathways of mammalian NER: GG-NER and TC-NER. 
(i) XPC-RAD23B recognizes DNA damage-induced structural change as the initiation step of GG-NER. TC-
NER is initiated by stalling of an elongating RNAP at a blocking lesion on the transcribed strand within an active 
gene. After these initial recognition steps, GG-NER and TC-NER pathways involve many of the same protein 
components. (ii) Following recognition, the TFIIH complex is recruited. Through the activity of the helicase 
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subunits, XPB and XPD, TFIIH promotes opening of the DNA duplex around the lesion, facilitating recruitment 
of XPA and RPA. (iii) The XPF–ERCC1 complex is recruited to the lesion via a direct interaction with XPA, 
while XPG is specifically engaged through an interaction with TFIIH. The two endonucleases, XPF–ERCC1 and 
XPG, are responsible for carrying out incision 5'and 3', respectively, to the DNA damage. (iv) After dual incision 
and removal of the damage-containing oligonucleotide fragment, a DNA polymerase carries out gap-filling 
repair synthesis in cooperation with RFC and PCNA. (v) Finally, the nick is sealed by either XRCC1–LIG3! or a 
FEN1–LIG1 complex. CAK, the cyclin-dependent kinase (CDK)-activating kinase; GG-NER, global genome-
NER; RFC, replication factor C; RPA, replication protein A; TC-NER, transcription-coupled NER; TFIIH, 
transcription factor II H. (Iyama T. et al., 2013). 
 
The GG-NER removes helix-distorting “blocking” lesions located throughout the genome, 
presumably in a cell cycle-independent manner (Fagbemi A. F. et al., 2011). Two protein 
complexes XPC-RAD23B recognized a damage-induced structural change in DNA, binding 
the strand opposite the lesion and not the chemical adduct itself (Min J. H. et al., 2007; 
Scharer O.D. et al., 2007), after mediate the recruitment of the transcription factor II H 
(TFIIH) complex, which contains ten subunits, including two helicases XPB (3'-5') (Coin F. et 
al., 2007) and XPD (5'-3') (Mathieu N. et al., 2010; Sugasawa K. et al., 2009). Through its 
helicase activity TFIIH promotes opening of the DNA duplex around the lesion, creating a 
“bubble” platform for recruitment of XPA and replication protein A (RPA), and assembly of 
the pre-incision complex. XPA promotes the release the cyclin-dependent kinase (CDK)-
activating kinase (CAK) associated with TFIIH, and the association of RPA with the single 
stranded damaged DNA (Camenisch U. et al., 2009; Missura M. et al., 2001). The 
dissociation of CAK allows the recruitment of the XPF-excision repair cross complementing 
1 (ERCC1) complex and XPG, XPF–ERCC1 complex is recruited to the lesion via a direct 
interaction with XPA (Tsodikov O.V. et al., 2007; Orelli B. et al., 2010), while XPG is 
recruited through TFIIH. The two endonucleases XPF-ERCC1 and XPG carry out the incision 
5' and 3' to the DNA damage respectively, and an oligonucleotide of 24-32 nucleotide 
containing the lesion is excised. The single strand gap is filled by DNA polymerases &, # or ' 
in cooperation with replication factor C (RFC) and proliferating cellular nuclear antigen 
(PCNA). Finally, the nick is sealed in dividing cells by either a XRCC1-DNA ligase III 
(LIG3) or a flap endonuclease 1 (FEN1)–DNA ligase I (LIG1) complex (Mocquet V. et al., 
2008), or in non-dividing cells by XRCC1–LIG3! (Moser J. et al., 2007). 
In the transcribed strand of active genes lesions are preferentially repaired via TC-NER. In 
order to repair the damage, TC-NER uses many of the same protein components of GG-NER. 
Although this molecular mechanism is not yet known, the current model proposes that it is 
started by stalling of an elongating RNAP at a lesion on the transcribed strand. This arrested 
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RNAP serves as a critical signal via in which acts CS proteins, CSA and CSB, that facilitate 
the eventual removal of the damage and restart of transcription. After recruitment of the 
TFIIH complex the helicases XPB and XPD unwind DNA helix and after the same protein 
machinery described for GGNER is presumably called upon for incision, excision of the 
lesion containing strand, gap-filling and nick ligation. The fundamental role of transcriptional 
factor TFIIH in these repair mechanisms underlines a direct biochemical link between 
transcription and DNA repair. For example, transcriptional activators (such as Gal4–VP16 
and RAR) can stimulate DNA repair (Frit P. et al., 2002). Conversely, a DNA repair complex 
(that contains XPC) seems also to function as a co-activator for OCT4 (octamer-binding 
protein 4). Finally, NER factors are recruited to active promoters and facilitate chromatin 
modification to regulate transcription in the absence of exogenous genotoxic attack (Le May 
N. et al., 2010) . Indeed, NER factors seem to be associated with the transcription machinery 
at the promoters of several activated nuclear receptor-dependent genes. The recruitment 
occurs in a sequential order following PIC assembly and it is distinct from the order that is 
required for a repair complex. Although NER factors are not essential for PIC formation, it is 
likely that NER components optimize the efficiency of transcription influencing chromatin 
remodelling (Compe E. & Egly J., 2012).!
 
DNA damage: double strand break (DSB) 
The double strand breaks (DSBs)! are one of the most deleterious forms of DNA damage. 
These lesions are generated when the two complementary strands of the DNA double helix 
are broken simultaneously in neighboring sites (resulting in physical cleavage of the DNA 
backbone) so the coupling of the bases and the structure of chromatin become insufficient to 
maintain the ends of the juxtaposed DNA. Dissociated ends can recombine with other 
genomic sites leading to mutations and chromosomal aberrations. DSBs can cause problems 
for DNA transcription, replication and chromosome segregation and it may result in genomic 
instability, such as translocations, if misrepaired (Bohgaki T. et al., 2010). They can arise 
endogenously through the action of ROS that are produced by normal cellular metabolism, or 
through replication-fork collapse, during the processing of interstrand crosslinks, or following 
exposure to IR (radiation ionizing). The machinery involved in repair of these lesions must be 
able to (i) detect DNA damage in different chromatin structures; (ii) remodel the local 
chromatin architecture to provide access to the site of damage; (iii) reorganize the 
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nucleosome-DNA template for processing and repair of the damage; and, importantly, (iv) 
restore the local chromatin organization after repair has been completed (Brendan D. et al., 
2013).!Eukaryotic cells have complex systems that detect and signal the presence of these 
lesions. The double strand break repair (DSBR) is divided into two major pathways: 
homologous recombination (HR) and non-homologous end joining (NHEJ). HR operates in 
dividing cells and in S phase or G2 phase, when the double-strand breaks are repaired using 
the long regions of homology (> 100bp) available from sister chromatids during separation; 
whereas NHEJ can function in both dividing and non-dividing cells and independently of cell 
cycle.!
 
Homologous recombination (HR) 
During the HR, the damaged chromosome forms a pairing complex with a not damaged DNA 
molecule with which it shares the homologous sequence. Under these conditions the lost 
genetic information on one allele can be recovered on the other, wich remained intact. The 
enzymatic machinery responsible for this process is identical to the crossing-over one during 
meiosis. The steps of the repair by homologous recombination are: 1. processing of the ends 
to single strand; 2. homology pairing; 3. copying the information from the non-damaged 
strand; 4. resolution of the complex and reconstitution of the double helix. 
Homologous recombination starts with the recognition of the DSB by the MRN complex, 
(MRE11, RAD50, NBS1) which initiates 5'-3' end resections to create the 3' ssDNA overhang 
(Stracker T. H. et al., 2011) Further resection is carried out by exonuclease EXO1, and the 
resulting ssDNA is stabilized by binding of RPA. Subsequently, RAD52 promotes 
replacement of RPA with Rad51, leading to the formation of Rad51 nucleoprotein filaments. 
In this process BRC2 has a key role because stimulates the assembly of RAD51 onto the 
RPA-ssDNA complex (Jesen R. B. et al., 2010) RAD51-coated ssDNA moves into (invades) 
the similar or identical recipient DNA duplex in a process called strand invasion, which 
provides the genetic instruction for accurate repair, thus formed a displacement-loop (D-loop) 
(structure formed between the invading 3' overhang strand and the homologous chromosome). 
After the invasion, the DNA strand is extended by polymerase (Pol () and so the D-loop is 
changed to a cross-shaped structure known as a Holliday junction; alternative model, 
designated the synthesis-dependent strand annealing (SDSA) pathway, completes DSBR via 
non crossover products, without Holliday junction formation (Fig. 12)!
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The nonhomologous end joining recombination (NHEJ) is the major DSBR system in higher 
eukaryotes (Lieber M. R., 2010) particularly during phases of the cell cycle when a 
homologous sister chromatid is absent; it can operate during all phases of the cell cycle, but it 
is most active during G1. This mechanism brings the direct ligation of two DNA ends in close 
spatial proximity, it often results in an error-prone outcome, with partial loss of genome 
information at the site of the 
DSB. NHEJ provides three 
steps: (i) recognition of the 
two-ended DSB, (ii) 
processing to remove non-
linked termini or other forms 
of DNA damage near the 
break and to reveal short 
stretches of microhomology, 
and (iii) joining of two ends. 
The process starts when 
Ku70/Ku80 (Ku) 
heterodimer binds the two DSB ends and recruits the DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs). This multiprotein complex both stabilizes and aligns the DNA ends 
(Getts R. C. et al., 1994). The 
interaction between two 
DNA-PKcs positioned at 
each DSB terminus activates 
its intrinsic protein kinase 
activity, bringing to DNA-
PKcs autophosphorylation and dissociation. Depending on the complexity of the DSB and the 
nature of the ends, different processing factors are then recruited. In one example, DNA-PKcs 
activates the endonuclease, Artemis, which cuts the 3' and 5' single-stranded overhangs at the 
DNA ends to reveal complementary nucleotide stretches . After generation of terminal 
overhangs by Artemis, and prior to ligation, PNKP is recruited via an interaction with the 
XRCC4–Ligase IV (LIG4) protein complex to remove 3'-P groups or add 5'-P residues (Koch 
C. A. et al., 2004). In instances where short nucleotide gaps remain after microhomology 
Figura 12!DSB repair pathway. The 5’-3’ exonuclease activity of MRN 
complex creates strand invasion and ATM phosphorylation on each side 
of the break. RPA assists the assembly of RAD51-B to D, and XRCC2 
and XRCC3. RAD52 stimulates filament assembly while RAD54 
identifies the homologous sequence. Finally, the resolution of Holliday 
junctions is completed by resolvases and DNA ligases. NHEJ, Ku and its 
subunits Ku70(XRCC6) and Ku80(XRCC5) bind the broken DNA 
termini, recruiting PKcs and Artemis. XRCC4 allows the Ligase IV 
along with XLF/Cernunos factor, APLF, WRN, PNK, and Polµ to bind 
DNA and ligate both DSB ends. (Peg G. et al., 2011)  
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mediated annealing, DNA polymerases µ and ) function to fill in the small gap segments 
(Andrade P. et al., 2009). Finally, once appropriate termini have been generated, XLF-
Cernunnos (XLF) can interact with the XRCC4–LIG4 complex to stimulate end joining, the 
final step of the repair process (Fig. 12).  
 
Mismatch repair (MMR) 
The architecture of the MMR pathway is well conserved from bacteria to mammals. This 
system recognizes and repairs base-base mismatches and insertion–deletion loops (IDLs) that 
arises primarily as errors or intermediates of DNA replication or homologous recombination. 
This system is very important for the cell in fact leads to an !100-fold increase in DNA 
replication fidelity by preventing base substitutions or repeat sequence instability. To preserve 
genome integrity, MMR must occur selectively on the new synthesized DNA strand that 
contains the mispaired nucleotide. Thus, it is critical to discriminate between the nascent and 
template DNA strands. In prokaryotes, the E. coli endonuclease, MutH, recognizes the new 
synthesized strand by its unmethylated status. In eukaryotic cells this does not appear to be 
the mechanism of strand discrimination. Study reveals that the MMR machinery is associated 
with the replication apparatus, proposing that the 5' ends of existing Okazaki fragments serve 
as markers for strand discrimination. MMR pathway has been extensively studied in E.coli., it 
requires the following protein components: MutS, MutL, MutH, DNA helicase II 
(MutU/UvrD), four exonucleases (ExoI, ExoVII, ExoX, and RecJ), single stranded DNA 
binding protein (SSB), DNA polymerase III holoenzyme, and DNA ligase (Burdett V. et al., 
2001) MutS, MutL, and MutH initiate MMR and play specialized biological roles in the 
process. MutS homodimer recognizes base-base mismatches and small nucleotide 
insertion/deletion (ID) mispairs (Modrich P. et al., 1996) and recruits MutL. MutL enhances 
mismatch recognition, and recruits and activates (in presence of ATP) the endonuclease 
activity of MutH. MutH specifically incises the unmethylated daughter strand of 
hemimethylated sequence dGATC (Junop M.S. et al., 2001) and this strand-specific nick 
provides a starting point for excision of the mispaired base. The UvrD helicase unwinds the 
ends of the nicked error-containing strand from the template and it generates single-strand 
DNA until mismatch that is removed through exonucleolytic degradation.!
In eukaryotes enzymes of MMR have a high homology to E.coli MMR proteins E. coli. In 
human cells, it was been identified five MutS homologues (MSH) but only MSH2, MSH3 and 
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MSH6 participate in MMR in the form of heterodimers. The most abundant mismatch-
binding factor is MutS! that initiates the repair of base–base mismatches and IDLs of one or 
two extrahelical nucleotides, whereas the repair of larger IDLs is initiated by MutS%. MutS 
!/% recognizes the damage and recruits MutL!.!hMutL! possesses an ATPase activity and 
regulates termination of mismatch-provoked excision (Zhang Y. et al., 2005). Recent studies 
show that MutL! possesses a PCNA/replication factor C (RFC)-dependent endonuclease 
activity which plays a critical role in 3* nick-directed MMR involving EXO1 (Kadyrov F. A. 
et al., 2006). PCNA interacts with MSH2 and MLH1 and it is thought to play roles in the 
initiation and DNA resynthesis steps of MMR (Gu L. Et al., 1998) in fact during DNA 
replication, PCNA sliding clamp is loaded onto the 3* terminus of an Okazaki fragment or 
onto the 3* end of the leading strand by replication factor C (RFC), it coordinates Exo1 to 
excise the to excise the mismatch from the nascent strand, generating a multinucleotide gap. 
The removed DNA segment is then resynthesized by polymerase & and the nicked sealed by 
LIG1 (Larrea A. A. et al., 2010). 
 
Transcription 
In eukaryotes gene expression is a highly complex and regulated process. The first level of 
complexity encountered by the cellular transcriptional machinery is the organization of the 
genome into chromatin. The dynamic interactions of different cellular factors such as histone 
modifying enzymes, ATP-dependent remodelers and histone chaperones with the chromatin 
components facilitate gene expression.  
Transcription is the process by the information in DNA is copied into RNA. It is performed 
by RNA polymerase. In the nucleus of eukaryotes, transcription is carried out by three 
different RNA polymerases, RNA polymerase I, II and III (Pol I, II and III) that transcribe 
distinct classes of genes: Pol I is responsible for the transcription of the large ribosomal RNA 
genes (28S, 18S and 5.8S), Pol II for the transcription of the protein-coding genes and some 
small nuclear RNAs and Pol III transcribes some structural and catalytic RNAs, including 
most small nuclear RNAs, tRNAs and 5S rRNA (Sentenac A., 1985). All three nuclear RNA 
polymerases are complex enzymes, consisting of 8 to 14 different subunits each. Eukaryotic 
transcription is a sequence of event that exhibits regulation at multiple steps. It has three main 
steps: initiation, elongation and termination. Initiation consists in the binding of RNA 
polymerase to double-stranded DNA; this step involves a transition to single-strandedness in 
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the region of binding; in particular this process starts when an activator binds a DNA specific 
sequence (enhancer DNA elements) which promotes before a sequential recruitment of 
general transcription factors (GTFs) and after RNA polymerase II (RNAPII) to the target gene 
promoters ( Thomas M. C. et al., 2006). In many eukaryotic organisms, the promoter contains 
a conserved gene sequence called the TATA box. Various other consensus sequences also 
exist and are recognized by the different TF families. The TATAA sequence is recognized by 
a general transcription factor called TFIID. TFIID is composed by multiple subunits, 
including the TATA-binding protein (TBP), which binds and distorts specifically to the 
TATAA consensus sequence, and 10-12 other polypeptides, called TBP-associated factors 
(TAFs). TBP then binds a second general transcription factor (TFIIB) forming a TBP-TFIIB 
complex at the promoter. TFIIB in turn serves as a bridge to RNA polymerase, which binds to 
TBP-TFIIB complex in association with a third factor, TFIIF. Following recruitment of RNA 
polymerase II to the promoter, the binding of two additional factors (TFIIE and TFIIH) is 
required for initiation of transcription (Fig. 13A). TFIIH is a multisubunit factor that appears 
to play at least two important roles. First, two subunits of TFIIH are helicases, which may 
unwind DNA around the initiation site. Another subunit of TFIIH is a protein kinase that 
phosphorylates Ser5 residue of the repeated sequences present in the C-terminal domain 
(CTD) of the largest subunit of RNA polymerase II in particular. Phosphorylation of these 
sequences is very important because permits the transition from abortive to productive 
transcription initiation (Fig. 13B). After the formation of PIC at the gene promoter the RNA 
polII is stalled on promoter regions, in this condition it produces transcripts of less than 5 
nucleotides that resulting in abortive initiation. In order to create a condition for productive 
transcription initiation, specific post-translational modifications are required on the C-
Terminal domain (CTD) of RNAPII and N-terminal histone tails of the nucleosome. To 
increase chromatin accessibility, gene-specific activators mediate the recruitment of histone 
modifying enzymes such as lysine acetyltransferases (KAT), acetyltransferases such as p300, 
CBP and PCAF that add acetyl-groups to several residues of histones H3 (K9, K14) and H4 
(K16), lysine acetyltransferases (KAT), lysine/arginine methyltransferases, histone 
demethylases and kinases to the chromatin which work together with nucleosome remodelers 
to reorganize the chromatin architecture. On the other hand the CTD of RNA polII is subject 
to a switch of post-translational modification (there is an increase of phosphorylation status of 
Ser2 and gradual loss of Ser5 phosphorylation of the CTD repeats) through the positive 
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transcription elongation factor, P-TEFb, that plays crucial role to facilitate the entry of RNA 
polymerase II into the transcription elongation. After these events Pol II leaves the promoter, 
TFIIB and TFIIF are released, whereas other factors such as activators, TBP, Mediator, TFIIH 
and TFIIE remain largely promoter-associated and form what is termed a reinitiation 
intermediate or scaffold, to facilitate subsequent rounds of transcription (Yudkovsky N. et al., 
2000).!The elongating RNAPII recruits several factors which regulate the rate of transcription. 
The processivity of transcription is facilitated by elongation factors such as TFIIS and Spt5 as 
well as the histone chaperone complex, FACT. One of the key epigenetic marks associated 
with elongation is methylation of histone H3 at K36 by the methyltransferase SET2. Another 
modification of histones associated with elongation is H2B mono-ubiquitination, which is 
present at both promoters and within the open reading frame (ORF) (Li B. et al., 2007; Fuda 
N. J. et al., 2009). The remarkable processivity of RNAPII requires that the transcription 
elongation complexes maintain stable association of RNAPII with the DNA since any event 
of disengagement from the template will result in abrupt transcription termination. A stretch 
of 8–9 bp nascent RNA remains bound to the template DNA during transcript elongation. The 
maintenance of RNA:DNA hybrid is a critical determinant for the processivity of RNAPII 
during transcription elongation and any disruption of this heteroduplex may result in 
premature termination of transcription (Fig. 13C).!
The dissociation of RNA polII from the DNA template marks the end of a transcription cycle. 
Termination is the last step in the series of regulates events required for gene transcription; 
this event may also serve to promote subsequent round a of transcription. Transcription 
termination occurs through the poly A-dependent pathway; during this process RNA polII 
transcribes the Poly_A signal, 5*-AAUAAA-3* which is followed by a G/U-rich sequence 
towards the 3* end, that reduce its processivity and leads to its pausing further downstream. 
After that, endoribonucleolytic cleavage of the nascent transcript occurs in polyadenylation 
sequence. In humans, there are different protein complexes that facilitate the key events of 
transcription termination, which include the cleavage and polyadenylation specificity factor 
(CPSF), the cleavage stimulatory factor (CstF) and Poly (A) polymerase (Kuehner J. N. et al., 
2009). The subunit Rpb1 of RNAPII acts as a scaffold for the recruitment of these termination 
complexes. The Ser2-phosphorylated CTD of RNAPII plays a key role in both 3* processing 
and transcription termination (Ahn S. H. et al., 2004). Both CPSF and CstF complexes are 
recruited to this phosphorylated residues. The CPSF complex binds to the transcribed poly 
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(A) site on the pre-mRNA, induces RNAPII pausing, and eventually stimulates cleavage and 
release of RNAPII at the gene terminus ( Nag A. et al., 2007) (Fig. 13D).  
!
Figura 13 The transcription cycle. (A). Depending on the transcriptional competence of RNAPII, it can 
potentially enter a paused state. Presence of negative factors such as NELF and DSIF inhibits productive 
transcription initiation resulting in abortive transcription. Nucleosomes flanking such a paused promoter are 
characterized by the presence of a bivalent 
histone mark: methylation of histone H3 at lysines 4 and 27 (H3K4/27). Paused RNAPII is also enriched with 
phosphor Ser7 mark (orange balloon) at its C-terminal domain (CTD). The kinase activity of the CDK9 subunit 
of the pTEFb complex alleviates this repression via phosphorylation of NELF and DSIF which results in 
dissociation of phosphorylated NELF from RNAPII, while DSIF may move along with the elongating RNAPII. 
(B). RNAPII can switch to productive initiation mode when all the inhibitory signals/factors are overcome. 
The nucleosomes flanking the active promoters harbor the histone marks for active transcription. Active 
initiation is dependent on TFIIH-mediated promoter melting (red bubble) and phosphorylation of the CTD 
repeats at serine 5 (green balloon). Along with the phosphorylation of Ser5-CTD, productive transcription 
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initiation also requires the phosphorylation of TFIIB at serine 65. The phospho-Ser5-CTD recruits capping 
enzyme to the 5* region of nascent mRNA (green string) which triggers RNAPII-escape from the promoter to the 
open reading frame (ORF) of the gene. (C). Following promoter clearance, RNAPII proceeds for elongating the 
transcript while a part of the PIC components remains associated at the promoter forming a reinitiation 
scaffold.Meanwhile, GTFs such as TFIIB, TFIIF and likely TFIIE fall off. The elongating RNAPII CTD repeat 
is progressively phosphorylated at serine 2 by cyclin-dependent kinase 9 (CDK9), while the SSU72 phosphatase 
removes the phospho-Ser5 mark. Phospho-Ser2-CTD (purple balloon) recruits mRNA splicing complex for co-
transcriptional splicing of nascentmRNA. The nucleosomes occupying the ORF are enrichedwithmethylation of 
histone H3 at lysine 36which is a mark of active elongation (D). Once the RNAPII reaches a pause signal (poly 
A) at the gene terminal, 3* end processing and termination specific complexes such as CPSF and CstF are 
recruited. The CTD repeat is hyperphosphorylated at serine 2 at the gene terminus. Phospho-Ser7 (orange 
balloon) regulates the termination of snRNA genes by recruiting the Integrator complex. The region already 
transcribed by RNAPII is efficiently reassembled into chromatin with the aid of histone chaperones and 
deacetylases (HDACs). (Shandilya J. and Roberts S. G., 2012) 
 
This mechanism of transcript termination is a general norm for most RNAPII transcribed 
protein-coding genes.!
Transcription by RNA polymerase II is coupled to RNA processing, including capping, 
splicing and cleavage/ polyadenylation. The C-terminal repeat (CTD) of RNA pol II 
orchestrates both processes by recruiting RNA processing factors. Indeed, CTD directly binds 
polyadenylation factors and its truncation inhibits transcript cleavage in vivo. Ssu72 is a 
phosphatase protein that catalyzes the dephosphorylation of the C-terminal domain of RNA 
polymerase II. Genetic and physical interactions between Ssu72 and RNAP II have been 
demonstrated and it has been hypothesized a role for Ssu72 in basal (noninduced) 
transcription by RNAP II (Pappas D. L. Jr & Hampsey M., 2000). Ssu72 was initially 
identified in a screen for suppressors of sua7-1, a cold-sensitive mutation in yeast TFIIB, 
hence Ssu72 (Suppressor of sua7-1 clone 2). Recent analysis revealed that Ssu72 
dephosphorylates Ser-5 in the CTD of RNA pol II and regenerates initiation competent hypo-
phosphorylated RNA pol II (Krishnamurthy S. et al., 2004). Large-scale analysis of protein 
complexes in yeast identified Ssu72 as a component of a cleavage and polyadenylation factor 
(CPF) complex, it interacts directly with the Pta1 subunit of CPF and is implicated in 
transcript cleavage and termination (Dichtl B. et al., 2002). Alternatively, Ssu72 may exert 
two independent functions: transcription/RNA processing in the nucleus and as yet to be 
defined activity in the cytoplasm. Interestingly, there are no apparent Ssu72 homologs in 
bacterial or archaeal genomes, implying that Ssu72 function is specific for eukaryotes.!
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Transcription is a cyclic process in which a same sequence can be transcribed more times. 
Some studies revealed that the terminal and promoter regions of active genes can interact via 
a phenomenon known as gene looping (Fig. 14). In yeast and humans, transcription initiation 
factor TFIIB is known to interact with the cleavage and polyadenylation factor (yCPF and 
hCPSF) and CstF complexes; this 
association with termination-specific 
complexes is regulated by the 
phosphorylation status in fact, the 
phosphorylation of TFIIB at Ser65 not 
only helps productive transcription 
initiation, but also facilitates gene looping 
via through its interaction with CstF 
components (Wang Y. et al., 2010). Also 
TFIIH kinase subunit (CDK7) have a 
crucial role in the formation of gene 
looping, in fact CDK7 is the major kinase 
involved in phosphorylation of Ser5 and 
Ser7 residues of RNAPII; in addition 
TFIIH may be involved in reinforcing the 
promoter–terminator contacts for active RNAPII recycling. Another promising candidate for 
facilitating gene loop formation is human positive cofactor 4 (PC4), a multifunctional protein 
involved in transcriptional regulation (Banerjee S. et al., 2004).  
Chromatin state can limit access of transcription factors and RNA polymerase to DNA 
promoters, contributing to the restrictive ground state of gene expression. In order for gene 
transcription to occur, the chromatin structure must be unwound the chromatin structure and 
the presence of specific transcription factors there are other control activities in the cell, such 
as epigenetic mechanisms, including DNA methylation and imprinting, noncoding RNA and 
histone post-translational modifications (Phillips T., 2008). 
"#$%&'! ()! Transcription recycling via gene looping. The 
terminator and promoter regions of a gene juxtapose 
during active transcription in order to facilitate RNAPII 
recycling and multiple rounds of transcription. The 
prebound GTFs and mediator in the reinitiation scaffold 
stabilized by the activator along with phospho-TFIIB 
interact with RNAPII and the termination complexes such 
as CPSF, CstF, and mediate such promoter–terminator 
contacts known as gene looping and thereby increase the 
efficiency of reinitiation by RNAPII. (Shandilya J. and 
Roberts S. G., 2012) 
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The maintenance of the genome integrity and its accurate replication are prerequisites for life. 
The processing of genetic information by transcription, which include RNA templates for 
protein synthesis and regulatory information to coordinate a chemical reactions, is crucial for 
cell function and survival. These processes can be threatened by alterations in the DNA 
structure that interfere with the progression of DNA and RNA polymerases, or compromise 
the fidelity of replication and transcription. The perturbation of genome integrity can be 
induced by DNA damage. Damage to DNA arises from the exposition to exogenous 
genotoxic agents such as ionizing radiation, ultraviolet radiation (UV) or environmental 
toxins; or for endogenous sources, such as reactive oxygen species (byproduct of cellular 
metabolism) or errors during DNA replication. These events can generate DNA lesions, 
including modified bases, abasic sites, the formation of DNA adducts, the production of 
single- (SSBs) and double-strand breaks (DSBs) (Lindahl T. et al., 1993). 
The cellular ‘toolbox’ of responses to genomic stress includes checkpoints that result in 
arrested cell cycle progression, stabilization of DNA at blocked replication forks and 
recruitment of DNA repair enzymes, to facilitate progression of DNA and RNA synthesis. 
(Harper J. W et al., 2007; Ljungman M., 2005). DNA lesions can lead to a prolonged 
transcription arrest followed by a strong signal for cellular apoptosis. For some types of 
lesions, the RNAPII might be able to carry out translesion transcription but with 
transcriptional mutagenesis. 
Cells have evolved multiple, often overlapping mechanisms to sense and demarcate the DNA 
lesions, the four major pathways are: base excision repair (BER), nucleotide excision repair 
(NER), mismatch repair (MMR) and recombinational repair. Transcription and DNA repair 
have the same action target: the DNA; therefore it is not surprising that these two processes 
are often coupled, interdependent and crossfunctional. A connection between transcription 
and repair was first suggested by experiments showing that transcribed strands of DNA are 
repaired more rapidly than not transcribed strands in both E. coli and mammalian cells 
(Mellon I. et al., 1987), so transcription complex and DNA repair system are biochemical 
linked. Since DNA damage blocks transcription, this transcription-repair coupling is thought 
to be advantageous by allowing the cell to preferentially repair damage to actively expressed 
genes.  
NER factors seem to be associated with the transcription machinery at the promoters of 
several activated nuclear receptor-dependent genes. The recruitment occurs in a sequential 
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order following PIC assembly and is distinct from the order that is required for a repair 
complex. Although NER factors are not essential for PIC formation, it is likely that NER 
components optimize the efficiency of transcription influencing chromatin remodelling 
(Compe E. et Egly J., 2012). An evidence of this biochemical connection is given by the 
multi-protein complex transcription initiation factor TFIIH. TFIIH is indispensable during 
basal transcription, but it has a crucial role in NER, in fact the XPB and XPD helicases 
associated with it are required to initiate the transcription of eukaryotic genes; but these 
helicases appear to be required for the unwinding of DNA during nucleotide-excision repair 
and the correct repair of lesion. 
Active DNA demethylation play a key role in transcriptional control and resetting of 
epigenetic memory during embryonic development and cellular reprogramming (Wu S, C. et 
Zhang Y., 2010). There are multiple mechanisms by which 5-methylcytosine (5mC) is 
removed, the common endpoint is the excision of the deaminated and/or oxidized derivatives 
of 5mC by the BER enzyme thymine DNA glycosylase (TDG) (Cortazar et al., 2007; 
Franchini et al., 2012). Dynamic DNA demethylation occurs at promoters and enhancer of 
genes in mouse ESCs; TDG depletion compromised the reactivation of poised genes during 
ESC differentiation and embryogenesis, it underline the crucial role of DNA glycosylase in 
embryogenesis. 
Independent of its catalytic activity, TDG acts as a scaffold to bridge the transcriptional 
coactivator CBP/p300 to transcription factors like c-JUN, RAR/RXR (Cortellino et al., 2011; 
Um et al., 1998), and estrogen receptor ! (ER!) (Chen et al., 2003) to facilitate histone 
modification. 
Transcription process exposes the DNA template to damage by genotoxic agents and 
generates potentially harmful DNA structures that are prone to mutagenesis and 
recombination; in fact it requires the separation of the two strands of a DNA double helix by 
RNA polymerase II (RNAPII), so single-stranded regions can be exposed to chemical 
modifications such as the deamination of cytosine that if not repaired by BER could lead to C-
to-T substitution (Conticello, 2008). 
In addition to nucleotide substitutions, ssDNA regions are prone to recombination as well as 
the formation of local secondary structures (e.g., hairpins and loops) formed at DNA sequence 
repeats (Kim & Jinks-Robertson, 2012) and the harmful duplex DNA-RNA, formed when 
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nascent messenger RNA hybridizes with template DNA, particularly prone to mutagenesis 
and recombination (Aguilera & Garcia-muse, 2012). 
In the genes actively expressed spontaneous rates of mutagenesis and recombination events 
lead phenomena known as transcriptional-associated mutation (TAM) and transcription-
associated recombination (TAR).  
While global DNA damage is generally associated with gene silencing, DSB formation and 
localized DNA base damage are implicated in transcriptional activation by nuclear hormone 
receptors such as estrogen receptor (Perillo B. et al., 2008). The hormone 17%-estradiol (E2) 
regulates transcription of target genes by binding to estrogen receptors (ER! and ER%), which 
then bind with high affinity to estrogen-responsive DNA elements (EREs). After hormone 
activation, ER! interacts with transcription co-activators that covalently modify histone 
proteins within nucleosomes, in particular it recruits and binds LSD1, flavin-dependent 
monoamine oxidase, which can demethylate lysines 4 and 9 mono- and di-methylated of 
histone 3 in via redox process. Demethylation by LSD1 is an oxidative process that results in 
the production of reactive oxygen species (ROS) in particular hydrogen peroxide (H2O2) 
responsible of a burst of DNA oxidation, specifically this process can lead the oxidation of 
Guanine to produces 8-oxoGuanine (8-oxo-dG). 
DNA oxidation involves not only G but also C. In fact C can be oxidized only when 
methylated in vivo. It has been reported that estrogens induce cycles of the CpG 
methylation/idroximethylation of cytosine which is settled on the opposite strand by the DNA 
methyltransferase enzyme (Metivier et al., 2003), DNMT3a and TET1. These modified bases 
are removed by repair system such as base excision repair (BER) and nucleotide excision 
repair (NER), that generate a transient DNA nick, relax chromatin tensions and it allows the 
physical connections between distant intergenic regions and so induces a permissive 
chromatin architecture for transcriptional activation. DNA damage can have opposite effects 
on transcription, infact exist a mechanism enable to distinguish between DNA damage event 
linked to gene activation from those that cause undesirable consequences. 
If damage is primarily induced which is the destiny of transcriptional unit after repair? 
DSBs are produced when cells are exposed to DNA damaging agents including ionizing 
radiation (IR), chemical agents and UV light that create replication blocking lesions (alkyl 
adducts, pyrimidine dimers, and crosslinks), they can be also generated naturally when 
replication forks encounter blocking lesions such as those produced by metabolic byproducts 
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of cellular respiration (ROS) leading to fork collapse. Eukaryotic cells repair DSBs primarily 
by two mechanisms: nonhomologous end-joining (NHEJ) and homologous recombination 
(HR). DSBs produced by nucleases and IR, can be repaired by either pathway while DSBs 
produced by replication fork collapse are repaired primarily (or exclusively) by HR (Shen Z. 
et al., 2007). 
Mutants in the Saccharomyces cerevisiae RAD52 epistasis group display hypersensitivity to 
ionizing radiation and are defective in DSB repair through homologous recombination 
(Nicholas, 1998), in addition the depletion of RAD54 in mice dramatically aggravates the 
ionizing radiation sensitivity, at the embryonic and not adult stage, of severe combined 
immune deficiency that are impaired in DNA double-strand break repair through DNA end-
joining (Essers J. et al., 2000). A common feature of cellular response to DNA damage 
induced by UV, X-ray irradiation or genotoxic drugs is hyperphosphorilation of CTD of Rpb1 
subunit of RNA polymerase II (Rpb1-CTD). Rpb1-CTDis the docking site for a factors that 
interact with it and induce its phosphorylation/dephosphorylation at Ser/Thr residues, regulate 
its activity and transcription progression along the gene. P-TEFb is one of the kinases that are 
involved in the regulation of RNA polymerase II through the phosphorilation of CTD tail; it 
activity is regulated by a dynamic equilibrium between small active complex and large 
inactive complex, the equilibrium between this complexes can be perturbed by transcription 
arrest. Site-specific DSBs trigger disruption of the P-TEFb LC leading to accumulation of 
active SC P-TEFb, as consequence Rpb1-CTD is hyperphosphorylated as consequence there 
are the activation of the p53-dependent transcriptional pathway and cell cycle arrest in G2/M 
phase (Napolitano G. et al., 2013). 
The exposure of ER!-expressing breast cancer cells to E2 induces +H2AX foci, which are 
markers of DNA DSBs; +H2AX foci require ER!, transcription and the catalytic activity of 
topoII% and occur at the promoter of the E2 inducible gene PS2. Furthermore, E2-induced 
+H2AX foci only appear following progression through S phase and colocalize with Rad51, 
suggesting that HRR is utilized for repair of E2-induced DSBs. Transient DSBs generated at 
ER!-responsive genes as a result of the activity of topoII% can become stabilized and that the 
topoII% cleavage complex can create a barrier to DNA replication and lead to replication 
stress and DSB formation (Williamson L. M. et al., 2010). 
 Based on this background I can introduced the aim of my project targeted to the study of 
relationships between transcription, chromatin remodeling and DNA repair mechanisms used 
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three different models: (i) Gene expression regulated by nuclear receptors, (ii) Damage and 
direct site repair, (iii) Human primary cell lines in differentiation (CD4+ T lymphocyte). In 
particular I analyzed: 
(i) The molecular mechanisms involved in the transcription of genes regulated by 
nuclear receptors (retinoic and estrogen receptor) in “committed” cellular 
model for the expression of these receptors: MCF7. To identify the link 
between transcription, post-translational modifications of histone H3 and 
genomic damage. I focused my attention on: a) methylation profiles of lysines 
4 (K4) and 9 (K9) in histone H3 after hormonal stimulation; b) recruitment of 
demethylating enzymes, LSD1 (KDM1A) and JMJD2A (KDM4A) in 
association with the enzymes of repair systems BER, NER, DNMT3A, TET1; 
c) the role of these enzymes in 3D organization of genes PS2, BCL2, CAV1, 
CASP9 and CYP26 in the early phase of transcriptional activation; d) the 
kinetics oxidation/repair of oxidative damage upon strand plus and strand 
minus (in PS2 gene). 
(ii) The molecular mechanisms involved in DNA damage repair, the link between 
DNA damage and gene silencing in a pioneer model of DSB and repair with 
homologous recombination (HR). In particular my studies focused on a) the 
relationship between DNA methylation of repair site and changes of chromatin 
methylation; b) the link between de novo methylation at the site of DSB repair 
and chromatin looping; c) the connection among the recruitment enzymes of 
repair systems (BER) and DNA methylation after HR. 
(iii) The relationship between chromatin remodeling of FOXP3 gene and 
immunophenotypic differentiation of human primary CD4+ T lymphocytes; I 
have study a) the formation of intergenic interaction and the histone code of  
FOXP3 gene during activation in vitro of nTreg (CD4+CD25+ T cells) and 
Tconv; b) FOXP3 splicing variants that induce suppressive function of iTreg 
cells tightly depended on glycolysis; c) the role of glycolytic enzyme enolase 
(ENO1) in the modulation of FOXP3 splicing variants expression. 
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Nuclear hormone receptors are ligand-activated transcription factors that bind lipophilic 
molecules and regulate gene expression by interacting with specific DNA sequences of their 
target genes. Nuclear receptor ligands are chemically diverse, including hydrophobic 
molecules such as steroid hormones (e.g. estrogens, glucocorticoids, progesterone, 
mineralocorticoids, androgens, vitamin D3, ecdysone, oxysterols and bile acids), retinoic 
acids, thyroid hormones. The receptor linked to the specific ligand binds as homodimer or 
heterodimer specific hormone response elements (HRE), which are located in the enhancer 
region of the gene promoter/regulatory regions promoting transcriptional activation. 
I focused my attention on the study of transcriptional activation of genes regulated by retinoic 
and estrogen receptor. I have studied the effect of activation of the retinoic acid receptor, at 
the RARE-promoter chromatin of CASP9 and CYP26A1 genes, at 15 and 45 min following 
RA exposure, and we found that histone H3 lysine 4 and 9 are demethylated by the lysine 
specific demethylase, LSD1 and by the JMJ-domain containing demethylase, D2A. The 
action of the oxidase (LSD1) and a dioxygenase (JMJD2A) in the presence of Fe++ elicits an 
oxidation wave that modifies the DNA locally and recruits the enzymes involved in base and 
nucleotide excision repair (BER and NER). These events are essential for the formation of 
chromatin loop(s) that juxtapose the RARE element with the 5' transcription start site and the 
3' end of the genes. The RARE bound-receptor governs the 5' and 3' end selection and directs 
the productive transcription cycle of RNA polymerase. 
The same evaluations were be made for regulative elements ERE-promoter-Poly_A of PS2, 
BCL2, CAV1 estrogen-responsive genes; in addition I have analyzed the kinetic of 
oxidation/repair of two strands of different regions of PS2 gene to do that we used Ligation 
Proximity Amplification (LPA) technique. This method consists in a first stage of annealing 
of oligonucleotides above oxidized G; during the following step there is a ligation of the 
oligonucleotides through a SALSA 65 ligase which generates a template strand subject of a 
subsequent amplification. The method use the sensitivity of thermostable ligase SALSA 65 to 
recognize mismatches between oligonucleotides and the template caused by the presence of a 
modified bases. To confirm that the mismatches is a consequence of 8oxoG we exploit the 
glycosylase and AP-lyase activity of FPG enzyme (8-oxoGuanine DNA Glycosylase from 
E.coli) that specifically recognizes the 8-oxoG. The method is sensible to 8-oxoG and not to 
all modified bases inasmuch the sensitivity evaluated using the same technique on filaments 
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synthesized introducing modified bases: 8-oxoG and FormilC underlined that after FPG 
treatment is altered the amplification efficiency of filaments containing oxidized G. 
The results obtained show that the repair and oxidation on two stands of regulative regions of 
PS2 is asynchronous; in the transcription direction is repaired before the strand plus (TATA 
region) because it is not the template for mRNA synthesis and so it’s free to protein factors; in 
not codogenic direction is repaired before the strand minus (CnG region). Our data point out 
that DNMT3a is essential for productive transcription induced by estrogens and for the correct 
repair of oxidize G; in fact DNMT3A protect the C point in front to 8-oxoG promoting the 
correct repair of damage base and preventing the simultaneous repair of two 8-oxoG put on 
the different strand which can cause double strand break. The changes in methylation and 
hydroxymethylation of CpG are also associated with the recruitment of DNMT3A and TET1 
and the changes of hydroxymethylation are associated with the timing and the location of 
oxidized Gs, suggesting that the 2 events (G and C methylation-oxidation) are tightly 
associated. 
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whereas the RA-induced CYP26A1 expression is driven by
a compact RARE–promoter (5). We first analyzed the re-
cruitment of RA receptors and RNA polymerase II to the
promoter and RARE sites. Second, we studied the changes
of methylation of lysine 4 (K4) and lysine 9 (K9), following
the recruitment on the chromatin sites of two demethylat-
ing enzymes, LSD1 (KDM1A) and JMJD2A (KDM4A).
It has been reported that LSD1 demethylates H3K4me2
or H3K9me2 and JMJD2A demethylates H3K4-K9 me3
(6). Third, we analyzed the formation after RA exposure of
specific chromatin-DNA domains that connect the 5′ end-
promoter-RARE and the 3′ end site of the RA-target gene.
Our data indicate that histone demethylation, DNA oxida-
tion and chromatin looping induced by RA are temporally
and causally associated with the onset of productive tran-
scription induced by RA, and inhibition of any of these
three events abolishes RA-induced transcription.
MATERIALS AND METHODS
Cells and transfections
Human breast cancer MCF-7 cells were grown at 37◦C in
5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with phenol red, L-glutamine (2 mM), in-
sulin (10g/ml), hydrocortisone (3.75 ng/ml) and 10% fetal
bovine serum (FBS) (Invitrogen). Non-tumorigenic breast
MCF10-2A cells were grown in a 1:1 mixture of DMEM
and Ham’s F12 medium supplemented with 20-ng/ml epi-
dermal growth factor, 100-ng/ml cholera toxin, 0.01-mg/ml
insulin and 500-ng/ml hydrocortisone, 95%; horse serum,
5%. Cells were provided with fresh medium every 3 days.
To evaluate the effect of RA, cells were grown in phenol
red-freemedium containing 10% dextran-charcoal-stripped
FBS for 1–3 days, before being challenged with 300-nMRA
for different times according to the experimental protocol.
To obtain LSD1 knock down with siRNA, cells were
transiently transfected, using a Neon R© Transfection Sys-
tem, with siRNA in medium without serum to a final con-
centration of 10 nM and incubation was continued for 48
h. Scrambled RNA, at the same concentration, was used as
negative control. The same procedure was used to obtain
JMJD2A, OGG1 and APE1 knock down with the specific
siRNAs (see Supplemental Information). To rescue LSD1
activity in knock down experiments with siRNAs, LSD1
full-length cDNA was inserted into the CMV 3xFLAG ex-
pression vector (Sigma-Aldrich). LSD1ALA mutant has
been described elsewhere (7,8). To rescue JMJD2A activity,
cells were transfected with pCMV6-AC-GFP plasmid con-
taining JMJD2A full-length (RG200574, OriGene Tech-
nologies, Inc.). To assess the transfection efficiency at sin-
gle cell level, all transfections were traced with pEGFP Vec-
tor (Clontech) or with BLOCK-iT Alexa Fluor R© Red Fluo-
rescent Control and analyzed by fluorescence-activated cell
sorting (FACS).
RNA extraction and quantitative reverse transcription poly-
merase chain reaction and quantitative polymerase chain re-
action
Total RNA was extracted using TRIzol
(Gibco/Invitrogen). cDNA was synthesized in a 20-l
reaction containing 1 g of total RNA, 100 U of Su-
perscript III Reverse Transcriptase (Invitrogen) and 2 l
random hexamer (20 ng/l) (Invitrogen). mRNA was
reverse-transcribed for 1 h at 50◦C, and the reaction
was heat inactivated for 15 min at 70◦C. The products
were stored at −20◦C. Quantitative reverse transcription
polymerase chain reactions (PCRs) and quantitative PCRs
(qPCRs) were performed on a 7500 Real Time PCR System
(Applied Biosystems) using the SYBR Green-detection
system (FS Universal SYBR Green MasterRox/Roche
Applied Science). The complete list of oligonucleotides
used is reported in Supplementary Table S1.
Chromatin immunoprecipitation
Cells were transfected and/or treated as indicated in the
legends of the figures. The cells (∼2.5 x 106 for each an-
tibody) were fixed for 10 min at room temperature by
adding 1 volume of 2% formaldehyde to a final concen-
tration of 1%; the reaction was quenched by addition of
glycine to a final concentration of 125 mM. Fixed cells were
harvested and the pellet was resuspended in 1 ml of Ly-
sis Buffer (see Supplemental Information) containing 1X
protease inhibitor cocktail (Roche Applied Science). The
lysates were sonicated to have DNA fragments 300–600 bp.
Sonicated samples were centrifuged and supernatants di-
luted 2-fold in the chromatin immunoprecipitation (ChIP)
buffer (Supplemental Information). An aliquot (1/10) of
sheared chromatin was further treated with proteinase K,
extracted with phenol/chloroform and precipitated to de-
termine DNA concentration and shearing efficiency (in-
put DNA). The ChIP reaction was set up according to
the manufacturer’s instructions. Briefly, the sheared chro-
matin was precleared for 2 h with 1 g of non-immune
IgG (Santa Cruz Biotechnology) and 20 l of Protein A/G
PLUS-Agarose (Santa Cruz Biotechnology) saturated with
salmon sperm (1mg/ml). Precleared chromatin was divided
in aliquots and incubated at 4◦C for 16 h with 1 g of
the specific antibody (Supplemental Information) and non-
immune IgG, respectively. The immunocomplexes were re-
covered by incubation for 3 h at 4◦C with 20 l of protein-
A/G agarose, beads were washed with wash buffers accord-
ing to the manufacturer’s instructions and immunoprecip-
itated DNA was recovered and subjected to qPCR using
the primers indicated in the legend of the specific figures,
primers sequences and qPCR protocols are described in
Supplemental Information and in Supplementary Table S1.
8-Oxo-7, 8-dihydro-2′-deoxyguanosine DNA assay
For 8-Oxo-7, 8-dihydro-2′-deoxyguanosine (8-oxo-dG) de-
tection, 106 MCF-7 cells were seeded onto glass slides and
treated with 200 or 500-nMRA for 15–30 min. Control cul-
tures were treated with equivalent vehicle volumes and con-
centrations. After treatments, the cells were fixed 15 min
with 4% paraformaldehyde in phosphate buffered saline
(PBS). The slides were then washed three times with Tris-
buffered saline (TBS)/Tween-20 and permeabilized by se-
rial washes in methanol solutions, prior to be washed with
TBS/Tween-20, blocked for 1 h at 37◦C and incubated
with fluorescein isothiocyanate-labeled protein, that binds
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8-oxo-dG, for 15 h at 4◦C (Biotrin OxyDNA Test, Biotrin,
UK). Cover slips were mounted in Moviol and viewed by
fluorescence. To obtain LSD1 knock down, cells were trans-
fected with specific or control siRNAs. After 48 h, cells were
subjected to different treatments, according to experimen-
tal needs, and processed for fluorescence microscopy. For
single-cell transfection assays, cells were co-transfected with
BLOCK-iTAlexaFluor R©RedFluorescent Control. The ef-
ficiency of transfection was 65%+10. All images were cap-
tured with Axiocammicroscopy (Zeiss) with a 63x objective
in the same conditions of brightness and contrast.
Chromosome conformation capture
The chromosome conformation capture (3C) assay was per-
formed as described (9) with minor adaptations. Briefly, the
NcoI restriction enzymewas used. The cells (2.5× 106) were
crosslinked in 12 ml of PBS with 1% formaldehyde for 10
min at room temperature. The reactionwas quenched by ad-
dition of glycine to a final concentration of 125 mM. Fixed
cells were harvested and the pellet resuspended in 1 ml of
ice-cold lysis buffer (the same used for ChIP experiments).
Nuclei were washedwith 0.5ml of restriction enzyme buffer,
centrifuged and resuspended in 100 l of restriction en-
zyme buffer. Sodium dodecyl sulphate (SDS) was added to
a final concentration of 0.1%, and nuclei were incubated at
37◦C for 15 min. Triton X-100 was added to a final concen-
tration of 1% to sequester SDS. Digestion was performed
with 100 U of restriction enzyme at 37◦C for 16 h. The re-
striction enzyme was inactivated by addition of SDS to 2%
and incubation at 65◦C for 30 min. The reaction was di-
luted into 1-ml ligation reaction buffer (see Supplemental
Methods) and incubated at 16◦C for 18 h with 50 U of T4
DNA Ligase (Roche Applied Science). Ethylenediaminete-
traacetic acid (10 mM) was added to stop the reactions.
Samples were treated with Proteinase K (200 g/ml) and
incubated for 5 h at 55◦C and then overnight at 65◦C to re-
verse the formaldehyde crosslinks. The following day, the
DNA was purified by phenol/chloroform extraction and
ethanol precipitation. Samples were redissolved in 20 l of
Tris-EDTA (TE) buffer. To prepare a control template, we
used a pool of plasmids containing an equimolar amount
of the CASP9 or CYP26A1 inserts spanning the genomic
regions of interest. Five micrograms of plasmid DNA were
digested with NcoI in 50 l of 1x buffer for 8 h at 37◦C and
then ligated in 20 l with 5 U of T4 Ligase at 16◦C for 4 h.
The efficiency of digestion at the end of 3C treatment was
quantified by real-time PCR, amplifying a fragment span-
ning two NcoI (uncut) in different 3C DNA preparations.
Primer sequences and positions and details of PCR and
qPCR protocols are described in Supplemental Informa-
tion and Supplementary Table S1. PCR products were sep-
arated on 1.2% agarose gels, stained with ethidium bromide
and quantified with the imageJ program (RasbandWS, Im-
ageJ, National Institutes of Health, Bethesda, MD, USA;
http: //rsb.info.nih.gov/ij/). The amplified fragments at the
end of the procedure were verified by DNA sequence anal-
ysis.
Statistical analysis
All data are presented as mean ± standard deviation in at
least three experiments in triplicate (n ≥ 9). Statistical sig-
nificance between groups was determined using Student’s
t-test (matched pairs test or unmatched test was used as in-
dicated in figure legends). All tests were performed using the
JMP Statistical DiscoveryTM software by SAS.
RESULTS
Recruitment of RA receptor and activation of RNA poly-
merase II at RA-target promoters
The biological activity of RA is mediated by its binding
to RA receptors (RAR, RAR and RAR ), which func-
tion as hetero-dimers with RXRs, targeting specific sites
(RAREs).We have used breast cancer cellsMCF-7, because
they express RARs and respond to RA (10). We studied in-
duction by RA of CASP9 and CYP2626A1 (Figure 1a and
Supplementary Figure S1a) by exposingMCF-7 cells toRA
and measuring mRNA levels at different times following
stimulation. Figure 1b and Supplementary Figure S1b show
that both mRNAs accumulate 30 min after RA exposure.
After a transient reduction at 60 min (a slight, but repro-
ducible, decrease inCYP26A1mRNA), their levels reached
amaximum 4 h after RA exposure. InCASP9, a RARE ele-
ment is localized in intron II, 9.5 kb downstream of the TSS
(Figure 1a). CYP26A1, instead, contains a RARE contigu-
ous with the promoter (−150 bp from the TSS) and another
site at the 3′ end close to the polyA (Supplementary Figure
S1a; 11). These sites are essential for RA induction of tran-
scription (4,12,13), which depends on RAR, because un-
der the same conditions, RA is not able to induce CASP9
and CYP26A1 mRNAs in MCF10 cells, devoid of RA re-
ceptor (Supplementary Figure S1e and f) (14).
To monitor recruitment of the RA receptor to the pro-
moter and RARE elements after RA stimulation, we as-
sessed the timing of association of RA receptor with the
chromatin of CASP9 and CYP26A1 by ChIP. We included
in our analysis very early times after RA induction (min) to
detect the earliest chromatin changes induced by the hor-
mone. Figure 1c shows that RAR is rapidly (15 min) re-
cruited to theRARE element and to the upstreampromoter
of CASP9. We noticed that the levels of RAR recruited to
the promoter and RARE chromatin were not stable, but os-
cillated between 15 and 60 min after RA exposure. RAR
and RXR were also recruited to the RARE/promoter
of CYP26A1 (Supplementary Figure S1c and d). RAR
did not accumulate to the RARE or promoter of CASP9
gene in unresponsive MCF10 cells (Supplementary Fig-
ure S1f). Recruitment of RAR and RXR was associated
with accumulation of total and serine 5-phosphorylated
RNA polymerase II (Pol II and p-Pol II, respectively) at
the RARE and promoter regions of CASP9 and CYP26A1
(Figure 1d and e, and Supplementary Figure S1d). As ex-
pected, Pol II and p-Pol II accumulated preferentially at the
promoter relative to the RARE following RA induction.
Note that recruitment of total Pol II and p-Pol II to RARE
oscillated synchronously with the recruitment of RAR. p-
Pol II progressively accumulated at the CASP9 promoter
with the time of RA stimulation (Figure 1d and e, and Sup-
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Figure 1. Retinoic acid (RA) induction of CASP9mRNA and recruitment of retinoic acid receptor alpha (RAR) and phosphorylated RNA polymerase
II to retinoic responsive element (RARE) and promoter of CASP9 gene. (a) Structure of CASP9 gene. The TSS and the direction of transcription are
indicated by a green arrow; the exons, promoter, polyA addition sites and RARE are shown by different colors indicated at the upper right corner. The
black arrows indicate the primers used for ChIP and mRNA analysis. (b) Total RNA was prepared from MCF-7 hormone-starved or stimulated with
300-nM RA for 15, 30, 60 and 240 min and analyzed by qPCR with specific primers (panel (a)) to CASP9 mRNA normalized to 18S RNA levels. The
statistical analysis derived from at least three experiments in triplicate (n ≥9; mean ± SD); *P< 0.01 (matched pairs t-test) compared to RA-unstimulated
sample, **P < 0.01 (matched pairs t-test) comparing 30–60 min of RA exposure. (c, d, e) qChip analysis of RA-dependent occupancy of RAR, RNA
polymerase II (Pol II) and phosphorylated RNA polymerase II (p-Pol II) at the promoter and RARE. MCF7 cells were stimulated with 300-nM RA for
15, 30, 60 and 240 min. The chromatin was immunoprecipitated with antibodies directed against RAR, Pol II, p-Pol II. Panel (c) shows the recruitment
of RAR to the promoter and RARE sequences of CASP9 gene. Panels (d) and (e) show the recruitment of Pol II (d) and p-Pol II (e) at the promoter
and RARE. The black, horizontal line (brackets ± SD) in each plot indicates the percent of input from a control ChIP (Ab: non-immune serum). The
statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P< 0.01 (matched pairs t-test) compared to RA-unstimulated
sample; ◦◦P < 0.01 (matched pairs t-test) compared 15–30-min stimulated samples.
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plementary Figure S1d). The levels of p-Pol II at theCASP9
RARE dipped at 30 min and then increased over the next
240 min, preceding by 30 min the oscillations of the mRNA
levels (Figure 1b). The oscillation of RAR recruitment to
the CYP26 RARE promoter–RARE is delayed by 30 min
compared to that of CASP9 and mirrors the smaller and
higher peaks of mRNA accumulation at 30 and 240 min
following RA exposure (Supplementary Figure S1c and d).
mRNA levels of four other genes induced by RA display a
similar pattern with a small peak at 30–60 min and a large
peak at 240 min after RA (not shown). In CASP9 normal-
ization of p-Pol II with total Pol II shows that this ratio in-
creases dramatically 30 min after RA at the promoter, while
it is stable at the RARE (Figure 1d and e) mirroring the
rise and reduction of RNA at 30 and 60-min RA, respec-
tively (Figure 1b and Supplementary Figure S1b). However,
we note that at 30 min the change of the ratio is due to a
significant depletion of total PolII from the promoter (Fig-
ure 1d) which may explain the reduction of mRNA 30 min
later (Figure 1b). We believe that the loss of total Pol II at
the promoter 30 min after RA does not reflect an increased
Pol II phosphorylation, but instead, a change in chromatin
structure leading to depletion of Pol II with other proteins
bound to the promoter, including RAR (Figure 1c).
Histone H3K4 and H3K9 methylation marks induced by RA
Methylation of lysine 4 in histone H3 (H3K4) marks tran-
scribed loci, whereas dimethyl-lysine 9 in the same histone
(H3K9me2) is associated with transcription silencing (15).
To find the histone marks modified by RA exposure, we an-
alyzed the methylation profiles of H3K4 and H3K9 in cells
after treatment with RA. ChIP analysis was performed with
specific antibodies against methylated H3K4 and H3K9.
The regions analyzed were the promoter-TSS, the RARE
element and two polyA addition sites located at the 3′ end of
theCASP9. Two segments of the gene 2 kb distant from the
TSS were also included in the analysis. As a result of methy-
lation and demethylation events induced by RA, the levels
ofmethylatedK9orK4, normalized to the input chromatin,
were selectively modified shortly after RA exposure. Fig-
ure 2 shows that promoter-associated H3K4 me2 and me3
were transiently demethylated 15 min after RA challenge
and then progressively remethylated (Figure 2a and b).
Rapid demethylation of H3K4 at RAREwas also observed,
but remethylation was slower than at the promoter. RA
induced a transient loss of H3K9me2 and H3K9me3, fol-
lowed by accumulation of H3K9me2 but not of K3K9me3
(Figure 2c and d). The methylation changes observed were
not due to loss of H3 levels at these sites (Figure 2e and
f). These cyclical methylation–demethylation events were
strikingly synchronous and specific to the RARE and pro-
moter regions of CASP9. In contrast, H3 methylation was
unaffected by RA at a site 2 kb downstream of RARE
in intron II or in a non-RA-induced gene, TGFBI (Fig-
ure 2g). A similar methylation–demethylation cycle was ob-
served at the CYP26A1 promoter–RARE chromatin (Sup-
plementary Figure S2a and b). MCF10 cells, which do not
respond to RA (14; Supplementary Figure S1e and f), do
not show changes in methylation of H3K4, K9 me2/3 at
15-min RA (Supplementary Figure S2c). We also probed
the 3′ end of CASP9 gene, where two major polyA addi-
tion sites are located. H3K4me2 and me3 and H3K9me2 at
the polyA1 and polyA2 sites also underwent transient and
early demethylation. H3K9me3 was permanently demethy-
lated at the polyA2 site, but was essentially unchanged at
the polyA1 site (Supplementary Figure S2d–i). We con-
clude that the polyA1 and polyA2 sites undergo methy-
lation changes similar to those seen at the promoter and
RARE, raising the possibility that these regions are func-
tionally and physically associated in a unique chromatin do-
main.
To complete the description of chromatin factors di-
rectly or indirectly linked to the modification of histone
marks following RA induction of transcription, we mea-
sured the recruitment of a major histone methyltrans-
ferase (SUV39H1, which methylates H3K9) (16,17) (Sup-
plementary Figure S3a and b) or an alternative modifica-
tion of H3K9, such as H3K9 acetylated (H3K9Ac) (Sup-
plementary Figure S3c and d), or the recruitment of the
co-repressors, NCoR1 and NCoR2 (18,19) (Supplemen-
tary Figures S3e and f and S3g and h, respectively) to
the RARE–promoter and polyA addition sites of CASP9
and CYP26A1 genes. Supplementary Figure S3 shows that
the recruitment of these proteins to these sites following
RA induction mirrors the demethylation–methylation cy-
cles described above. SUV39H1 accumulates at the pro-
moter, RARE and polyA addition sites with a sharp peak
30 min following RA exposure (Supplementary Figure S3a
and b). The SUV39H1 recruitment overlaps with the peak
at 30min of bi- and tri-methylatedH3K9 inFigure 2c and d.
On the other hand, H3K9Ac oscillates symmetrically with
the demethylation wave of H3K9me2 and H3K9me3, sug-
gesting that H3K9 nucleosomes undergo mutually exclu-
sive demethylation–acetylation cycles (Supplementary Fig-
ure S3c and d). NCoR1 is transiently recruited at 15-min
RA, while NCoR2 is present in the absence of RA and pro-
gressively disappears from the RARE chromatin following
RA induction (Supplementary Figure S3e–h). Collectively,
these data describe a series of intertwined oscillating cyclic
events driven by RA and targeted to the RARE–polyA ad-
dition sites of CASP9 and CYP26A1 genes. The earliest
temporal event we are able to detect following RA expo-
sure is the massive demethylation of H3K4 and H3K9 in-
duced by RA at 15 min. This suggests that K4 and K9
demethylation enzymes are also recruited to CASP9 and
CYP26A1. H3K9me3 can be demethylated by enzymes of
the Jumonji C (JMJC) family (20,21), whereas H3K4me2
is demethylated in vitro (22) and H3K9me2 in vivo (7,23–
25) by LSD1 (KDM1). We decided to monitor the re-
cruitment at the RARE promoter chromatin of CASP9
and CYP26A1 of LSD1 and JMJD2A, which demethylate
H3K4me2 or H3K9me2 and H3K9me3, respectively. Fig-
ure 3a, b and Supplementary Figure S4a show recruitment
of both LSD1 and JMJD2A histone demethylases to the
RARE elements and promoters of CASP9 and CYP26A1
following RA treatment. Notably, the kinetics of recruit-
ment of LSD1 and JMJD2A parallels the kinetics of loss
of the H3K4me2 and H3K9me2/3. H3K9me2/3 accumu-
lation at 30-min RA is associated with the recruitment of
SUV39H1 (16) to the promoter, RARE and polyA addi-
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Figure 2. Methylation–demethylation cycles of histone H3K4/K9 induced by RA atCASP9 promoter–RARE chromatin. MCF7 cells were serum starved
and exposed to 300-nM RA at the indicated times (0, 15, 30, 60 and 240 min). qChIP was carried out using specific antibodies recognizing H3K4me3,
H3K4me2, H3K9me3 and H3K9me2. The specificity of the antibodies was tested by competition with the specific methylated peptide(s). (a, b) H3K4me2
and H3K4me3 occupancy at the CASP9 promoter and RARE. (c, d) H3K9me2 and H3K9me3 occupancy at the CASP9 promoter and RARE. The black
arrows indicate the loss of all methylated H3K4 and H3K9 (except H3K4me2 at the RARE) at 15-min RA. (e, f) ChIP Histone H3 at the promoter and
RARE after RA induction. (g) ChIP analysis of CASP9 II intron and of TGFBI exon 13 (non-RA-induced gene), in cells exposed to RA for 15, 30 and 60
min. For each antibody, the control IgG signal is shown (brackets ± SD). The statistical analysis was derives from at least three experiments in triplicate
(n ≥ 9; mean ± SD); *P < 0.01 (matched pairs t-test): compared to the RA-unstimulated sample; **P < 0.01 (student t-test): compared to the same time
point at the promoter and RARE.
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Figure 3. LSD1 and JMJD2A upon RA exposure are recruited to the CASP9 promoter and RARE sites and are essential for CASP9 induction by RA
and methylation–demethylation cycle. (a, b) Recruitment of LSD1 and JMJD2A to the promoter and RARE of CASP9 gene. MCF7 cells were serum
starved and exposed to 300-nMRA at the indicated times (15, 30, 60 and 240 min). qChIP was carried out using specific antibodies recognizing LSD1 and
JMJD2A. The panels show the time course of the recruitment of LSD1 (a) and JMJD2A (b) to the RARE and promoter sequences of CASP9 analyzed
by qPCR. The black, horizontal line in each plot indicates the percent of input from a control ChIP (Ab: non-immune serum). (c, d) LSD1 and JMJD2A
depletion inhibits RA-induced transcription ofCASP9. MCF7 were transiently transfected with LSD1 siRNA or JMJD2A siRNA. After 48 h, total RNA
was prepared from control cells (starved) or RA-induced cells (300-nMRA for 45min) and analyzed by qPCRwith specific primers toCASP9mRNA. The
statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P< 0.01 (matched pairs t-test) compared to RA-unstimulated
sample; **P< 0.01 (student t-test): comparison between SCR and specific siRNAs; ◦◦P< 0.01 (student t-test): comparison between promoter and RARE
regions. (e) Depletion of LSD1 or JMJ2DA inhibits the methylation changes induced by RA. qChIP was performed on cells transfected with LSD1
siRNA or JMJD2A siRNA and induced with 300-nM RA for 15 min. qChIP was carried out using specific antibodies recognizing H3K4me3, H3K4me2,
H3K9me3 and H3K9me2. The statistical analysis derives from at least three experiments in triplicate (n≥ 9; mean ± SD); *P< 0.01 (matched pairs t-test)
compared to RA-unstimulated sample; **P < 0.01 (student t-test): comparison between SCR and specific siRNAs. Transfection efficiency was monitored
by FACS (Alexa Fluor or co-transfected pEGFP Vector).
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tion sites (Supplementary Figure S3a and b). A new wave
of demethylation of H3K9me3 occurs at 60–260-min RA
as indicated by reduction of H3K9me3 and accumulation
of H3K9me2 (Figure 2c and d). The methylation changes
(H3K9me2/3) and the kinetics of LSD1 and JMJD2A re-
cruitment to CYP26A1 chromatin are very similar to those
seen at RARE (Figure 2b and Supplementary Figures S2b,
3a and b and S4a). We believe that this similarity is due to
the fact that the promoter and RARE are physically con-
tiguous in CYP26A1 but are separated in CASP9.
To demonstrate that both lysine demethylases were nec-
essary for RA-induced transcription, we knocked down
LSD1 and JMJD2A with specific siRNAs and induced the
cells with RA (Supplementary Figure S4b and c). Knock
down of either demethylase, as shown by retention of
di- and tri-methylated H3K4 and H3K9, significantly re-
duced RA-induced expression of CASP9 (Figure 3c and
d) and CYP26A1 (Supplementary Figure S4d and e). Re-
expression of the wild-type LSD1 or JMJD2A and not a
mutant formof these enzymes restoredRA-inducedCASP9
RNA levels (Figure 3c and d and data not shown) and re-
duced the levels of H3K4 and H3K9 both me2 and me3 as
in control cells (Figure 3e). These data were unexpected be-
cause LSD1 and JMJD2A do not demethylate H3K4me3,
although JMJD2A has been shown to bind H3K4me3 in
vitro (26,27).We suggest that JMJD2A targets toH3K4me3
another enzyme able to demethylate H3K4me3. Also, si-
lencing of either LSD1 or JMJD2A increases H3K4me3
levels, as a result of increased methylation of the me2 forms,
which accumulate when LSD1 is not functional.
To explore further the relationship between H3K9 and
H3K4 methylation and LSD1, we overexpressed an N-
terminal dominant-negative mutant (T110A) of LSD1
(LSD1ALA). Thismutant is still enzymatically active, but is
unable to target transcription factors (7,8). The LSD1ALA
mutant protein was defective in binding to the promoter
or RARE elements of CASP9 or CYP26A1 following RA
induction (Figure 4a and Supplementary Figure S5a, re-
spectively) and inhibited activation ofCASP9 orCYP26A1
transcription upon RA exposure (Figure 4b and Supple-
mentary Figure S5b). The methylation levels both H3K4
andH3K9me2were already low in the absence ofRA (basal
in Figure 4c–f) because LSD1ALAwas constitutively active
and not inducible by RA (Supplementary Figure S5c and
d). LSD1ALA was constitutively recruited to chromatin
because not only it inhibited RA induction of CASP9 or
CYP26A1 expression but also lowered the levels of methy-
lated H3K4me2 or H3K9me3 at promoters of non-RA-
induced genes (such as TGFBI; Figure 4g), which methyla-
tion status does not change upon RA induction. However,
the methylation–demethylation cycle at the RARE, pro-
moter and polyA addition sites (Figure 4 and Supplemen-
tary Figure S56) was abolished both inLSD1 and JMJD2A-
depleted cells (Figure 3e) and in LSD1ALA expressing cells
(Figure 4c–f) and was not dependent upon the basal methy-
lation levels of H3K4 and H3K9 (me2/3), which were high
in the former and low in the latter cells, respectively (Fig-
ures 3e and 4c–f).
Collectively, these data indicate that RA induces the
recruitment of both LSD1 and JMJD2A to the chro-
matin of CASP9 and CYP26A1 and demethylation of
H3K4me2 and H3K9 me2/me3 at the RARE, promoter
and polyA2 sites. These localized demethylation events by
both demethylases are essential for the induction of tran-
scription of CASP9 and CYP26A1 by RA (Figure 4b and
Supplementary Figure S5b).
Recruitment of base or nucleotide excision repair enzymes to
the RARE/promoter chromatin following RA induction
It was recently reported that nucleotide excision repair
(NER) enzymes are recruited to promoter and RARE el-
ements. NER is essential for the formation of discrete
chromatin loops and induction of transcription by RA
(28). Similarly, transcription-induced recruitment of base
excision repair (BER) enzymes (such as 8-oxoguanine-
glycosylase, OGG1) toMYC-Ebox DNA or to estrogen re-
sponsive elements has been described (25,29). Activation of
a Fe++ dioxygenase (JMJD2A) and a FAD oxidase (LSD1)
at the same chromatin sites (ERE or Ebox-promoters) trig-
gers local oxidation. Oxidized guanine (8-oxo-dG) is recog-
nized by OGG1 (8,25). That oxidation of guanine also oc-
curs after RA induction of transcription is shown in Supple-
mentary Figure S7a. We observed a rapid (15 min) nuclear
accumulation of 8-oxo-dG in discrete foci in MCF7 cells
exposed to RA. As predicted, production of 8-oxo-dG foci
was inhibited by LSD1 knockdown (Supplementary Figure
S7b). ChIP analysis showed that OGG1 was recruited to
the promoter andRARE elements ofCASP9 (Figure 5a) 15
min following RA treatment. At 30 min, occupancy at these
sites byOGG1markedly decreased. At 240min, OGG1was
detected at theRARE element but not at the promoter. Sim-
ilar oscillation ofOGG1 binding to theRARE/promoter of
CYP26A1 was also seen (Supplementary Figure S8a). RA
induces the binding of OGG1 to the ERE and promoter
sites with the same timing of nuclear 8-oxo-dG accumula-
tion (Supplementary Figure S7) indicating that 8-oxo-dG
accumulates at specific segments of RARE, promoter and
polyA addition sites. In fact, OGG1 recruitment was not
seen in non RA-induced genes or in segments distant (1–2
kb) from the TSSs ofCASP9 orCYP26A1 (Supplementary
Figure S8g).
Complexes enucleated by OGG1 seem important not
only for the repair of oxidized lesions but also for assembly
of transcription initiation complexes at estrogen- or Myc-
dependent promoters (8,25,30,31). To dissect the compo-
nents of the OGG1 complex that could link repair and RA-
induced transcription, we probed for other BER enzymes
that associate with a RARE element or its cognate pro-
moter after RA induction. Specifically, we monitored the
recruitment of: (i) the APurinic site Endonuclease1, APE1,
which recognizes the apurinic site generated by OGG1 and
cleaves the phosphodiester backbone, immediately 5′ to the
site; (ii) thymineDNAglycosylase (TDG), which is required
for BER of deaminated methylcytosine, a frequent prod-
uct of base oxidation; and (iii) uracil glycosylase (UNG),
which removes uracil or oxidized cytosine. Figure 5b, c and
d (Supplementary Figure S8a for CYP26A1) show that all
these enzymes are recruited to the promoter and to RARE
chromatin 15 min following RA induction similar to the re-
cruitment of RAR and Pol II (compare Figure 5 with Fig-
ure 1). We knocked down two of these enzymes (OGG1 and
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Figure 4. Expression of a dominant negative LSD1 mutant inhibits RA-induced methylation changes and CASP9 induction by RA. (a) Recruitment
of wild type (WT) and mutant LSD1 (LSD1ALA) to the CASP9 RARE–promoter. The LSD1ALA mutant contains a substitution of threonine with
alanine in position 110 and has been described elsewhere (17,19). MCF7 were transiently transfected with LSD1 vectors (WT or mutant), starved (Basal)
or treated with 300-nM RA for 30 min and were analyzed by qChIP using Anti-FLAG antibodies to recognize the recombinant LSD1. The panel shows
the recruitment of the flagged LSD1WT and LSD1ALA to the RARE and to the promoter sequences of CASP9. The black, horizontal line indicates the
percent of input from a control ChIP (Ab: non-immune serum). (b) LSD1ALA inhibits RA-induced CASP9 transcription. Total RNA was prepared from
MCF7 transiently transfected with LSD1WT or LSD1ALA. After 48 h, mRNAs from control cells (starved) or RA-induced cells (300-nMRA for 45 min)
were analyzed by qPCR with specific primers to CASP9 mRNA. (c, d) LSD1ALA inhibits RA-induced H3K4 demethylation. H3K4me2 and H3K4me3
occupancy at the promoter and RARE of CASP9 in LSD1ALA expressing cells as in (b). (e, f) LSD1ALA inhibits RA-induced H3K9 demethylation.
H3K9me2 and H3K9me3 occupancy at the promoter and RARE of CASP9 in LSD1ALA expressing cells as in (b). (g) ChIP analysis of TGFBI exon
13 (non-RA-induced gene), in transfected cells exposed to RA for 15, 30 and 60 min. For each antibody, the control IgG signal is shown (brackets ±
SD). The statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P < 0.01 (matched pairs t-test): compared to the
RA-unstimulated sample; **P < 0.01 (student t-test): comparison between control and the LSD1ALA expressing cells at the same time.
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Figure 5. Recruitment of BER and NER enzymes to CASP9 chromatin following RA induction. MCF7 cells, starved or treated with RA for 15, 30
and 240 min, were analyzed by qChIP using specific antibodies recognizing the 8-oxoguanine-DNA glycosylase-1 (OGG1), AP endonuclease (APE1),
Thymine-DNA glycosylase (TDG), Uracil-DNA glycosylase (UNG), XPG and RPA. (a, b) The recruitment of OGG1 and APE1 to the CASP9 promoter,
and RARE sequences. (c, d) The recruitment of TDG andUNG to the same regions ofCASP9. The black, horizontal line in each plot indicates the percent
of input from a control ChIP (Ab: non-immune serum). (e, f) BER knockdown impairs the expression of RA-induced CASP9. Serum-deprived MCF7
cells were treated for 45 min with 300-nMRA and specific siRNA targeting OGG1 or APE1; CASP9 expression levels were quantified by qPCR. To assess
the transfection efficiency cells were co-transfected with pEGFP Vector (Clontech) and analyzed by FACS. (g, h) The recruitment of XPG and RPA to
the CASP9 promoter and RARE. The statistical analysis derives from at least three experiments in triplicate (n ≥ 9; mean ± SD); *P < 0.01 (matched
pairs t-test) compared to RA-unstimulated sample; **P < 0.01 (student t-test): comparison between SCR and specific siRNA; ◦◦P < 0.01 (student t-test):
comparison between the two amplicons.
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APE1; Supplementary Figure S8b and c) and asked if this
impacted onRA-induced transcription. Figure 5e and f and
Supplementary Figure S8d–f summarize the results of these
experiments. The activity of OGG1 and APE1 was essen-
tial for RA-induced transcription, since the wild type, but
not a OGG1 dominant negative or a catalytically defective
mutant APE1, reactivate CASP9 transcription induced by
RA in depleted cells (Figure 5e and f; Supplementary Fig-
ure S8d and e and data not shown).
Our results clearly indicate that depletion of these BER
enzymes significantly reduced RA-induced transcription.
We also probed for an NER enzyme (XPG) and for RPA,
a single strand binding protein (Replication Protein A) in-
volved in NER, on RARE by ChIP. XPG and RPA selec-
tively accumulated at RARE chromatin following 15min of
RA stimulation (Figure 5g and h and Supplementary Fig-
ure S8a). It has been reported recruitment of NER enzymes
to the RARE or other inducible promoters 3–4 h after hor-
monal induction, a period corresponding to maximal ac-
cumulation of specific mRNA levels (28). As expected, de-
pletion of XPG and RPA reduced RA-induced transcrip-
tion (not shown; 28). Our results show that BER and NER
accumulate early at the RARE and promoter, shortly be-
fore we could detect mRNA accumulation (Figure 1b and
Supplementary Figure S1b). The modifications we describe
mark the first transcription cycle of CASP9 and CYP26A1
induced by RA.
Formation of dynamic chromatin loops governing the selec-
tion of 5′ and 3′ borders of RA-induced transcription units
The data shown above indicate that the CASP9 and
CYP26A1 promoter, RARE and polyA addition sites un-
dergo similar changes in histone H3K4 and H3K9 methy-
lation and accumulate BER and NER enzymes after RA
treatment. This coordination is consistent with the idea that
these regions are physically associated after RA induction.
Note that the CASP9 RARE and 5′ start site are 9.5 kb
apart and the polyA site is 22 kb to the 3′ end ofRARE (Fig-
ure 1a). Recall that the methylation status H3K4 andH3K9
was not modified at chromatin neighboring these sites (2
kb at the 5′ and 3′ ends) and BER–NER enzymes were not
recruited to these sites in RA-treated cells (Figure 2e and
Supplementary Figure S8g).
These data suggest that RA induces early changes of spe-
cific chromatin domains that bring the TSS, the RARE and
the polyA addition sites into close proximity. To find the rel-
evant chromatin domains assembled in response to RA, we
systematically analyzed the structure ofCASP9 (Figure 6a)
and CYP26A1 (Supplementary Figure S9a) chromatin by
the 3C technique (see the Materials and Methods section).
Briefly, fixed chromatin DNAwas cleaved with a restriction
enzyme (NcoI) and ligated after dilution. Real-time qPCR
was then used to detect the ligated DNA segments. Fig-
ure 6a shows the summary of such analysis by using several
probes and ‘baits’ centered on the TSS, RARE and 3′ end
of CASP9 (see the legend of Figure 6 for the detailed band
analysis).
RA enhanced formation of two loops connecting the 5′
and 3′ ends of the gene with the RARE element. Exten-
sive quantitative analysis of these loops revealed: (i) a 5′ end
loop connecting the RARE to the promoter (A-F1, A-F2)
was induced by RA (Figure 6b); (ii) a loop (F1-L, F2-L)
connecting theRARE region to the 3′ end ofCASP9, where
two different polyA addition sites generate twomRNAends
(AB209147; AK303743). Assembly of this loop was almost
entirely dependent on RA treatment (Figure 6c); (iii) a loop
connecting the 5′ and the 3′ ends of the gene, bridging the
above-mentioned loops (A-L) (Figure 6d). We wish to note
that transcription of CASP9 is promoted by many different
stimuli. Thus, the loops formed in the absence of RA may
nevertheless reflect basal transcription.
Strikingly, formation of all of these loops is cyclical. They
first appear 15 min following RA exposure, disappear at 30
min and reform by 60 min. This oscillation resembles that
displayed in previous figures showing CASP9 mRNA syn-
thesis, promoter and RARE occupancy by protein factors
and histone modifications (Figures 1–5). The CYP26A1
gene also formed chromatin loops upon RA treatment.
Since RARE and promoter are contiguous in CYP26A1
we detected essentially one major loop connecting the 5′
(promoter-RARE) with the 3′ end of the gene (polyA ad-
dition sites). This loop peaked 15 min after RA and slowly
disappeared (Supplementary Figure S9b and c) similar to
the early loop induced by RA on CASP9 chromatin (Fig-
ure 6e). The physical association of the 5′ and 3′ ends of
CASP9 and CYP26A1 genes induced by RA implies that
the same proteins are present at the chromatin of the pro-
moter, RARE and 3′ end sites. The physical contiguity (600
bp) of the two polyA addition sites (1 and 2) does not dis-
criminate which polyA1 or 2 is included in the RA-induced
loop of CASP9 gene.
To find a 3′-end-specific RA-dependent marker of
CASP9, we investigated the localization on CASP9 chro-
matin of Ssu72, a protein which marks the 3′ end of genes
and interacts with the general transcription initiation factor,
TFIIB (32). Supplementary Figure S10a, b and c shows that
Ssu72 binds the promoter and RARE with the same kinet-
ics seen with RAR and Pol II following RA exposure, i.e. a
peak at 15 min corresponding to the early RA-induced loop
(Figure 6e). At 15 min after RA, Ssu72 disappeared from
the polyA2 and concentrated at the promoter and RARE
(Supplementary Figure S10a and b). Apparently, Ssu72 was
present at the polyA2 site of CASP9 gene in the absence
of RA induction, except at 15′ min after RA, when the re-
ceptor and the promoter were recruiting Pol II and RAR
(Supplementary Figure S10a–c).
How relevant are these loops to RA-induced transcrip-
tion and how they are linked to the demethylation cycles
induced by RA? To address this question we measured the
loops involving RARE in cells expressing the LSD1ALA
mutant. Expression of LSD1ALA inhibited RA-induced
demethylation (Figure 4c–f and Supplementary Figure S6)
and RA-induced transcription (Figure 4b). Supplementary
Figure S10d shows that the formation of the 15-min loops
connecting RARE to the polyA1/2 site or to the promoter
upon RA exposure was inhibited: some loops were delayed
(RARE-polyA1/2) and some others were completely elim-
inated (RARE–promoter).
We conclude that the demethylation cycles triggered by
RA govern the ordered formation of the loops essential for
RA-induced transcription.
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Figure 6. Formation of dynamic chromatin loops during early RA-induced transcription. 3C analysis of CASP9 chromatin in MCF7 cells exposed to 300
nM of RA for various periods of time. (a) The histograms show the frequency of ligation of the CASP9 NcoI fragments amplified with primers indicated
below the NcoI restriction map. All the combinations of primers indicated were performed on ligated chromatin; the histogram shows qPCR amplifications
above 1%, relative to the control. Each loop was detected with different primers pairs and the two histograms show the analysis by using several probes
and ‘baits’ centered at the TSS, RARE and 3′ end of the CASP9. Differences between recombinant, Basal and RA-treated cells derived-chromatin were
tested for statistical significance using Student’s t-test: *P < 0.01 as compared to untreated control. (b, c, d) Time course of chromatin looping following
RA induction. 3C analysis was carried out as described in the Materials and Methods section and the loops shown in panels (b, c, d) were quantified by
qPCR (left panels) and verified by gel electrophoresis (right panels) and DNA sequencing (data not shown). The results shown derive from at least three
experiments in triplicate (n ≥ 9; mean ± SD). *P < 0.01 as compared to untreated samples. (e) The panel shows the time course of loop formation. Data
were collected from real-time qPCR and from semi-quantitative, nested PCR, experiments. The extra band seen in panel (c) is a skipped restriction site
that adds 187 bp to the expected fragment (210 bp). This band is specific because the same loop (RARE-polyA) analyzed with another primer (F1) does
not produce extra bands. Also, following the treatment with RA, this longer fragment accumulates while the shorter one (cleaved by the enzyme in the
chromatin) almost disappears. This indicates that this site is protected in vivo and is not cleaved efficiently by NcoI restriction enzyme.
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DISCUSSION
The data reported here show that the methylation changes
of K4 and K9 of histone H3 are linked to the recruitment
of repair enzymes and, most importantly, to the formation
of chromatin-DNA loops that juxtapose the 5′ end TSS,
the enhancer (RARE) and the 3′ end of the transcribed
gene (Figure 6 and Supplementary Figures S9 and S10).
Histone methylation–demethylation cycles (33) and the for-
mation of loops connecting the 5′ gene ends, 3′ ends and
enhancers have been described extensively in many genes
induced by nuclear receptors (28,33). However, these as-
pects of chromatin movement, although required for tran-
scription induction by nuclear hormones, have not been
mechanistically and temporally linked. Likewise, the asso-
ciation of methylation–demethylation cycles with NER en-
zyme recruitment to RA-induced promoter(s) and the for-
mation of loops upon exposure to RA has not been de-
scribed, although depletion of these enzymes seriously com-
promises transcription and chromatin looping induced by
RA (28). However, notwithstanding the plethora of data,
the mechanism used by RA or other inducers to trigger
the recruitment of NER enzymes and formation of chro-
matin loops is still not known. Our experiments show that
demethylation–methylation cycles of H3K4 and K9 at the
RARE, promoter (Figure 2) and 3′ gene end (Supplemen-
tary Figure S2d–g) are the initiating and earliest events in-
duced by the recruitment of the RA–RAR complex to the
RARE. The timing and the kinetics of demethylation of
H3K4 and K9 are similar at the promoter, RARE (Fig-
ure 6d) and the 3′ end of the gene, suggesting that these
sites, although not contiguous in the DNA, are included
in the same complex, driven by active RA–RAR. Inhi-
bition of demethylation of H3K4 and H3K9 by depleting
the demethylating enzymes (LSD1 or JMJD2A) or by ex-
pressing a dominant negative LSD1 variant (7,8) inhibits
RA-induced transcription (Figure 3c and d and Supplemen-
tary Figure S4d and e), nuclear dG oxidation (Supplemen-
tary Figure S7b), recruitment of BER (25) and NER en-
zymes and formation of loops induced by RA (Supplemen-
tary Figure S10d). Formation of the chromatin loops with
discrete 5′ and 3′ borders is facilitated by local DNA ox-
idation following demethylation by LSD1, which presum-
ably releases supercoiling and rigidity of the helix and tar-
gets BER andNER enzymes to oxidized bases (34; Antonio
Pezone & Antonio Porcellini, manuscript in preparation).
In all cases, BER and NER enzymes are essential to local-
ize and repair DNA nicks and altered bases produced by
dG and 5mdC oxidation (25,31,35). We wish to stress that
inhibition of H3K4-K9 methylation–demethylation cycles
or depletion of BER or NER enzymes or overexpression
of LSD1ALA does not influence the expression or modify
the chromatin of RA-independent genes (Figures 2g and 4g
and Supplementary Figures S4f and g and S8f). Locally,
LSD1-triggered demethylation produces hydrogen perox-
ide, which oxidizes dG (Supplementary Figure S7) and both
H3K9me2 and H3K4me2, as LSD1 substrates (7,8,25) may
favor dG oxidation. We do not know if H3K9m2/3 coexist
with H3K4me2/3 nucleosomes, but our data show a rapid
demethylation 15 min after RA, involving both H3K4 and
H3K9 N-terminals at the RARE–promoter and polyA ad-
dition sites (Figure 2 and Supplementary Figure S2d–g).
At these sites, 4 h after RA, the content of H3K9me3 and
H3K4me3 is low and high, respectively, as expected in tran-
scriptionally active genes (36). The presence ofH3K4me2/3
and H3K9me2/3 at time 0 at the promoter or RARE may
indicate that these sites are poised between repression and
activation depending on the strength of the specific stimu-
lus. Also, RARE nucleosomes containing H3K9me2 may
express less CASP9 and this may contribute to the setting
of discrete expression states in cell populations.
Further complicating comparative analysis of the data
published thus far are the different temporal frames used
in various studies to describe the molecular events induced
by transcriptional activators. These studies have been car-
ried out at 1 h (37) to several hours or days (28) after hor-
monal induction. At these times, synchronization is lost.
Each cell is starting and restarting the transcription cycle
and only the mature RNA accumulates exponentially and
can be easily detected even in asynchronous transcribing
cell populations. The H3 (K4-K9) methylation code, hours
and days after the initial RA induction, is not informative
sinceH3K4me2/3 andH3K9me2/3 content is high and low
both in control and chronically stimulated cells, respectively
(33).
An important feature of RA-induced transcription re-
ported here is the timing and synchronous oscillation with
a period of ca. 30 min of chromatin bound RAR, Pol II,
H3K4-H3K9 demethylation, H3K9Ac and looping involv-
ing the RARE and the 5′ and 3′ of CASP9 and CYP26A1
genes (Figure 6). RA-induced mRNA levels of CASP9,
CYP26A1 and five other genes (A. Pezone, unpublished ob-
servations) oscillate with a period of 60 min from the ini-
tial induction with RA. With the time (2–4 h) this periodic
oscillation is lost (Figure 6). We do not know if this loss
of synchrony with the time is due to our inability to track
these chromatin changes in non-synchronized cell popula-
tions or whether the oscillation we observe is limited to
the first transcription cycle. An early and similar cycle of
transcription induced by estrogens has been reported to be
unproductive in terms of RNA accumulation. This cycle
is suggested to prepare the promoter for subsequent tran-
scription followed by two different transcriptionally pro-
ductive cycles (38–40). However, our data suggest that (i)
the first cycle (unproductive in 38–40) is indeed the cycle
(15–30 min) that sets and defines the physical borders of the
transcription unit induced by the hormone (in our case RA)
and (ii) the oscillations in RAR recruitment (Figure 1) and
chromatin looping (Figure 6) are driven by methylation–
demethylation cycles of histone H3K4 and H3K9, caused
by alternate recruitment of demethylating (LSD1-JMJD2A
in Figure 3a and b and Supplementary Figure S4a) and
methylating (Supplementary Figure S3a and b) enzymes.
We believe that these oscillations are important for BER
and NER enzymes to repair oxidized DNA (Figure 5 and
Supplementary Figure S8a) to restart the cycle.
We wish to note that although the structural orga-
nization of the RARE is different comparing CASP9
(RARE 4 kb downstream the promoter) with CYP26A1
(RARE contiguous with the promoter) genes, the timing of
methylation–demethylation, the oscillation of RAR and
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LSD1-JMJD2A recruitment to the RARE promoter ap-
pear very similar
Why should the definition of the physical borders of a
transcription unit be important? Each gene in eukaryotes
is indeed the target of many stimuli, which can indepen-
dently induce transcription. The protein Ssu72 has been
identified in yeast as an element required for marking the 3′
end of the chromatin loops and transcription directionality
(41,42). The human protein Ssu72, although has not been
shown to be involved in DNA-chromatin loops, may have
a similar function in human cells as suggested by the crys-
tal structure of the complex of RNA polymerase C termi-
nal domain, a scaffold protein symplekin, and human Ssu72
(43).
The accumulation of Ssu72 in the various sites ofCASP9
gene, before and after RA induction, may indicate the
changes of chromatin engaged in RA-induced and RA-
independent transcription. This protein is present at 3′ end
ofCASP9 3′ end before RA induction, disappears from this
site at 15 min and reappears 30 min after RA treatment
(Supplementary Figure S10a–c). Fifteen minutes after RA
stimulation, Ssu72 moves from the 3′ end to the CASP9
TSS and RARE (Supplementary Figure S10a–c), where its
concentration oscillates synchronously with methylation–
demethylation cycles and recruitment of BER andNER en-
zymes (Figures 2 and 5 and Supplementary Figure S10).
These data indicate that Ssu72 specifies the 3′ end of both
RA-dependent and -independent transcription units (Sup-
plementary Figure S10c), which are also marked by end-
and time-selective-specific chromatin loops. Importantly,
after RA induction, RA-independent transcription is shut
off to allow the formation of RA-dependent loops. This is
shown by the shift of Ssu72 from the polyA2 addition site
(in the absence of RA) to the RARE (15 min after RA)
(Supplementary Figure S10a–c) and by the time synchrony
of the loops induced by RA (Figure 6e). LSD1 is essential
for this event, because the synchrony of loop formation is
lost in cells expressing the LSD1ALA mutant: some loops
disappear (promoter-RARE) or are delayed (promoter-
polyA or RARE-polyA) and resemble loops formed in the
absence of RA (Supplementary Figure S10d). It is worth
noting that LSD1 has been recently shown to control the
rhythmicity and the circadian clock and that amutant in the
residue adjacent (aa 111) to that of LSD1ALA (aa 110) is
unable to reset clock oscillations (44). We suggest that RA-
induced synchronous demethylation–methylation cycles in-
hibit ongoing local transcription and trigger recruitment of
BER and NER enzymes to the chromatin of CASP9 pro-
moter, RARE and 3′ end. The simultaneous DNA and his-
tone changes bring in close proximity the 5′, enhancer and
3′ ends of CASP9 and induce the formation of loops (Fig-
ure 6 and Supplementary Figure S10). Figure 7 shows a
summary of temporal changes induced by RA on the target
chromatin, including histone H3K9 acetylation, methyla-
tion, demethylation, recruitment of co-repressors NCoR1-
2, of BER and NER enzymes and the formation of the loop
connecting RARE and promoter in CASP9 gene. We pro-
pose that these cycles are intertwined and triggered by his-
tone methylation–demethylation cycles.
We believe that RA-induced synchronization of DNA
chromatin loops is required for calibration and rapid rein-
Figure 7. RA-induced cycles of histone H3K9 methylation, acetylation,
recruitment of NCoR1–2, BER, NER and RARE–promoter chromatin
loop. Time course of the major modifications of histone H3K9 at the
RARE ofCASP9 andCYP26A1 genes. The original data are in Figures 2,
5 and 6 and Supplementary Figures S2, S3, S8, S9 and S10. On the ordinate
are indicated: i. fold-induction (arbitrary units); ii. the type of assay (ChIP
or 3C). The time of RA induction is shown on the abscissa. The bottom
panel shows the frequency of loop formation between RARE–promoter of
CASP9 gene in cells expressing wild type or LSD1ALA (Supplementary
Figure S10d).
duction of transcription rather than for high levels of tran-
scription. The massive accumulation of RA-specific mR-
NAs, in fact, occurs hours after the initial RA exposure (45).
This efficient reinduction of transcription may represent a
‘transcription memory’, which has been noted before and
requires gene looping and Ssu72 in yeast (46,47).
The periodic variation of recruited receptor at the en-
hancer represents a simple mechanism to titrate and cali-
brate the concentration of RA molecules present in the en-
vironment. Any drop in the inducer levels reduces the con-
centration of active receptor at the enhancer leading to dis-
solution of the chromatin DNA loop enucleated initially by
the active receptor (RARE–promoter). Conversely, a rise in
levels of the inducer rapidly reactivates transcription by sta-
bilizing the loops (transcription memory) (see the Supple-
mentary Movie).
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Supplementary Data are available at NAR Online.
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3.2 Histone and DNA methylation cycles are coupled by DNA 
oxidation to induce transcription by nuclear receptors 
 
Abstract 
Changes of histone methylation code, DNA hydroxymethylation and formation of chromatin 
loops are associated with transcription induction by nuclear hormones, but it is not known if 
these events are the consequence or the cause of transcription initiation. We have located 
genomic regions that synchronously recruit estrogen receptor (ER!) and enzymes that 
demethylate histone H3, (e.g. LSD1) and recognize oxidized G (e.g. OGG1). We have found 
in three prototypic estrogen-induced genes that the periodic recruitment of these enzymes and 
their products at the enhancers and polyA sites are functionally linked to generate localized 
DNA damage and bring to formation of chromatin loops that juxtapose the 5' and 3' ends of 
induced genes. DNA methyltransferase 3a (DNMT3a) recruits BER and NER enzymes at the 
ERE and Poly_A sites, favoring strand specific repair of oxo-dG and methylation of the 
complementary C. Loss of DNMT3a results in accumulation of G to T mutations at these 
sites.! We suggest that coupling transcription with methylation and repair enzymes is an 
evolutionary strategy to reduce the mutational burden induced by DNA oxidation necessary 
for chromatin looping. 
 
Introduction 
Histone methylation-demethylation, targeted DNA damage and formation of chromatin loops 
that juxtapose physically distant DNA regions have been variously associated with 
transcription in general and, specifically, with transcription induction by nuclear hormones 
[1]. Studies of synchronized transcription, in the time window of the observation, have 
documented several oscillatory cycles of histone methylation-demethylation, DNA oxidation 
and mRNA accumulation [2]. The interplay between histone modification writers and readers 
on chromatin has been extensively investigated, yielding a long list of histone methyl 
transferases and demethylases that variously associate with transcription induction or 
repression [3]. However, although the detailed structure and activity of these proteins, it is not 
known if these enzymes modify the accessibility of RNA polymerase complex to critical 
chromatin-DNA sites or directly participate to the assembly of the initiation complex at the 
transcription start site.  
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In recent years, evidence of transcription associated with DNA damage has been reported in 
neurons [4] or in nuclear hormones sensitive cells [5,6]. DNA repair enzymes have been 
found associated with the transcription initiation complex in the absence of exogenous 
genotoxic stimuli [7] and the phosphorylated histone H2AX, a specific signature of DNA 
damage, is enriched at transcription start sites (TSS) [8]. High levels of transcription increase 
dramatically mutation rates in S.cerevisiae and this is tightly associated with BER and NER 
pathways [9,10,11]. 
However, the following questions still pend: 1. What are the cause and the nature of this DNA 
damage and how is it induced? 2. Is the DNA damage the consequence of, or does it drive the 
formation of the transcription initiation complex?  
We have proposed that DNA damage at the TSS is caused by DNA oxidation. All the histone 
demethylation enzymes are mono or di-oxygenases, which generate formaldehyde and modify 
the local chromatin redox state [12]. We have reported that oxidation of DNA G residues was 
a consequence of histone demethylation by the mono-flavin oxidase LSD1 and was important 
for estrogen-induced transcription. In addiction not only G can be oxidized but also C can be 
methylated by DNA methyltransferases and oxidized by a new class of di-oxygenases protein, 
TET enzymes [13]. 
According to these informations, we have hypothesized that both histone and DNA 
methylation-demethylation [14] cycles are causally connected to DNA oxidation. Histone 
demethylation induced direct oxidation of Gs residues through ROS production, while the Cs 
oxidation is an effect of DNA demethylation. Both G and C oxidation is finalized to reduce 
transcription-generated supercoiling and to allow the formation of DNA loops that juxtapose 
the transcription start site, the enhancer and the 3' end of the gene [2].  
Here, we have presented data on estrogen-induced genes that support this model. First, 
promoter array analysis have showed that oxidation, histone demethylation and DNA repair 
enzymes accumulate at the transcription start sites and estrogen responsive elements (ERE) 
upon hormone challenge. Second, on 3 prototypic estrogen-induced genes, we have described 
the oscillatory recruiting of histone methylation and demethylation enzymes with BER, NER 
enzymes and DNMT3a. Third, we have showed that these recruitment cycles are 
synchronized with the cycles of chromatin loops of the induced genes and that the inhibition 
of histone demethylation and/or BER or NER cycles prevents formation of loops and the 
induction of transcription. Finally, we have uncovered the role of DNA methyl transferase3a 
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(DNMT3a), which links BER and NER enzymes at the enhancer and polyA sites, favoring 
strand-specific repair of the GC dinucleotide at the 5’ and 3’ end of the chromatin loops. 
 
Material and Method 
Cells, treatment and transfections 
Human breast cancer MCF-7 cells were grown at 37 °C in 5% CO2 in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with phenol red, L-glutamine (2 mM), insulin (10 
,g/ml), hydrocortisone (3.75 ng/ml), and 10% fetal bovine serum (FBS, South America 
origin, Brazil, Invitrogen, Rockville, MD, USA). Cells were provided with fresh medium 
every 3 days. To evaluate the effect of estrogen challenge, cells were grown in phenol red-free 
DMEM containing 10% dextran–charcoal-stripped FBS for 1 to 3 days, before being 
challenged with 50 nM 17%-estradiol (E2) for different times according to the experimental 
needs. 
To obtain LSD1 dominant negative expression, the cells were transiently transfected, using a 
Neon® Transfection System, with LSD1 full-length cDNA and LSD1 dominat negative (ala) 
were inserted into the CMV 3xFLAG, Sigma-Aldrich, St. Louis, MO, USA, in medium 
without serum and incubation was continued for 48 h as previously published (Ambrosio et 
al., 2013). 
 
Chromatin Immuno-Precipitation (ChIP) 
The cells (~2.5 x 106 for each antibody) were fixed for 10 minutes at room temperature by 
adding 1 volume of 2% formaldehyde to a final concentration of 1%, the reaction was 
quenched by the addition of glycine to a final concentration of 125 mM. Fixed cells were 
harvested and the pellet was resuspended in 1 ml of Lysis Buffer (10 mM Tris-HCl pH 8.0, 10 
mM NaCl, 0.2 % NP40) containing 1X protease inhibitor cocktail (Roche Applied Science). 
The lysates were sonicated in order to have DNA fragments from 300 to 600 bp. Sonicated 
samples were centrifuged and supernatants diluted 2 fold in the ChIP Buffer (1% Triton X-
100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl pH 8.0). An aliquot (1/10) of sheared 
chromatin was further treated with proteinase K (4U every 1 x 106 nuclei), extracted with 1 
volume of phenol/chloroform/isoamyl alcohol (25:24:1) and precipitated in LiCl 0,4 M/ 
ethanol 75% to determine DNA concentration and shearing efficiency (input DNA). The ChIP 
reaction was set up according to the manufacturer’s instructions. Briefly, the sheared 
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chromatin was precleared for 2 h with 1 ,g of non-immune IgG (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) and 20 ,l of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology) 
saturated with salmon sperm (1 mg/ml). Precleared chromatin was divided in aliquots and 
incubated at 4 °C for 16 h with 1 ,g of the specific antibody (for the codes, see below) and 
non-immune IgG respectively. The immuno-complexes were recovered by incubation for 3 h 
at 4 °C with 20 ,l of protein-A/G PLUS agarose, beads were washed with wash buffers 
according to the manufacturer’s instructions and immunoprecipitated DNA was recovered 
through phenol/chloroform/isoamyl alcohol extraction and ethanol precipitation and 
redissolved in TE buffer (10 mM Tris-HCl, 1mM EDTA, pH 8.0). Samples were subjected to 
qPCR using the primers indicated in the legend of the specific figures, primers sequences are 
reported in Table 1. Real Time-qPCRs were performed using FastStart Universal SYBR 
Green Master (Rox) (Roche Applied Science) with cycle conditions as follows: 95 °C 10 min; 
40x (95 °C 10 sec, 55 °C 30 sec, 72 °C 30 sec); 72 °C 10 min.  
 
Chromosome conformation capture (3C) 
The 3C assay was performed as described previously (Dekker J. et al., 2002) with minor 
adaptations. Briefly: the AvaII and BamH1 restriction enzymes were used (Roche Applied 
Science). The cells (2.5 x 106) were crosslinked in 12 ml of PBS with 1% formaldehyde for 
10 min at room temperature. The reaction was quenched by the addition of glycine to a final 
concentration of 125 mM. Fixed cells were harvested and the pellet resuspended in 1 ml of 
ice-cold lysis buffer (the same used for ChIP experiments). Nuclei were washed with 0.5 ml 
of restriction enzyme buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1mM 
Dithioerythritol, pH 7.5) at 37 °C, centrifuged and resuspended in 100 ,l of restriction 
enzyme buffer. SDS was added to a final concentration of 0.1%, and nuclei were incubated at 
37 °C for 15 min. Triton X-100 was added to the final concentration of 1% to sequester SDS. 
Digestion was performed with 100 U of the restriction enzyme at 37 °C for 16 h. The 
restriction enzyme was inactivated by the addition of SDS to 2% and incubation at 65 °C for 
30 min. The reaction was diluted into 1 ml ligation reaction buffer (66 mM Tris-HCl, 5 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.5) and incubated at 16 °C for 18 h with 50 U of T4 
DNA Ligase (Roche Applied Science). EDTA (10 mM) was added to stop the reactions. 
Samples were treated with Proteinase K (200 ,g/ml) and incubated for 5 h at 55 °C, and then 
overnight at 65 °C to reverse the formaldehyde crosslinks. The following day, the DNA was 
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purified by phenol/chloroform/isoamyl alcohol extraction and ethanol precipitation. Samples 
were redissolved in 20 µl of TE buffer. To prepare a control template, we used a pool of 
plasmids containing an equimolar amount of the PS2, BCL2 or CAV1 inserts spanning the 
genomic regions of interest. Five micrograms of plasmid DNA were digested with AvaII or 
BamH1 in 50 ,l of 1x buffer for 8 h at 37 °C and then ligated in 20 ,l with 5 U of T4 Ligase 
at 16 °C for 4 h. The efficiency of digestion at the end of 3C treatment was quantified by real 
time PCR, amplifying a fragment spanning two AvaII or BamH1 (uncut) in different 3C DNA 
preparations. Primer sequences are reported in Table 1. PCR were performed using FastStart 
Taq DNA Polymerase (Roche Applied Science) with cycle conditions as follows:  
• BCL2 oligo 1-2/3-4 (Prenested) 95 °C 5 min; 5x (95 °C 45 sec, 57 °C 30 sec, 72 °C 40 
sec) 25-44x (95 °C 45 sec, 55 °C 30 sec, 72 °C 30 sec); 72 °C 10 min;  
• BCL2 oligo 1-2/3-4 (Nested) 95 °C 5 min; 5x (95 °C 45 sec, 57 °C 30 sec, 72 °C 30 
sec) 30-40x (95 °C 45 sec, 54,5 °C 30 sec, 72 °C 30 sec); 72 °C 10 min;  
• PS2 oligo 1-2 (Prenested) 95 °C 5 min; 5x (95 °C 45 sec, 58 °C 30 sec, 72 °C 40 sec) 
35x (95 °C 45 sec, 56 °C 30 sec, 72 °C 30 sec); 72 °C 10 min;  
• PS2 oligo 1-2 (Nested) 95 °C 5 min; 5x (95 °C 45 sec, 58 °C 30 sec, 72 °C 30 sec) 30-
40x (95 °C 45 sec, 56 °C 30 sec, 72 °C 30 sec); 72 °C 10 min;  
• CAV1 oligo 8-2 (Prenested): 95 °C 5 min; 5x (95 °C 45 sec, 60 °C 30 sec, 72 °C 30 
sec); 25x (95 °C 45 sec, 58 °C 30 sec, 72 °C 30 sec); 72 °C 10 min; 
• CAV1 oligo 8-2 (Nested): 95 °C 5 min; 5x (95 °C 45 sec, 62 °C 30 sec, 72 °C 35 sec); 
35x (95 °C 45 sec, 60 °C 30 sec, 72 °C 35 sec); 72 °C 10 min; 
PCR products were run on 1.2% agarose gels, stained with ethidium bromide and quantified 
with the imageJ program (Rasband WS, ImageJ, National Institutes of Health, Bethesda, 
Maryland, USA, http: //rsb.info.nih.gov/ij/). The amplified fragments at the end of the 
procedure were verified by DNA sequence analysis. 
 
 Antibodies  
 ERa ab32063 (Abcam); H3K4me2 ab32356 (Abcam); H3K4me3 ab1012 (Abcam); 
H3K9me2 ab1220 (Abcam); H3K9me3 ab8898 (Abcam); Total H3 ab1791 (Abcam); OGG1 
sc-33181 (Santa Cruz Biotechnology); APE1 ab2717 (Abcam); LSD1 ab17721 (Abcam); 
JMJD2A sc-271210 (Santa Cruz Biotechnology); DNMT3a ab2850 (Abcam); TET1 
GTX124207 (Genetex); TDG sc-292440 (Santa Cruz Biotechnology); XPG sc-13563 (Santa 
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Cruz Biotechnology); XPC sc-74411 (Santa Cruz Biotechnology); XPA ab85914 (Abcam); 
RPA ab2175 (Abcam); Normal rabbit IgG sc-2027 (Santa Cruz Biotechnology); Normal 
mouse IgG sc-2025 (Santa Cruz Biotechnology). 
 
Ligation-dependent Probe Amplification (LPA) 
Technique premise. The technique is a variant of Multiplex ligation-dependent probe 
amplification (MLPA) that has been developed to assess the presence of 8-oxoguanina base 
(8-oxoG). It involves the use two pairs of oligonucleotides each complementary to strand plus 
(+) and minus (-) of analyzed DNA regions. The junction point between the two 
oligonucleotides that recognize the same strand is located on a C (the 3'end of oligo L) and G 
(the 5'end of oligo R) of a CpG dinucleotide. The oxidation of both G located in the junction 
point produces a mismatch with used oligo pair, compromising the ligase reaction for both 
strands. To confirm that the mismatches is a consequence of 8oxoG we exploit the 
glycosylase and AP-lyase activity of FPG enzyme (8-oxoGuanine DNA Glycosylase from 
E.coli) that specifically recognizes the 8-oxoG, inducing a inefficiency ligation profile similar 
to the same samples not treated with FPG. 
Experimental protocol. The LPA assay was performed as described previously (Jan P. 
Schouten et al., 2002) with minor adaptations. Briefly: 1,g of DNA samples were divided in 
4 parts (each of them with 250 ng), two of them were digested with 1U of FpG enzyme (New 
England Biolabs) for 1 h at 37 °C and 5 min at 98 °C in a Buffer1 (10 mM Bis-Tris-Propane-
Hcl, 10mM MgCl2, 1mM DTT, pH 7.0) supplemented with BSA. The other two were used as 
not digest samples control to which were added the storage buffer of FpG (20 mM Tris HCl, 
50 mM NaCl, 0.5 mM EDTA, 200 µg/ml and 50% glycerol). 
Then, KCL 5x buffer (750 mM KCl, 50 mM Tris pH, 5 mM EDTA) and strand specific 
probes (12.5 fmol/sample) were added to digested and not digested samples and heated for 1 
min at 95 °C and then incubated for 16 h at 60 °C for ERE, CnG, TATA and INTRON1 
regions and 2 h at 60 °C for Poly_A region. For each analyzed region were outlined: a pair of 
primers complementary to the minus strand (-) (Right probe oligonucleotide (RPO(-))/(Left 
probe oligonucleotide (LPO(-)) and a pair of primers complementary to the plus strand (+) 
RPO (+)/ LPO (+)). The primers RPO (-) and RPO (+) were phosphorylated at t 5' end with 
20U T4 kinase enzyme to 500 picomoles of oligo, in the presence of 100 nM ATP for 45 min 
at 37 ° C. 
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Ligation of annealed oligonucleotides was performed by diluting the samples to 60,l with 
dilution buffer (5 mM Tris HCl pH 8.5, 2.6 mM MgCl2, 0.013% Triton x-100, 0.2 mM NAD) 
containing 1 U Ligase SALSA-65 enzyme (MRC Hollad), and incubation for 1h at 56 °C. The 
ligase enzyme was inactivated by heating at 98 °C for 15 min and ligation products were 
amplified by qPCR. For more experiments, 10 ,l of the ligation reaction was added to 25 ,l 
qPCR buffer. Real Time-qPCRs were performed using FastStart Universal SYBR Green 
Master (Rox) (Roche Applied Science) with cycle conditions as follows: 10 min at 95 °C; 35 
cycles (30 s at 95 °C, 30 s at 60 °C and 40 s min at 72 °C); 10 min at 72 °C. DNA was 
amplified by PCR using primers listed in the Table 2. 
 
Total genome analysis of 8-oxoG and 5hmC 
MCF7 were pretreated for 2h with 2,5 µM of !-amanitin (AMA). After washing out the cells 
were stimulated with 50 nM E2, or 10 nM 4-hydroxytamoxifen (4-OHT) or 10 µM parnate 
(Par) at different time (0, 15, 30, 45 and 60 min). DNA was extracted, clevaged with nuclease 
P1 and analyzed through spectrometry [15]. This experiment was done in collaboration with 
the laboratory of Prof. Ryszard Olinski (Department of Clinical Biochemistry, Nicolaus 
Copernicus University (Karlowicza)). 
 
Revelation of hydroxymethylated citosine  
The Oxidative Bisulfite assay was performed as described previously (Michael J Booth, et al. 
2013) with a mirror adatpion. Briefly: 1,g of DNA samples were denatureted in NaOH 0.05 
mM at 37 °C for 30 min and oxidated with 1,l of Potassium Perruthenate (KRuO4, Sigma) 
(15 µM) in ice for 1 h, vortexing every 15 min. As control, KRuO4 solvent was added to the 
samples. The oxidative and not oxidative samples were undergoes bisulfite conversion (EZ 
DNA Methylation-GoldTM Kit, Zymo Research) with cycle conditions as follows: 10 min at 
98 °C, 4 h at 53 °C. DNA was amplified by PCR using primers listed in the Table 3 using 
HotStratTaq DNA polymerase (Qiagen) with cycle conditions as follows: 15 sec at 95 °C; 35 
cycles (40 sec at 95 °C, 40 sec at 52 °C and 40 sec at 72 °C); 10 min at 72 °C. The samples 
were sequenced with Sanger method. 
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Statistical analysis 
All data are presented as mean ± standard deviation in at least three experiments in triplicate 
(n-9). Statistical significance between groups was determined using Student’s t test (matched 
pairs test or unmatched test were used as indicated in figure legends). All tests was performed 
using the JMP Statistical Discovery™ software by SAS, Statistical Analysis Software. 
 
Results 
Estrogen receptor clusters histone methylation-demethylation and repair enzymes at 
discrete genomic sites. 
We first identified the genomic regions capable of recruiting, upon estrogen stimulation, 
estrogen receptor ! (ER!), lysine specific de-methylase (LSD1) and 8-oxoguanine DNA 
glycosylase (OGG1). Immune-precipitated DNA fragments with specific antibodies to ER!, 
LSD1 and OGG1 from estrogen- stimulated cells (50 nM for 45 min) were used as probes 
to screen arrays of human promoters (Affymetrix, human promoter 1.0 R array). These arrays 
interrogate regions proximal to transcription start sites and contain probes covering 59 percent 
of CpG islands annotated by UCSC in NCBI human genome assembly (Build 34). Each 
promoter region spans approximately from 7.5 kb upstream through 2.45 kb downstream of 5' 
transcription start sites. 
We focused our attention on the sites that synchronously recruit the estrogen receptor ! and 
the enzymes indicated above upon E2 stimulation. We mapped these regions in each 
chromosome but for simplicity we have shown in the figure 1A the percentage of ER! 
interaction with LSD1 and OGG1 in mono, bivalent and trivalent complexes on different 
genomic regions of chromosome 18. After E2 stimulation, the co-recruitment of ER!, LSD1 
and OGG1 increases on regulative regions. On estrogen responsive genes CAV1, BCL2 and 
PS2 (poised respectively on chromosome 7, 18 and 21) the stimuli makes the linkage of above 
mentioned factors happen on the same regions (Figure 1B). 
 
Intertwined Cycles of histone H3 methylation and recruitment of DNA repair enzymes 
at ERE and polyA sites of E2-induced genes. 
Estrogens induce the transcription of several genes. Some genes are induced de novo, others 
are already transcriptionally active and the hormone super-induce them. We determined the 
histone code changes induced by the hormone in both types of genes. To do that we analyzed 
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the H3 histone methylation code of the lysine 9 and 4 on ERE and Poly_A chromatin regions 
of pS2 (induced by E2), CAV1 and BCL2 (super-induced by E2) genes. Figure 2 presents a 
summary of the most of chromatin changes and the recruitment of ER!, BER, NER and DNA 
methylating enzymes on PS2 gene. Receptor upon estrogen stimulation is highly and stably 
recruited to ERE and Poly_A at 1-2 hours (data not shown); in short kinetics (0-60 min E2) 
this recruitment is not stable in fact ER! link rapidly ERE at 30-45 min and decrease at 60 
min. The binding of the receptor oscillates at the 3' end Poly_A site during E2 stimulation in 
the same way of ERE, suggesting that the 2 regions are synchronized or probably interact 
(Fig. 2A). 
We observed the same kinetics on CAV1 (Fig. S1A) and BCL2 (Fig. S2A) regulative regions. 
In pS2 ERE and Poly_A regions, we found that estrogen induces cycle of methylation and 
demethylation. The stimuli leads to a peak of demethylation of the H3K9me3/me2 at 30 and 60 
min and methylation at 45 min on analyzed regions. At the ERE region, H3K4me2 increases at 15 
min and remains high up to 45 min, whereas H3K4m3 increases at 45 min. At the Poly_A region 
we observe an increase of H3K4me3 at 15 and 45 min, whereas the H3K4me2 increases only at 
45 min (Fig. 1B). 
After estrogen exposure on CAV1 ERE and Poly_A regions, we found that H3K9me2 was 
methylated at 30 min on ERE and at 45 min on Poly_A while H3K9me3 did not show remarkable 
oscillations. H3K4me3-me2 increase at 15 min and 45 min and decrease at 30 min (Fig. S1B). 
In BCL2 ERE and Poly_A regions only H3K4m2 and H3K9m3 revealed oscillatory kinetics. In 
particular H3K4m2 had an unique peak at 30 min on both regions, whereas H3K9m3 increase at 
15 min, decrease at 30 min and are re-methylated at 45 min (Fig. S2B). 
Collectively, all the regions ERE and Poly_A sites of the estrogen-induced genes analyzed, show 
discrete oscillations of methylation and demethylation involving H3K9 and H3K4. In addition, 
we noted that the location of the ERE (intron or exon) and the basal transcriptional state of the 
gene may modify the intensity of the methylation- demethylation changes. 
These dynamic methylation changes of K4 and K9 induced by E2 exposure suggest that on these 
regions de-methylation enzymes were recruited; in particular on ERE region JMJD2A 
demethylates H3K9me3 (15 min E2) and LSD1 demethylates H3K9me2 and H3K4me2 (15-45 
min E2), while the kinetic of these enzymes recruitment upon E2 stimulation do not presents 
remarkable fluctuations on other one regulative region except of a peak of JMJD2A for CAV1 
and BCL2 genes at 45 min. (Fig. 2C, Fig. S1C, Fig S2C). 
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Periodic recruitment of BER, NER enzymes at ERE and polyA sites. Transcription is 
associated with a burst of DNA oxidation dependent from histone demethylation [16] in 
particular the activation of a Fe++ dioxygenase (JMJD2A) and a FAD oxidase (LSD1) triggers 
local oxidation. Oxidized guanine (8-oxodG) is recognized by OGG1 [17]. In addition, it was 
recently reported that NER enzymes are essential for the formation of chromatin loops and 
DNA de-methylation induced by retinoic acid at the target genes [18]. These data suggest that 
both BER and NER enzymes participate to the formation of chromatin loops induced by 
nuclear hormones and are essential for the correct repair of DNA oxidation lesions. Therefore, 
we analyzed the recruitment of BER enzymes, XPC, XPG, XPA and RPA (NER) at the ERE 
and PolyA chromatin regions after E2 induction. ChIP analysis shows that OGG1 is recruited 
very early (15' E2) on ERE and Poly_A of studied genes, but on CAV1 and BCL2 show a second 
peak at 45 min (Fig. 2D, Fig. S1D, Fig. S2D). APE1, which process the abasic site (s) generated 
by OGG1, is recruited at 15 and 45 min on ERE of BCL2 and at 30 min on CAV1; the kinetics 
of recruitment is the same (45 min E2) on Poly_A of all gene analyzed (Fig. 2D, Fig. S1D, Fig. 
S2D). Others analyzed enzymes do not show particular oscillations, except RPA that display a 
peak on Poly_A of CAV1 between 15 and 30 min, and TDG (Tymidine DNA Glycosilase 
which is required for base excision repair of deaminated methylcytosine, a frequent product of 
base oxidation) that bind the same region of CAV1 and BCL2 after 15 min of E2 challenge 
(Fig. 2E, Fig. S1E, Fig. S2E). 
In addition, we noticed important and selective differences in the recruitment of XPC and 
XPG: XPC is recruited earlier at the ERE than XPG (15 min versus 45 min), while at the 
Poly_A both XPC and XPG are recruited with the same timing (Fig. 2E, Fig. S1E, Fig. S2E). 
These data suggest a hierarchy in the recruitment of BER and NER and between different 
types of NER enzymes. In fact, OGG1 is recruited early with XPC at the ERE this 
information is relevant, because XPC is part of the Global Genome NER that recognizes 
lesions caused by the distortion of the double helix, suggesting that it recognized the oxidative 
or apurinic site independently of the presence of stalled PolII. 
 
Periodic recruitment of DNMT3a and TET1 enzymes at ERE and Poly_A sites. The gene 
transcriptional activation seems to be associated to DNA methylation/hydroxymethylation 
cycles, indispensable for a faithful transcriptional process. DNA oxidation involves not only 
G but also C. In fact C can be oxidized only when methylated in vivo. It has been reported 
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that estrogens induce cycles of the CpG methylation within the PS2 promoter through 
recruitment of DNMTs enzymes [14]. 
In this process a crucial role seems to be played by the DNA methyltransferase 3a (DNMT3a) 
which acts as a cofactor for OGG1, working closely with it in the repair of 8-oxo-guanine, 
through the methylation of cytosine which is opposed to the oxidized guanine; also TET1 
plays a key role in repair because hydroxylating methylated cytosine by DNMT3a does not 
allow the tautomerization of C and allows the correct replacement of the oxidized G. We 
analyzed the recruitment of DNMT3a and TET1 at the ERE and Poly_A chromatin regions 
after E2 induction. The results obtained reveal that on ERE region DNMT3a and TET1 are 
recruited after 15 min of stimulation, and they recruitment remain more or less constant up to 
60 min E2. On Poly_A the levels of both enzymes increased to 15 min E2 and in the times of 
stimulation higher have slight fluctuations with a pick of DNMT3a at 30 min from the 
stimulation. We observed the same oscillations on all genes studied (Fig. 2F, Fig. S1F, Fig. 
S2F). 
 
Estrogen induces strand specific oxidation and repair: coordinated repair of 8-oxodG 
and 5hmC.  
Repair of 8-oxodG. Repair enzymes have a crucial role in transcriptional activation, in fact 
their silencing reduce significantly specific mRNA production and increase basal transcription 
(data not shown). 
Among the events that lead to their recruitment there is the Gs oxidative burst on promoter 
region, this process is mediated by monoammino-oxidase activity of LSD1 that produces 
reactive oxygen species (ROS) that oxidizes G to 8-oxo-deoxyguanosine (8-oxoG). In first 
analysis we assessed the guanine oxidation induced by transcriptional activation with total 
genome analysis, evaluating the 8oxo-G accumulation in short kinetic after estrogens 
stimulation, after treatment with !-amanitin (transcription inhibitor), parnate (monoammino-
oxidase inhibitor) and 4-hydroxytamoxifen (estrogen inhibitor) (Fig. 3). The results obtained 
underline that the oxidation occurs after 15 min of hormonal stimulation and that it is directly 
linked to transcription, chromatin remodeling depending to LSD1 activity and estrogen 
stimulation, in fact the treatment with specific inhibitors breaks down completely the 
phenomenon (Fig. 3). To directly document the DNA oxidative lesions and to monitor site-
specific repair, we mapped precisely oxodGs using Ligation Proximity Amplification (LPA) 
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technique (see Material and Method). First of all we evaluated the technique sensitivity and 
specificity and sensitivity using it to amplify synthesized strands with 10% or 50% of 
modified bases such as 8-oxoG or formilC (deoxyformilcytosine). The method is sensible 
because detect molecules that contain also only the 10% of 8-oxoG, and specific because it is 
not influenced by other modified bases such as formilC. The treatment with FPG underlines 
that the efficiency reduction is due specifically to the presence of 8-oxoG (Fig. 4) 
After we analyzed the kinetic of oxidation/repair of two strands of different regions of PS2 
gene in estrogen kinetic stimulation. The data express the efficiency variation on basal 
conditions in which a lower efficiency corresponds to a higher oxidation degree and vice 
versa. 
On ERE region of PS2 the damage repairing kinetics is asynchronous for stand plus (+) and 
strand minus (-); in fact both stands show oxidation at 5min but on strand (-) the first 
oxidation peak occurs to 15 min E2 when the strand (+) is completely repaired. Also the 
amplification peak due to the complete repair of the strand (-) manifests at 30 min when the 
strand (+) is oxidized. The second oxidation cycle kinetic is similar on two strands probably 
the cells have lost the transcriptional synchronization (Fig. 5A). 
To assess whether the oxidation was a peculiarity of CG dinucleotide we have analyzed a 
CnG region 24 bases upstream to ERE region (so we investigated if the penultimate base 
mismatch influences ligase SALSA 65 activity). The obtained data show an asynchronous 
oxidation/repair on two strands. The strand plus (+), after initial oxidation, which extends till 
to 15 min, shows the repairing peak (maximum efficiency of LPA) at 30 min, while the strand 
(-) is already repaired after 15 minutes from the stimulus. The kinetics of repair in this region 
is inverted instead of ERE region because repair of damage can not take place on two adjacent 
regions at the same time (Fig. 5B). 
In TATA region analysis is important to consider that it presents the start of transcription, so 
the strand minus (3'$5') is the template for mRNA synthesis. In this region the strand (+) is 
more damaged in basal condition than strand minus but both strands undergo a gradual repair 
that extends till to 30 min for strand plus and till to 15 min for strand (-). The two strands 
keep on asynchronism of oxidation/repair but the strand (-) is the less damaged because it is 
transcribed (Fig. 5C).  
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On Poly_A region was interesting to observe how the strand (+) and (-) have a kinetic 
oxidation/repair analogous to ERE and TATA regions of same gene, suggesting that these 
regions could be physically close (Fig. 5D). 
In addition to these regulatory regions it was analyzed an intronic region in which there is not 
observed a particular variation of the kinetics of oxidation and repair, in fact both strands have 
asynchronous low level of oxidation and repair. This underlines that the oxidative wave does 
not extend to that region (Fig. 5E). 
 
Repair of 5hmC. Estrogen induces recruitment of DNMT3a and TET1 to regulate the wave of 
DNA methylation and oxidation. This coordinated recruitment of enzyme that methylate 
(DNMT3a) and hydroxymethylate (TET1) of cytosine may be crucial for repair. In addition, 
the presence of the TET1 oxidation products (5-hmC and 5-formylC) marks active 
transcription [19]. In first analysis we have assessed the cytosine oxidation induced by 
transcriptional activation with total genome analysis, evaluating the 5-OHdmC accumulation 
under the same conditions described above. The results do not show large fluctuations of 
oxidized Cs after estrogen induction, doing deduce that oxidized Cs are probably localized 
and unstable, so it is produced and repaired immediately (Fig. 6). 
To determine if E2-induced G and C oxidations are coordinated, we performed a modified 
bisulfite assay on ERE region of TFF1 to determine methylation and hydroxylation of specific 
Cs. The use of potassium perruthenate (KRuO4) selectively oxidizes 5hmC into 5- formyl-
cytosine (5fC), which after bisulfite conversion is read as uracil in the sequence. We 
analyzed by oxBS-sequencing [20] five CpG on ERE region (Fig. 7). Figure 7 shows that the 
five CpGs upon E2 challenge are differentially methylated in a strand specific fashion with a 
peak at 45' E2, corresponding to the peak of histone H3K9 methylation (Fig. 2B), and they 
have a different levels of C  hydroxymethylation. In particular the C -400 on strand (+) is 
methylated during all time of estrogen stimulation, while it has a peak of C hydroxyl-
methylation at 15 and 30 min on strand (-) and then returns to baseline at 45-60 min (Fig. 7A). 
The C -388 has a low level of methylation/ hydroxyl-methylation on both strands it is 
oxidized with the same timing on the (+) and (-) strands, respectively (Fig. 7B). The C -370 on 
strand (+) is methylated for all the time of stimulation and formilated at 45 min E2, while it is 
hydroxyl-methylated at 45 min and completely formilated at 60 min on strand (-) (Fig. 7C). The 
C -354 is formilated 30 min to 60 min on strand plus ad present as 5-OHdmC at 45 min E2 on 
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the other strand (Fig. 7D), at last the C -301 is low formilated and hydroxyl-methylated 
respectively at 45 min and 15 min from stimulation (Fig. 7E). 
We conclude that estrogens induce a sharp C hydroxyl-methylation peak at specific Cs at 15-
30' E2 in a strand-specific manner. These data indicate a precise order in timing and space of 
repair induced by E2 and show that both oxidized C and G are precisely marked. We believe 
that methylation of C marks the abasic site and favors an efficient and precise repair.  
 
DNA oxidation drives the formation of chromatin loops induced by estrogens.  
Our data indicate that estrogens induce the same histone modifications in distal segments of 
target genes, suggesting that these regions are functionally synchronized and may be 
physically associated in an unique estrogen induced domain. To positively identify these 
domains, we performed the 3C analysis of three E2-induced genes indicated, on chromatin 
isolated from E2-induced cells. Briefly, fixed chromatin DNA was cleaved with a 
restriction enzyme and ligated under very diluted conditions to favor intra-molecular 
interactions. PCR and DNA sequence were then used to identify the ligated DNA 
segments. 
The results obtained have shown that chromatin loops bridging the 5'-ERE and polyA sites 
are cyclically induced by E2 at 15 min and 60 min. After stimulation BCL2 forms two loops: 
1. A loop connecting the ERE region and Poly_A (oligo 1-2), 2. A loop connecting TSS and 
Poly_A (oligo 3-4). The first loop do not depend on estrogen stimulation in fact it is present in 
basal condition and it is formed with a cyclicality of 15 min then stabilized at 240 min when 
estrogen transcription ends. Instead the second loop is induced by the stimulus, it appears 15 
min following E2 exposure, disappear 30 min to 45 min and reform by 60 min (Fig. 8). Since 
ERE and promoter are contiguous in PS2 gene, we detected essentially one major loop 
connecting the 5' (promoter-ERE) with the 3' end of the gene (Poly_A region). This loop 
appear at 0 min, it becomes weak between 15 and 30 min and stabilizes between 45 and 
60min from the stimulation (Fig. 9). Estrogen induced chromatin interactions in CAV1 gene 
at 15, 45 and 60 min, these connections involve ERE1 and Poly_A2 region (oligo 8-2) (Fig. 
10). Data in the literature have shown that the transcriptional factory and looping gene is 
stabilized by RNA molecules that hybridize with the DNA, in fact the treatment with RNasiH 
destroys loop induced by estrogen in PS2 (Fig. 9B). We have also investigated if the loop 
formation depend to LSD1 histone demethylation activity. To demonstrate that LSD1 is 
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involved in loop formation, we transfected the cells with a dominant negative LSD1ala. This 
mutant is still enzymatically active, but is unable to target transcription factors; the LSD1ala 
mutant protein is difective in binding to the promoter or ERE element of studied genes 
following E2 induction. The expression of this LSD1 variant inhibits E2-induced chromatin 
loop altering the looping kinetics of analyzed genes (Fig. 8B, Fig. 9B, Fig. 10B). 
 
Discussion 
Transcription induced by estrogen is associated with chromatin modification dependent from 
histone methylation-demethylation cycles. Our data show that estrogens induce a change of 
the histone code on target genes. (Fig. 2B, S1B, S2B). Both lysines 9 and 4 methylation are 
stabilized after the first hour of induced-transcription, when the transcription become 
productive and this change can be depend to the location of the enhancer (intra or inter-gene) 
and the status of the basal transcription (see BCL2 and CAV1 genes). LSD1 and JMJD2A are 
the major histone demethylases responsible for histone modification induced by estrogen. We 
find a different timing of the recruitment of LSD1 and JMJD2A at the gene locations 
examined (Fig 2C, S1C, S2C). In transcriptional activation fundamental is the role of LSD1 
histone demethylase that generates a DNA oxidative burst [16] and consequently a DNA 
repair enzymes recruitment: BER and NER enzymes (Fig. 2D/2E, S1D/E, S2D/E). The initial 
lesions are recognized by OGG1 and APE1, which display the same oscillations of 
demethylation-methylation cycles (15 and 45-60). Following OGG1, NER are recruited at 30 
min. Interestingly, XPC is recruited earlier at the ERE than XPG (15 min versus 45 min), 
while at the Poly_A both XPC and XPG are recruited with the same timing (Fig. 2E, S1E, 
S2E). XPC is part of the Global Genomic NER, which recognizes helix distortions regardless 
of the presence of Pol II. On the other hand, XPG is part of Transcription-Coupled NER, 
which assists the RNA Pol II during recognition of the lesion [21]. These data suggest that the 
ERE and Poly_A lesions are differently recognized and repaired. OGG1 recognizes the 8-oxo 
Gs detecting a distortion of the helix. This can represent a signal for recruitment of XPC (GG-
NER) at enhancer and can determine a stall of RNA Pol II at the Poly_A, which recruits XPG 
(TC-NER). The results obtained underline that the estrogen oxidative damage on regulative 
regions of estrogen-dependent genes is responsible of the interconnection between repair and 
transcription start systems. The recruitment of LSD1, in fact, acts as a pivot between 
transcription and repair and it simultaneously allows both the opening chromatin, then the 
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access to the promoter regions by the transcriptional machinery, that the production of ROS, 
responsible of promoter oxidative wave. Through a total genome analysis we have seen a 
transcriptional 8oxo-G accumulation (15 min) (Fig. 3); after we have analyzed the kinetic of 
oxidation/repair of specific Gs on two strands of different regions of PS2 gene to do that we 
used Ligation Proximity Amplification (LPA) technique. The data show that estrogens induce 
oxidation and repair differentially at the (-) and (+) strands of regulative regions (Fig. 5). In 
fact, in the transcription direction is repaired before the strand plus (TATA region) because it 
is not the template for mRNA synthesis and so it’s free to protein factors; in not codogenic 
direction is repaired before the strand minus (CnG region). The asynchronism and specificity 
of strand oxidation can be explained by the need of the cell not to induce double strand break 
to each transcriptional cycle and to prevent a steric hindrance between the transcriptional 
machinery and repair enzymes. Our data show that DNMT3a is recruited at the enhancer and 
Poly_A sites at 15-30 min (Fig 2F, S1F, S2F), and it is essential for productive transcription 
induced by estrogens and for the correct repair of oxidize G, in fact DNMT3A protect the C 
point in front to 8-oxoG promoting the correct repair of damage base. The changes in 
methylation and hydroxymethylation of CpG are also associated with the recruitment of TET1 
and TDG at enhancer and Poly_A sites. TET1 recognizes and modifies the methylcytosine, 
while TDG recognizes and removes a variety of oxydized and deaminated cytosines. TET1 is 
recruited 15–30 min to the enhancer and 60 min after estrogen stimulation to the Poly_A. 
TDG is recruited to the Poly_A and enhancer of BCL2 but not to CAV1 and pS2 enhancers 
(Fig 2D/2F, S1D/1F, S2D/2F). 
We analyzed the methylation and hydroxylation status of DNA at single strand resolution. 
Bisulfite analysis shows that template and non template strands have a different levels and 
timing of methylation/hydroxymethylation, the changes of hydroxymethylation are associated 
with the timing and the location of oxidized Gs, suggesting that the 2 events (G and C 
methylation-oxidation) are tightly associated (Fig. 7). The local DNA oxidation following 
demethylation by LSD1 releases supercoiling and rigidity of the helix, so it allows the 
physical connections between distant intergenic regions, the chromatin loops with discrete 5' 
and 3' borders and transcriptional activation. These loops depend on LSD1 action in fact the 
expression of dominant negative (LSD1ala) alters the kinetics of gene looping and they are 
stabilized by mRNA that hybridized with DNA in effect the treatment with RNaseH destroys 
its interactions (Fig. 8, Fig. 9, Fig. 10). 
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Figure 1 
 
 
 
Estrogen receptor ! synchronizes the recruitment of histone demethylase (LSD1) and DNA repair enzyme 
(OGG1) at multiple sites across the genome. Screening human promoter array for ER!, LSD1 and OGG1 recruitment 
sites induced by estrogen. MCF7 were grown in 10% of dextran-coated charcoal stripped serum for 3h and stimulated 
with 50nM of E2 for 45 minutes. Formaldehyde-fixed chromatin was immunoprecipitated with antibody anti ER!, 
LSD1 or OGG1 and was resolved by GeneChIP Human promoter Array 1.0 (Affymetrix). Panel A shows the 
percentage of ER! interaction with LSD1 and OGG1 in mono, bivalent and trivalent complexes, on different genomic 
regions in presence (histogram red) or absence (histogram blue) of estrogen stimulation. Panel B shows occupation sites 
of ER!, LSD1 and OGG1 on CAV1, BCL2 and PS2 with or without E2 stimulation. The black boxes represent ER! 
binding sites, red ones LSD1binding sites and green ones OGG1 binding sites 3'UTR-5'UTR orientation. Estrogen 
stimulation lead to an increase of ER!, LSD1 and OGG1 co-occupancy on gene regulative regions. 
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Figure 2 
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Intertwined Cycles of histone H3 methylation and recruitment of DNA repair enzymes at ERE and polyA sites of 
PS2 gene. MCF7 cells were serum starved and exposed to 50 nM E2 at the indicated times (0, 15, 30, 45 and 60 
minutes). A- qChIP was carried out using specific antibodies recognized estrogen receptor alpha (ER!), H3K9Ac and 
total H3 on the estrogen responsive elements (ERE) and polyA of PS2 gene. Estrogen stimulation induces histone code 
changes; panel B shows H3K4m2/m3 and H3K9m2/m3 occupancy on PS2 ERE and Poly_A; The histone methylation 
and demethylation changes depend on the recruitment of histone demehylases on gene regulative regions. Panel C shows the 
recruitment of LSD1 and JMJD2A on above-mentioned regions. Histone methylation cycles overlap with the recruitment 
of BER, NER, DNMT3a and TET1. D- MCF7 cells were analyzed by qChIP using specific antibodies recognizing the 
OGG1, APE1 and TDG on ERE and Poly_A of PS2. Panel E shows the recruitment of NER enzymes (XPA, XPC, XPG and 
RPA) on studied regions; panel F shows the recruitment of DNMT3a and TET1 on the same regions of PS2. The results 
were normalized on estrogen unstimulated sample and on the percent of input. The statistical analysis derived from at 
least 3 experiments in triplicate (n -9; Mean±SD). 
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Figure 3 
 
 
 
Total genome analysis of 8-oxo-deoxyguanosine (8-oxoG). DNA extracted from MCF7 stimulated with 50 nM of E2 
alone (blue lines) or in combination with 2,5 µM !-amanitin (AMA) (red line) or 10 nM 4-hydroxytamoxifen (4-OHT) 
(green line in panel on the left) or 10 µM parnate (Par) (green line in panel on the left) at different time (0, 15, 30, 45 
and 60 min) was analyzed through spectrometry to evaluate the 8oxo-G accumulation in genome. The results shown are 
normalized on E2 unstimulated sample. S.E.M was employed as statistical analysis. 
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Figure 4 
 
 
 
LPA assay control. DNA extrated by unstimulated MCF7 was used to syntetized DNA strands with normal G and with 
10% and 50% of modified bases such as 8-oxoG and formilC (deoxyformilcytosine) in presence and absence of FPG 
(8-oxoGuanine DNA Glycosylase from E.coli) the treatment with FPG generates apurinic sites, where 8-oxoG was 
present. The generated nick do not support ligation and PCR of contiguous primers. The figure shows the results of 
LPA used to amplyfied strands with modyfied bases. Panel A shows amplification efficiency of plus strand syntetized 
with normal G and 10% of 8-oxoG and formilC with or without FPG treatment; panel B refers to amplification 
efficiency of plus strand syntetized with normal G and 50% of 8-oxoG with or without FPG treatment. The statistical 
analysis derived from at least 3 experiments in triplicate (n -9; Mean±SD). 
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Figure 5 
 
 
 
 
 
 
 
 
 
 
Estrogen induces strand specific oxidation and repair of 8-oxodG. MCF7 cells were serum starved and exposed to 
50 nM E2 at the indicated times (0, 5, 15, 30, 45 and 60 minutes). Resulting DNA was used to analized Gs (8-oxoG) 
oxidation level on different regulative regions of PS2 through Ligation-dependent Probe Amplification (LPA) method. 
Data is expressed as relative efficiency of minus strand; all data is normalized on PCR efficiency (not LPA standard) 
obtained on same DNA using primers couple for the same analyzed region. Panels A, B, C, D and E show the kinetics 
of oxidation/repair on plus strand (+) (on left) and minus strand (-) (on right) respectively on ERE, CnG, TATA, 
Poly_A and INTRON 1 regions at 0, 5, 15, 30, 45 and 60 min after estrogen induction. 
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Total genome analysis of 8-oxo-deoxyguanosine (5OHmdC). DNA extracted from MCF7 stimulated with 50 nM of 
E2 alone (blue lines) or in combination with 2,5 µM !-amanitin (AMA) (red line) or 10 nM 4-hydroxytamoxifen (4-
OHT) (green line in panel on the left) or 10 µM parnate (Par) (green line in panel on the left) at different time (0, 15, 30, 
45 and 60 min) was analyzed through spectrometry to evaluate the 5OHmdC accumulation in genome. The results 
shown are normalized on E2 unstimulated sample. S.E.M was employed as statistical analysis. 
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Figure 7 
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Estrogen induces strand specific oxidation and repair of 5hmC. MCF7 cells were treated with 50nM of E2 at the 
indicated times (0, 15, 30, 45 and 60 min). DNA was extracted and used for OxBS-sequencing to determine the 
methylation and oxidation of C induced by estrogens of 5 CpG on ERE region. The use of potassium perruthenate 
(KRuO4) oxidizes 5-hydroxymethyl-cytosine (5hmC) into 5-formyl-cytosine (5fC), which after bisulfite conversion is 
read as uracil in the sequence. A, B, C, D and E panels show the percentage of modified Cs on plus strand (on the left) 
and minus strand (on the right) respectively of CG41, CG53, CG71, CG87 and CG140. The black task bar represent 
methylcytosine (mC), red ones hydroxymethyl-cytosine (HmC) and green ones formilcytosine (FC). The statistical 
analysis derived from at least 2 experiments in duplicate. 
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Figure 8 
 
 
Formation of dynamic chromatin loops during early E2-induced transcription. 3C analysis of BCL2 chromatin in 
MCF7 cells exposed to 50 nM of E2 for various periods of time. A- Schematic representation of gene and sites of Bam 
H1 enzyme. All the combinations of primers indicated, were performed on ligated chromatin. Each loop was detected 
with different primers pairs. B- Time course of chromatin looping during E2 induction in control cells, cells transfected 
with LSD1 WT and with a dominant negative LSD1 ALA. 3C analysis was carried out as described in Methods and the 
loops shown in panels B were quantified by qPCR and verified by gel electrophoresis and DNA sequencing (data not 
shown). Oligos 1-2 in higher panel show the ERE-polyA interaction (213 bp stripe); the middle high panels show the 
TSS-polyA interaction (oligos 3-4, 361 bp stripe); the lower panels show control region (oligos 5-6, 317 bp stripe). 
Shown results derive from a least 3 experiments in triplicate (n-9; Mean±SD). 
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Figure 9 
 
 
Formation of dynamic chromatin loops during early E2-induced transcription. 3C analysis of PS2 chromatin in 
MCF7 cells exposed to 50 nM of E2 for various periods of time. A- Schematic representation of gene and sites of Ava II 
enzyme. All the combinations of primers indicated, were performed on ligated chromatin. Each loop was detected with 
different primers pairs. B- Time course of chromatin looping during E2 induction in control cells, cells transfected with 
LSD1 WT and with a dominant negative LSD1 ALA. 3C analysis was carried out as described in Methods and the 
loops shown in panels B were quantified by qPCR and verified by gel electrophoresis and DNA sequencing (data not 
shown). Oligos 1-2 in panels show the ERE/TSS-polyA interaction (316 bp stripe); oligos 5-6 show the amplification of 
control region (294 bp stripe). Panel +RNasi H shows the kinetics of chromatin looping after the treatment with 
RNasiH. Shown results derive from a least 3 experiments in triplicate (n-9; Mean±SD). 
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Figure 10 
 
 
 
Formation of dynamic chromatin loops during early E2-induced transcription. 3C analysis of CAV1 chromatin in 
MCF7 cells exposed to 50 nM of E2 for various periods of time. A- Schematic representation of gene and sites of Ava II 
enzyme. All the combinations of primers indicated, were performed on ligated chromatin. Each loop was detected with 
different primers pairs. B- Time course of chromatin looping during E2 induction in control cells, cells transfected with 
LSD1 WT and with a dominant negative LSD1 ALA. 3C analysis was carried out as described in Methods and the 
loops shown in panels B were quantified by qPCR and verified by gel electrophoresis and DNA sequencing (data not 
shown). Oligos 1-2 in panels show the Promoter/ERE1 interaction (156 bp stripe); oligos 8-2 show the polyA2-ERE1 
interaction (263 bp stripe); last to panels refer to control region amplification (250 bp stripe). Shown results derive from 
a least 3 experiments in triplicate (n-9; Mean±SD).  
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Intertwined Cycles of histone H3 methylation and recruitment of DNA repair enzymes at ERE and polyA sites of 
CAV1 gene. MCF7 cells were serum starved and exposed to 50 nM E2 at the indicated times (0, 15, 30, 45 and 60 
minutes). A- qChIP was carried out using specific antibodies recognized estrogen receptor alpha (ER!), H3K9Ac and 
total H3 on the estrogen responsive elements (ERE) and Poly_A of CAV1 gene. Estrogen stimulation induces histone 
code changes; panel B shows H3K4m2/m3 and H3K9m2/m3 occupancy on CAV1 ERE and polyA; The histone 
methylation and demethylation changes depend on the recruitment of histone demehylases on gene regulative regions. Panel 
C shows the recruitment of LSD1 and JMJD2A on above-mentioned regions. Histone methylation cycles overlap with the 
recruitment of BER, NER, DNMT3a and TET1. D- MCF7 cells were analyzed by qChIP using specific antibodies 
recognizing the OGG1, APE1 and TDG on ERE and Poly_A of CAV1. Panel E shows the recruitment of NER enzymes 
(XPA, XPC, XPG and RPA) on studied regions; panel F shows the recruitment of DNMT3a and TET1 on the same regions 
of CAV1. The results were normalized on estrogen unstimulated sample and on the percent of input. The statistical 
analysis derived from at least 3 experiments in triplicate (n -9; Mean±SD).  
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Intertwined Cycles of histone H3 methylation and recruitment of DNA repair enzymes at ERE and polyA sites of 
BCL2 gene. MCF7 cells were serum starved and exposed to 50 nM E2 at the indicated times (0, 15, 30, 45 and 60 
minutes). A- qChIP was carried out using specific antibodies recognized estrogen receptor alpha (ER!), H3K9Ac and 
total H3 on the estrogen responsive elements (ERE) and polyA of BCL2 gene. Estrogen stimulation induces histone 
code changes; panel B shows H3K4m2/m3 and H3K9m2/m3 occupancy on BCL2 ERE and Poly_A; The histone 
methylation and demethylation changes depend on the recruitment of histone demehylases on gene regulative regions. Panel 
C shows the recruitment of LSD1 and JMJD2A on above-mentioned regions. Histone methylation cycles overlap with the 
recruitment of BER, NER, DNMT3a and TET1. D- MCF7 cells were analyzed by qChIP using specific antibodies 
recognizing the OGG1, APE1 and TDG on ERE and Poly_A of BCL2. Panel E shows the recruitment of NER enzymes 
(XPA, XPC, XPG and RPA) on studied regions; panel F shows the recruitment of DNMT3a and TET1 on the same regions 
of BCL2. The results were normalized on estrogen unstimulated sample and on the percent of input. The statistical 
analysis derived from at least 3 experiments in triplicate (n -9; Mean±SD). 
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Table 1 
 
! *+,-.+/!"0+!12,*! 3014/!
#$%&!'('!)*! +,-#./0/#00//.000#..#/.-1,! 234!5!.))6!
#$%&!'('!(78! +,-.#.0/0/00###.###0##/0-1,! 234!5!.))6!
#$%&!&9:;</!)*! +,-#./#.#/#.0#00/.0####/0-1,! 234!5!.))6!
#$%&!&9:;</!(78! +,-0#..#.0./.###.##.#.0#.0-1,! 234!5!.))6!
#$%&!'('!)*! +,-#/.././/0#.0.#0#/0/0-1,! =#>4!
#$%&!'('!(78! +,-0/000.#/00.00/##/#/0-1,! =#>4!
#$%&!&9:;</!)*! +,-/0.///.0.0###/0##.#.-1,! =#>4!
#$%&!&9:;</!(78! +,-./000/.00..#.#.0..0#-1,! =#>4!
#$%&!'('!)*! +,-00/.#../0/.///0#.00//00-1,! #/?6!
#$%&!'('!(78! +,-0/.#.#0#/0/00/#/##/#/#-1,! #/?6!
#$%&!&9:;</!)*! +,-0/.0.0/..0#/0//##/-1,! #/?6!
#$%&!&9:;</!(78! +,-#//#/0#..#///0/0.0-1,! #/?6!
! *+,-.+/!"0+!51! 3014/!
@>%0@!6!A&B7C7DE7FG! +,-#/#00/#/#.00/.#..0/#./.-1,! =#>4!
@>%0@!6!AH7DE7FG! +,-####..##.#..0#.00./.#-1,! =#>4!
@>%0@!4!A&B7C7DE7FG! +,-#..#..0###..#.0/.00..0-1,! =#>4!
@>%0@!4!AH7DE7FG! +,-./.0#0#0.000/00.0.-1,! =#>4!
@>%0@!1!A&B7C7DE7FG! +,-//.##.#00#.0..###.0..#/#-1,! =#>4!
@>%0@!1!AH7DE7FG! +,-.#.0##..####/..#//#./../-1,! =#>4!
@>%0@!I!A&B7C7DE7FG! +,-#0/#0/#..#.###0##0#./##-1,! =#>4!
@>%0@!I!AH7DE7FG! +,-00/#0000.0//#.00000/00/.-1,! =#>4!
@>%0@!+! +,- /0..0#.//#/0.0/.0/0/00#.!-1,! =#>4!
@>%0@!J! +,-!/##0/0/####.#..0#.#!-1,! =#>4!
@>%0@!6!A&B7C7DE7FG! +,-0/..//0.#.##..#.000/-1,! &34!
@>%0@!6!AH7DE7FG! +,-/0.0//#0.00..#/#.#-1,! &34!
@>%0@!4!A&B7C7DE7FG! +,-.#/0/...#0.#/.0##..#!-1,! &34!
@>%0@!4!AH7DE7FG! +,-#.#./.##./00#//0#./-1,! &34!
@>%0@!1! +,-###/.000///0/000/#...#-1, &34!
@>%0@!I! +,-0.00##/..0##.##.#.#.0#-1, &34!
@>%0@!6!A&B7C7DE7FG! +,-#.000#0000/00.0//0/0-1,! #/?6!
@>%0@!6!AH7DE7FG! +,-0//0/0//0##/00//.0..../.-1,! #/?6!
@>%0@!4!A&B7C7DE7FG! +,-/#000//#0#0///#/00.0//0#-1,! #/?6!
@>%0@!4!AH7DE7FG! +,-##000/0//0##.0#00#.0#-1,! #/?6!
@>%0@!K!A&B7C7DE7FG! +,-0/00#//./##//00..#/.#/.#-1,! #/?6!
@>%0@!K!AH7DE7FG! +,-//0..000.0.0/0.00/...///0-1,! #/?6!
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Table 2 
 
 *+,-.+/!"0+!3*6! 3014/!
'('!>&@!L%HM3! +,-000..###.//000..00/##/#.0#/0//0.0/..#/./0.0/0/0/.00##-1,! 234!5!.))6!
'('!(&@!L%HM3! +,-00/////00#..00##0.0/#//#/0.00#.#/#0000.0.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
'('!>&@!&>M3! +,-000..###.//000..00/#/####0.0/0##/#.0..0.#/#00##//0##.....##-1,! 234!5!.))6!
'('!>&@!&>M3! +,-000..###.//000..00/#/####0.0/0##/#.0..0.#/#00##//0##.....##-1,! 234!5!.))6!
'('!(&@!&>M3! +,-00##/.#.#.#/#./.0//.#/#..#.0#/0.00.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
%H.(@H!>&@!&>M3! +,-000..###.//000..00/##////0#/00.00/0/0.//#.#/000.00#/000#####-1,! 234!5!.))6!
%H.(@H!(&@!&>M3! +,-00/0/##..#0/0//0.0#0/#0/00/00000#.0.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
%H.(@H!>&@!L%HM3! +,-000..###.//000..00/#/0#####.##.#0.#0#/#..#.#0//00.#.##-1,! 234!5!.))6!
%H.(@H!(&@!L%HM3! +,-00000###.0##/###.0/0../#.#.##/##.0#....00.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
././!>&@!&>M3! +,-000..###.//000..00/#.//#0#.#...//0#///#/0/0##.0###././///.##-1,! 234!5!.))6!
././!(&@!&>M3! +,-0000#.#000#00##.#.#/.###.0/#.#0000.#0.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
././!>&@!L%HM3! +,-000..###.//000..00/#0/####0/0.#/000/.0/0/00##0###0/0####-1,! 234!5!.))6!
././!(&@!L%HM3! +,-00/...././000#/00#.#.0...0#..///0/0#0../0.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
#C0!>&@!&>M3! +,-000..###.//000..00/#..#####.0#//00.#/#00.00##/####0.0/0##/#.-1,! 234!5!.))6!
#C0!(&@!&>M3! +,-0..0.#/#00##//0##.....##00##/.#.#.#/#./.0.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
#C0!>&@!L%HM3! +,-000..###.//000..00/#/./0.0/0/0/.00##00/////00#..00##0.0/#//#/-1,! 234!5!.))6!
#C0!(&@!L%HM3! +,-0.00#.#/#0000.00##/##0.0/##..0#/00000//0.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
&9:;</!>&@!&>M3! +,-000..###.//000..00/##...0/#./#.#////..00##./////..////0/0/.#-1,! 234!5!.))6!
&9:;</!(&@!&>M3! +,-0/./..//.#.0.0#.0..#/..#....///0//./.0//0.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
&9:;</!>&@!L%HM3! +,-000..###.//000..00/#..#/./..#...////0//.0//#/0#/#/0/..//./.#-1,! 234!5!.))6!
&9:;</!(&@!L%HM3! +,-0/.#.#....//...../00##//....0/0./0.#///00.#./0/..00/.#..0#.00#/#-1,! 234!5!.))6!
MCN87BDO:!>&/!)*! +,-000..###.//000..00/-1,! 234!5!.))6!
MCN87BDO:!>&/!(*! +,-0.0##/0#//0/.##//.#./0/-1,! 234!5!.))6!
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Table 3 
 
! *+,-.+/!"0+!07,869,:.!;,/43",9.! >@#M3!
'('!PND!LNCQD!(*! +,-.///#..#/.///#.##..###..-1,! 234!5!.))6!
'('!PND!LNCQD!)*! +,-00..../..././...0/0/00......-1,! 234!5!.))6!
'('!=%3!2:QD!)*! +,-/.000..../.0/0........-1,! 234!5!.))6!
'('!=%3!2:QD!(*! +,-////.#.##.##//##.//##..//-1,! 234!5!.))6!
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Chapter 4: DNA damage and direct site repair 
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DNA double-strand breaks (DSBs) is the most hazardous lesions for the cells. DSBs are 
generated when the two complementary strands of the DNA double helix are broken 
simultaneously at nearby sites. Physically dissociated ends can recombine inappropriately 
with other genomic sites, leading to chromosomal translocations. Eukaryotic cells have 
evolved complex, highly conserved systems to rapidly and ef"ciently detect these lesions and 
bring about their repair. These lesions are repaired either by homologous recombination (HR) 
or by nonhomologous end joining (NHEJ). HR can lead to gene conversion, a conservative 
process in which a donator DNA sequence with homology is copied into a broken locus, 
making the repaired locus an exact copy of donator sequence without altering the donator 
sequence. 
Cuozzo et al. have shown that there is an association between DNA damage, repair with 
homologous recombination and DNA methastable methylation (methylation pattern generate 
as consequence of DNA damage repair). To explore the molecular mechanisms involved in 
these processes we have been used system pioneered by M. Jasin (Jasin M. 1996; Pierce A.J. 
et al., 1999) DR-GFP plasmid. In this construct can be induced double-strand break (DSB) in 
“reporter” gene through the cleavage with a meganuclease, the repair of the damage if occurs 
with the homologous recombination (HR), re-establish the continuity of codogenic region and 
it allow the expression of “reporter” protein. DR-GFP plasmid contains two copies of GFP 
gene oriented as direct repeats and separated by a drug selection marker, the puromycin N-
acetyltransferase gene. An upstream cytomegalovirus (CMV) enhancer fused to the chicken 
%-actin promoter provided a strong and insulated transcriptional unit. Both copies of GFP do 
not produce a functional protein; the upstream GFP gene (cassette I) is transcribed but 
produces a truncated protein as it has been subjected to mutagenesis substituting 11 bp of the 
wild-type gene for introduce a recognition site for I-SceI, a rare-cutting endonuclease that 
does not cleave several eukaryotic genomes tested (Jasin M. et al., 1996) These substituted 
base pairs introduce two in frame stop codons that terminate translation. The downstream 
GFP (cassette II) is inactivated by upstream and downstream truncations. After DBS if the 
damage is repaired with HR and if occur a gene conversion between two GFP genes, in which 
the cassette II is the donor of wild-type sequence can be produced a functional copy of GFP. 
The low rate of GFP+ cells after DSB generation isolated with flow cytometric analysis 
permitted to hypothesize that some wild-type GFP recombinants were silenced by 
methylation, in fact the inhibition of methylation with 5-aza-2'-deoxycytidine (5-AzadC) 
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increased the number of GFP+ cells (clones with single integration) in a pool of cells carrying 
DR-GFP. In addition FACS analysis have shown that there is a bimodal fluorescence 
distribution caused by two different recombinant populations high (HR-H) and low-
expressing (HR-L) cells, it happens because hypomethylated/hypermethylated molecules are 
generated after DSB/HR in a 1:1 ratio. Morano et al. proved that the transient stalling of RNA 
polymerase II induced by !-amanitin during repair increased GFP methylation in fact the 
numember of L clones increase while the fraction of H clones decrease. They proposed that 
stalled RNA polymerase during repair favors the recruitment of enzymes that methylate the 
repaired DNA, consolidating the methylation of L clones. This event occurs only during 
repair because stalling Pol II before or after DSB repair does not modify GFP methylation and 
expression, and they depend on the stall of Pol II because the treatment with actinomycin-D 
that depletes RNA polymerase II from chromatin prevent the accumulation of H clones. The 
original methylation pro"les induced by HDR are remodeled in a transcription-dependent 
fashion during the "rst 15 days after repair, in fact the transcription convert a fraction of L to 
H cells by favouring loss of methylation. In particular the process consists in the introduction 
of a DSB in a copy of the gene (cassetta I) through the nuclease I-SceI, the lesion undergoes 
5'$3' end resection, after the 3' free single strand end of strand plus invades the DNA of the 
GFP cassette II, while 3' free single strand end of strand minus DNMT3a (DNA methyl 
transferase de novo) is recruited in the first 24h after damage and adds methyl groups. At 48h 
on this strand the stalling RNA Pol II stalling on this strand leads to the recruitment of 
DNMT1(DNA methyl transferase de novo) and NP95 that amplify the methylation of region, 
while on strand plus is recruited GAD45 which promotes the loss of methylation from 
repaired strand. So after repair hemi-methylated DNA is generated. In cells which are in 
replication phase, the passage of the replication fork before that DNMT1 copy methylation 
pattern on the complementary strand, generates two copies of GFP gene converted with 
different degree of methylation inherited from different cells; H clones with high fluorescence 
and with hypomethylated GFP gene and L clones with low fluorescence and with 
hypermethylated GFP gene. 
Cleared the link between DNA damage, repair and de novo methylation in this paper we have 
explored if DNA methylation patterns at repaired site are associated with change of chromatin 
structure (chromatin methylation and looping) after and before repair. 
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variations drive or are induced by local DNA methylation. These events could generate cells with the same geno-
type but with various levels of gene expression.
We address the following three questions in this paper. First, what is the relationship between chromatin 
changes and DNA methylation at the site of repair. Second, what is the origin of the polymorphism of somatic 
DNA methylation. Third, does, in fact, the extent and pattern of methylation following repair impart variation of 
gene expression in cell populations with an identical genotype? We chose to approach these questions in a system 
in which DNA damage and repair can be controlled temporally and spatially, focusing our attention on local 
transient as well as permanent changes induced by damage and repair.
Results
Spatial and temporal changes of the histone H3 methylation code after homologous repair of 
a DSB at the GFP locus. The DRGFP system. The critical features of the system we use to study repair and 
methylation can be summarized as follows. A reporter construct (Direct-Repeat GFP: DRGFP) is randomly inte-
grated in the genome of Hela cells at an average copy number of 1. I-SceI induces a double-strand break (DSB) in 
one GFP copy (I cassette) that can be repaired from the second copy (II cassette) by homologous recombination 
(HR), yielding GFP+ clones. 75–90% of the cells are repaired by NHEJ with or without small deletions at the I-SceI 
site6,13. Importantly, GFP+ cells can arise in this system only by HR6. I-SceI expression starts 2 h after transfection 
with an I-SceI plasmid, peaks at 24 h and slowly decays up to 48 h. At 48 h total HR, measured by qPCR, is approx. 
5.0 to 10%. Cells exposed to I-SceI but which are not GFP+ are termed UnRec (unrecombinant). GFP+ cells fall 
into two expression classes: high and low expressers, Rec H and Rec L, respectively.
Transient histone H3 methylation changes induced by a DSB. Our previous work showed that levels of GFP 
expression reflected local DNA methylation patterns at the repaired I-SceI site8. To determine if these pat-
terns were associated with changes in chromatin methylation, we probed the histone H3 PTMs, methylation 
of lysines 4 and 9, at the DSB and flanking sites 24 h, 48 h and 7 days after I-SceI expression. Chromatin was 
immune-precipitated with antibodies recognizing H3, H3K4m2/3 (an activation marker) or H3K9m2/3 
(a repression marker). The DNA was amplified with primers corresponding to several sites upstream or down-
stream of the DSB along with a reference gene, exon 9 of TSHR (Fig. 1A). ChIP experiments were repeated three 
times in triplicates (see Supplemental Statistical Tables).
Major alterations in chromatin modification (loss of H3K4me2/3 and gain of H3K9me2/3) appeared just 3′ 
to the DSB 24 h after the onset of I-SceI expression: These changes disappeared 7 days later, when I-SceI levels 
decayed (Fig. 1B, panels 6 and 10; and ref. 11). Histone H3 decreased transiently 5′ to the DSB, but there were few 
other changes in the histone methylation pattern in this segment (panels 5 and 9). The H3K9 or H3K4 methyla-
tion patterns at the PolyA addition site (panels 7 and 11) or within the control TSHR gene (panels 8 and 12) were 
unaltered.
The major fraction of GFP + cells did not appear until 48 h. Since loss of H3K4me2/3 was detectable as early as 
24 h post transfection, is likely that loss is induced by the DSB itself or by NHEJ repair of the DSB. These local his-
tone methylation changes did not involve nucleosome or histone eviction, since total H3 content did not change 
significantly at the I-SceI site (Fig. 1B, panel 2).
Dynamics of histone H3 methylation changes after DNA repair. At 7 days post-HR, we analysed H3K4me2/3 
(Fig. 1C) and found no clear change in status in control cells (no DSB), cells subjected to I-SceI, sorted GFP− 
(UnRec) and HR cells, GFP+ (Rec). We did observe, however that H3K9me2/3 marks appeared to be selectively 
modified in HR processed DSBs (Fig. 1C). To explore these changes in H3K9 methylation, we sorted the high 
GFP+ (Rec H) and the low (Rec L) GFP+-expressing cells, which had been repaired by HR (Fig. 2A) and analysed 
the histone modification at various sites using primers in Fig. 1A. This analysis was performed at 14 days post 
I-SceI exposure (a time when there was no further HR). This analysis yielded the following results. First, we saw 
little change in H3K4me2/3 levels in the intron 5′ to the DSB (primers a/c) when we compared control cells to 
Rec H or Rec L cells (Fig. 2B, panel 1). Second, H3K9me2/3 levels in Rec H cells were significantly reduced rel-
ative to control and Rec L cells (Fig. 2B panel 4). Third, the region immediately 3′ to the I-SceI site (primers r/h) 
was enriched in H3K4me3 in Rec H cells and in H3K9me3 in Rec L cells (Fig. 2B, panel 2 and 5). Fourth, GFP+ 
cells (both Rec H and Rec L) were strikingly different from control cells at the polyA addition site (primers p/q). 
Specifically, Rec H cells were characterized by high H3K4me3 levels (Fig. 2B, panel 3) whereas Rec L cells showed 
elevated H3K9me2/3 levels (Fig. 2B, panel 6). These changes were detectable in the population of HR cells but not 
in the mass, unsorted, population (Fig. 1B, panels 7 and 11, and 1C). From these data, we conclude that chromatin 
corresponding to the repaired GFP gene in recombinant GFP+ cells showed significant localized changes of his-
tone H3 K4-K9 methylation markers compared to control cells. H3K9me3 was elevated at the 3′ end of the DSB in 
Rec L cells, and depleted at the 5′ end of the DSB in Rec H cells. Conversely, H3K4me3 accumulated mainly at the 
polyA site in Rec H cells. Loss of the repressive H3K9me2/3 marks at the promoter region in Rec H cells and the 
dramatic increase in H3K9me3 just 3′ to the repaired DSB in Rec L cells are related to high and low GFP mRNA 
levels in this region in H and L clones, respectively8.
The changes in the methylation represent a permanent, HR-associated, modification in Rec L cells. Recall that 
Rec L cells acquired new methylated CpGs at the DNA region immediately 3′ to the DSB after recombination, 
consistent with the idea that histone and DNA methylation are causally related.
DNA Methylation stabilizes the H3K9m2/3 marker. Why does the elevated H3K9m3 mark persist in Rec L cells? 
We hypothesized that HR-induced methylation of repaired DNA may maintain H3K9m3 at the repaired site. 
To test this idea, we de-methylated DNA in Rec L cells with 5-azadC and measured H3K9m2/3 content at three 
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Figure 1. Spatial and temporal changes of histone H3 PTM after DSB at the GFP locus. (A) Schematic 
diagram of DRGFP plasmid and a reference locus (TSHR exon 9). Structure of the DRGFP plasmid integrated 
as single copy in different locations in Hela cells. Primers a and c cannot be used in cells transiently transfected 
with I-SceI plasmid because they are also present in intron 1 of the I-SceI expression vector. (B) H3K4m2/3 and 
H3K9m2/3 content of GFP and the reference gene. DRGFP cells were transfected with I-SceI and characterized 
24 h, 48 h and 7 days later. Cells were fixed and the chromatin analyzed by ChIP with the indicated antibodies. 
qPCR on each immunoprecipitate was carried out with the primers indicated in A. The specific antibodies are 
indicated at the top of each column. Each panel is identified by a numbered box in the upper left side.*P < 0.01  
(t test) as compared with untreated control or basal. (C) H3K4m2/3 and H3K9m2/3 content in cells sorted 7 days 
after transfection. CTRL are cells transfected with a control plasmid; UnRec were GFP− cells sorted and separated 
from GFP+ Rec cells after I-SceI transfection. *P < 0.01 (t test) as compared with UnRec or CTRL. The detailed 
statistical analysis of the data shown in panels (B,C) is reported in Supplemental Statistical Tables 1 and 2.
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Figure 2. Spatial and temporal changes of histone H3 K4-K9 methylation after homologous repair at 
the GFP locus in HR cells. (A) DRGFP Hela cells were transfected with the I-SceI vector and sorted for GFP 
expression 14 days later as described in Methods. The panels from the left to the right show the gating strategy 
used to sort Rec H and Rec L cells. The percent of viable cells was 90.6. The fraction of the total GFP+ cells 
(middle panel) or of Rec H and Rec L (left panel) is indicated. (B) H3K4m2/3 and H3K9m2/3 levels at GFP 
chromatin in purified Rec H and Rec L cells, 14 days after I-SceI transfection. The specific primers are indicated 
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locations in the GFP locus (Fig. 2C; primers defined in Fig. 1A). We found that 5-azadC significantly reduced 
H3K9m2 and H3K9m3 content in Rec L cells throughout the gene (Fig. 2C). Thus, DNA methylation at the 
repaired GFP locus is required to maintain chromatin H3K9 methylation within the region. Taken together, these 
data suggest that the extensive, rapid, localized and transient increase of H3K9m2/3 is induced by DSB formation 
in all treated cells (Fig. 1B, panel 10). Seven days later (after most of the breaks are repaired), this mark largely dis-
appears and is replaced by the activation marker H3K4m2/3. In the low-expressing Rec L fraction, in which GFP 
DNA is hypermethylated following HR, the repressive H3K9m2/3 marker remains at the I-SceI site. A schematic 
model of the histone methylation changes induced by the DSB and HR is shown in Fig. 2D.
Chromatin looping induced by damage and repair. We suggest that de novo DNA methylation at the site of DSB 
repair stabilizes the H3K9m3 mark, which alters the chromatin structure of the entire GFP gene. To map specific 
domains modified by DNA damage and repair, we examined the structure of chromatin at the repaired locus in 
UnRec (repaired by NHEJ) and Rec cells by chromosome conformation capture (3C). Among the primers used 
(Fig. 3A,B), only a few were able to amplify specific DNA fragments. PCR and sequence analysis showed these 
segments to be contiguous in the chromatin but not in the DNA. Two looped segments are shown in Fig. 3A. 
Loops A and C are specific to recombinant cells and mark different regions of GFP cassette I at the 5′ end relative 
to the I-SceI site: loop A links a region that includes a GFP transcription start site driven by the chicken β -actin 
promoter (5′ end, identified by primer d, from − 517 to − 279; green loop). Loop C includes a more distal 3′ region 
of the GFP coding sequence located downstream to the I-SceI site (5′ end identified by primers f, g, from + 70 to + 
300; blue loop). Figure 3A, right panel, shows that 48 h after I-SceI expression, at which time repair was complete, 
both loops were detectable in the mass culture. Thus, these loops form soon after the repair process. Figure 3B 
shows the chromatin loops detected in Rec H and Rec L sorted cells after I-SceI transfection. In addition to loops 
A and C, two other chromatin loops juxtapose different elements of the DRGFP insert. One loop connects the 
PGK1-PolyA addition site of the puromycin acetyl transferase gene with its promoter (loop D in red, Fig. 3B). 
This loop, present both before and after DNA damage and repair, marks the border of the puromycin acetyl trans-
ferase gene transcription unit, and serves as an internal positive control. Loop B, present in both recombinant and 
UnRec cells, serves as an additional internal control (Fig. 3B, orange loop, 5′ end identified by primer e). Loops A 
and C mark selectively recombinant cells as shown in Fig. 3A. Specifically, the frequency of loop A is high in Rec 
H and low in Rec L cells, whereas loop C abundance was the converse, low in Rec H and high in Rec L cells. Note 
that the 5′ end of loop C corresponds to the segment of GFP that is de novo methylated after repair. It is possible 
that local DNA methylation influences the formation or stability of loop C in L cells. Consistent with this notion, 
Rec L cells exposed to 5-azadC (and consequently hypomethylated) for 72 h formed less loop C and more loop A. 
Thus, Rec L cells may convert to Rec H cells following loss of DNA methylation (Fig. 3C, panels 1 and 3). These 
data suggest that these chromatin loops are related to the transcription efficiency of the repaired gene. To clarify 
this point, we first determined RNA polymerase II (Pol II) occupancy by ChIP analysis at the GFP promoter, the 
translation start site, the DSB region and the 3′ polyA site (Supplemental Fig. S1A). Pol II concentrations were 
highest at the GFP promoter and polyA sites in non-recombinant or Rec H cells. Pol II occupancy was reduced 
at all sites in Rec L cells relative to UnRec or Rec H cells. Second, we inhibited transcription with low doses of 
actinomycin D and monitored formation of loops A and C. Actinomycin D reduced the abundance of loop A in 
both Rec H and Rec L cells and loop C in Rec L cells (Fig. 3C, panels 2 and 4), suggesting that both loops are either 
generated or maintained by transcription. The results of these experiments are summarized in Fig. 3D.
In summary, DNA repair and associated transcription permanently modify the structure of local chromatin, 
generating chromatin loops that juxtapose the 3′ end of the transcribed gene with various 5′ sites. These struc-
tures reflect the transcriptional status of the gene and are influenced by local DNA methylation.
BER enzymes remodel DNA methylation soon after HR. We previously reported that GFP DNA 
methylation in HR cells was modified by transcription after repair. Thus, inhibiting transcription with short 
pulses of actinomycin D shortly after HR permanently increased DNA methylation of the repaired GFP gene11. 
We hypothesized that transcription was associated with active demethylation14,15. To test this idea, we focused 
on BER enzymes, which promote DNA oxidation and cytosine demethylation during transcription16–18. We first 
asked if APE1, the BER apurinic site nuclease, was recruited to GFP chromatin before or after repair. Indeed, 
APE1 was enriched mainly at the promoter site of all cell types, but was specifically enriched at the 3′ end of the 
DSB in Rec H and Rec L cells (Supplemental Fig. S1B). We note that APE1 was present at high levels along the 
entire gene in Rec H cells, suggesting a role for APE1 in the transcription of the repaired gene (Supplemental 
Fig. S1B). We have previously shown that OGG1, the 8-oxoG glycosylase and APE1 are important in Myc17, 
estrogen-16 and retinoic acid-18 induced transcription. We hypothesized that BER enzymes may control the rate 
at the top of each column as shown in Fig. 1A. The data are normalized to total H3 content. *P < 0.01 (t test) 
as compared with cells transfected with control plasmid (CTRL). (C) H3K9m2/3 content of GFP in chromatin 
derived from sorted Rec H or Rec L clones, untreated or treated with 5-azadC (10 μ M for 3 days and analyzed 
4 days later). ChIP analysis was performed with the indicated antibodies. qPCR on each immunoprecipitate 
was carried out with primers r/h, as shown in Fig. 1A. *p < 0.01 (Wilcoxon rank-sum test) as compared with 
untreated control or (primers a/c). (D) Histone H3 and DNA methylation changes following the DSB and 
HR, A schematic cartoon illustrating the major chromatin changes of H3K4me2/3 or H3K9me2/3 and DNA 
methylation (Δ ) following the DSB and the HR or NHEJ in recombinant (HR) and non recombinant (NHEJ) 
cells. The detailed statistical analysis of the data shown in panels (B,C) is reported in Supplemental Statistical 
Tables 3 and 4.
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Figure 3. Chromatin-DNA domains induced by damage-repair. (A) Left. GFP chromatin loops in 
recombinant (Rec, black) and unrecombinant (UnRec, white) cells 7 days after DSB. qPCR in 3C, performed 
with the primers indicated (HaeIII map), show the frequency of ligation (mean ± SD) of the DRGFP HaeIII 
fragments amplified with the specific primers. The ends of the loops are shown by the green (loop A) and blue 
(loop C) lines, corresponding to the regions indicated by arrows and boxes. Ligation efficiency is relative to 
the DRGFP plasmid digested with HaeIII, ligated and amplified by qPCR. Distance, in bp, is relative to I-SceI 
site (vertical arrow), *p < 0.01 (t test) Rec vs UnRec. Right. A representative gel of the ligated fragments (loops 
A and C) in cells exposed or not for 48 h to I-SceI. (B) GFP loops in Rec H and Rec L cells. The 5′ end of the 
loop A (green) includes an alternative GFP transcription start site, identified by primer d. Differences between 
non-recombinant, H or L cells *p < 0.01 (t test); °p < 0.01 (t test) H vs L cells. (C) Inhibition of methylation 
(panels 1, 3) or transcription (panels 2, 4) alters the chromatin loops induced by HR. Panels 1 and 3. Sorted 
GFP− (UnRec) or Rec H or Rec L cells were exposed to 5 or 50 μ M 5-azadC for 24 h + 24 h in standard medium. 
Loops A and C were monitored as described above. The results derive from at least 3 experiments in triplicate. 
*p < 0.01 as compared to untreated samples (Wilcoxon rank-sum test). Panels 2 and 4. Sorted GFP− (UnRec) 
or Rec H or Rec L cells were exposed to 5 μ M actinomycin D for 24 h, washed and analysed 48 h later. *p < 0.01 
(Wilcoxon rank-sum test) compared to untreated cells. (D) Model summarizing the features of Loops A and C. 
The red and green arrows indicate decrease or increase of loop formation, respectively, while the black arrows 
indicate no change. The two GFP transcription start sites are indicated by black and blue arrows.
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Figure 4. Inhibition of BER early after repair reduces transcription and increases methylation of the 
repaired DNA. (A) Chronology of BER-silencing experiments. Time 0 indicates I-SceI transfection and arrows 
the time of analysis or treatments. GFP+ cells were 10% ± 2% in all treatments. At days 12 and 32, 5-azadC (10 μ g/ml, 
blue arrows) was added for 24 h, removed and 24 h later cells were analyzed. (B,C) Analysis was performed at 
day 7 (red) or 14 (black) after treatments. GFP index is the product of GFP intensity and reciprocal cell fraction 
in the fluorescence gate to normalize frequency of GFP+ cells in H and L gates to intensity of signal, to compare 
different experiments. The data shown derive from 20 independent experiments. (B,C) Show GFP index in 
Rec H and Rec L cells, respectively. *p < 0.01 (Matched t test) compared to scrambled control. (Supplemental 
Fig. S3 and Table S2). (D) GFP mRNA levels 7 days after APE1 and TDG-silencing by qPCR for recombinant 
GFP. TDG protein levels are in Supplemental Fig. S3C. *P < 0.01 (Wilcoxon rank-sum test) compared to 
scrambled control. (E,F) Methylation analysis of GFP in mass cultures of I-SceI-transfected cells, in which 
APE1 levels were modified after HR (48 h after I-SceI and analyzed 7 days later, panel A). DNA was subjected 
to bisulfite analysis and sequenced with Myseq Illumina (Supplemental Table S3). Panel E shows the average 
methylation of the recombinant GFP. All the cells were exposed to I-SceI and these vectors: SCR shRNA (white 
shaded) scrambled shRNA; APE1 shRNA (green) shRNA APE1; APE1 shRNA + WT (purple) shRNA APE1 
and APE1 expression vector. The percent of methylation of recombinant GFP in all samples is normalized to 
the recombinant GFP cassette as shown in Supplemental Table S3; data were expressed as the mean ± SEM. 
*p < 0.01 (t test) compared APE1 shRNA vs SCR shRNA or vs APE1 shRNA + WT. Panel F shows the percent 
of CpG methylation in recombinant GFP in cells in which the levels of APE1 were modified early after repair. 
The position of the I-SceI/BcgI site corresponds to CpG 7 and 8. *p < 0.01 (Pearson’s chi-squared test) compared 
APE1 shRNA vs SCR shRNA (+ SceI) or vs APE1 shRNA + WT.
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of cytosine demethylation during transcription of the repaired gene in a precise time frame after repair. To con-
firm and define this critical period necessary to establish permanent DNA methylation changes, we depleted 
BER enzymes at 2 or 20 days after DSB formation (Fig. 4A). We selectively inhibited APE1 and two other BER 
enzymes, OGG1, and TDG (Supplemental Figs S2 and S3). TDG has also been directly implicated in active DNA 
demethylation19–21.
The effects on GFP expression were evaluated beginning 7 and 14 days after silencing, when the mRNA and 
protein levels expressed by the targeted genes had returned to normal (Supplemental Fig. S2C). The timing of the 
knock-downs relative to the formation of the DSBs is shown in Fig. 4A. Figure 4B,C display the effects of silencing 
OGG1, APE1 and TDG on GFP expression as assayed by cytofluorimetry. GFP expression is represented by a 
GFP index, which takes into account the distribution of Rec H and Rec L cell populations (% of Rec H and Rec 
L peaks) and the fluorescence intensity (see legend of Fig. 4). Silencing was initiated at 2 or 20 days after DSB 
formation and Rec H and Rec L peak percentages and fluorescence intensity were measured. The color code of 
the histograms shown in Fig. 4B,C indicates the time of analysis after initiation of silencing (7 and 14 days, red 
bars and black bars, respectively), and the effects of treating the samples with 5-azadC on GFP expression (blue 
bars). Since HR is complete by 2 days following exposure to I-SceI, BER depletion at or after this time had no 
effect on the frequency of GFP+ cells (Supplemental Figs S2 and S3), although it significantly altered the levels of 
GFP expression (Fig. 4B–E).
Figure 4B,C show that silencing of BER enzymes early after HR permanently inhibited GFP expression in both 
Rec H and Rec L cell populations, even when the concentration of the depleted proteins returned to pre-treatment 
levels (Supplemental Fig. S2C). Inhibition of GFP expression was due to specific reduction of APE1 and TDG 
mRNA, since it was reversed with plasmids expressing APE1 and TDG (Fig. 4D). APE1 silencing resulted in an 
elevation of DNA methylation (Fig. 4E) and consistent with this observation, 5-azadC restored GFP expression 
to normal levels in BER-depleted cells (Fig. 4B,C, blue bars). Depletion of the BER enzymes 20 days after DSB 
formation did not modify GFP methylation or expression (Fig. 4B,C). To gain insight into the methylation status 
of repaired GFP in cells in which APE1 levels were manipulated early after repair, we performed deep sequenc-
ing of bisulfite-treated DNA derived from of mass cultures (data set are available at Figshare; DOI:10.6084/
m9.figshare.3470099). We analysed at least 8,000 GFP molecules/samples (Supplemental Table S3) and measured 
total methylation of GFP in cells in which APE1 levels were down-regulated after repair. Total methylation did 
not differ significantly between recombinant and unrecombinant or control cells, because HR cells include both 
hypo- (H) and hyper-methylated (L) clones. However, GFP methylation increased in cells in which APE1 had 
been depleted early after repair. Reconstitution of APE1 eliminated this increase and restored methylation to 
control (scrambled shRNA) levels (Fig. 4E).
We next analysed the methylation status of individual CpGs in the HR region. We found that APE1 levels 
significantly affected the methylation pattern.
The percentage of methylation of each CpG, (numbered from 1 to 33), is tabulated within the I-SceI region. 
APE1 depletion stimulated methylation at a subset of these sites 1, 8, 9, 10, 12, 15, 16, 19, 23, 25, 27, 31. The 
methylation gain at the majority of these sites was eliminated when APE1 levels were restored by expressing the 
wild-type protein from an expression vector (*).
In conclusion, the data shown in Fig. 4F provide an extensive window on the methylation changes that fol-
low repair. Several sites, which we call seeds, are preferentially methylated and demethylated after HR, suggest-
ing that the DNA methylation status early after repair is subject to extensive remodelling by transcription and 
BER-associated demethylation.
Discrete DNA methylation patterns mark clones with distinct GFP gene expression levels. DNA 
methylation status is highly polymorphic and can be reshaped during and after DNA damage-repair events. Over 
time, the DNA methylation profiles of Rec H and Rec L cells stabilize and generate cells with different but heritable 
GFP expression levels. These clones are characterized by specific GFP chromatin domain patterns (Figs 1,2 and 3).
To relate the extent and placement of DNA methylation with gene expression, we compared the location 
and the number of methylated CpGs (mCpGs) with GFP expression levels in the most frequently modified GFP 
molecules isolated from sorted Rec H and Rec L cells. We ordered the methylated GFP molecules into families 
that share mCpGs at identical locations to define epigenetic haplotypes. Specifically, we asked if molecules with 
the same number of mCpGs, but located at different sites in the gene (i.e., different haplotypes), expressed similar 
levels of GFP. We also included in this analysis the most frequent UnRec molecules to reveal potential relation-
ships between GFP molecules present before and after HR. Figure 5A shows the similarity of the repaired GFP 
molecules on the basis of the position of mCpGs and GFP expression levels. There are two main branches in the 
tree: the first, indicated as I, includes essentially L clones with 10 or more mCpGs; the second, indicated as II 
and III, contains GFP molecules with intermediate frequencies of mCpGs (from 3 to 7) and includes both H and 
L clones. The arrows shown in the cartoon below the tree indicate that the L and H clones in these groups are 
very similar in terms of mCpG content. The clones with intermediate levels of mCpGs contain the same number 
of mCpGs but carry them in different locations. This reveals that the location of the mCpGs, rather than their 
absolute frequency is critical for GFP expression. We have mapped the mCpGs that characterize Rec H (green) 
and Rec L (red) clones. We find that some positions (for example mCpGs 9–10) are specific to Rec H clones, 
while others characterize Rec L clones (mCpGs 17–20; Fig. 5B). These mCpGs that characterize H and L clones 
were detected in a large unsorted pool of GFP+ molecules isolated from a mass culture of cells exposed to I-SceI 
(Fig. 4F). These mCpGs are stable over time and can be recovered with the same frequency after three years of 
continuous culture8,11.
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Figure 5. Methylated GFP molecules are polymorphic. (A) Qualitative analysis of GFP methylation profiles 
in UnRec, Rec H and Rec L clones. We compared the location of methylated CpGs in the most abundant 
GFP molecules (above 5–10%) derived from recombinant (Rec H and Rec L) and non-recombinant (UnRec,) 
cells. The sequence at the I-SceI site in UnRec molecules was edited to BcgI to eliminate the differences in the 
sequence between Rec and UnRec molecules and to permit the comparison of Rec and UnRec GFP molecules 
only on the basis of methylation. Cluster analysis (ClustalW) shows three main families of methylated 
molecules: I, represented essentially by Rec L clones; II and III represented by Rec H and Rec L clones. Colored 
circles indicate the number of methylated CpGs/molecule. (B) Specific CpGs are methylated in Rec H and Rec 
L clones following HR. Molecules containing 3 to 6 mCpGs were sorted from Rec H or Rec L cells pools and 
compared. The location of methylated CpGs at the 5′ and 3′ ends of the DSB is shown relative to the DSB (black-
yellow box centered at the 6–8 CpG). Methylation of CpG from 1 to 5 is not modified by DSB or HR (ref. 11). The 
histograms show the percentage of methylation of the specific CpGs in Rec H (green) and Rec L (red) clones.
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Figure 6. Homologous targeting of GFP to the mouse Rosa26 locus generates ES clones with variable 
DNA methylation and GFP expression. Three independent ES clones in which the EGFP gene was targeted to 
the mouse Rosa26 locus, (kindly provided by A. Simeone and D. Acampora, Intern. Inst. Gen. Biophys., IGB, 
Naples, Italy). These clones, containing a single copy integrated GFP, were purified 7 days after transfection with 
the targeting vector, amplified and analyzed by cytofluorimetry as described in Methods. The same clones were 
exposed to 5-azadC (0.5 μ M) for 4 days and analyzed 48 h later. Panel (A) shows: 1. the structure of the targeting 
vector; the two homologous regions are shown in red; 2. the structure of the mouse Rosa26 locus and; 3. the 
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Homologous targeting of GFP in ES cells also generates clones with various levels of GFP 
expression and DNA methylation. The data presented above indicate that HR repair of a DSB changes 
the methylation pattern of the repaired segment. In these experiments the DSB was artificially generated by 
the I-SceI meganuclease. To study DSBs, created by a different mechanism, we targeted CMV-GFP to a mouse 
DNA locus (Rosa26) by homologous recombination, which requires formation and repair of a DSB (Fig. 6A). 
Based on the I-SceI data, we predicted that the expression level of the inserted gene would differ in genetically 
identical clones. We isolated 3 mouse ES clones carrying a single copy of CMV-GFP targeted to the Rosa26 locus 
(A. Simeone and D. Acampora, unpublished observations and Fig. 6A). These clones, 44, 55 and 59, were char-
acterized for GFP expression. Clones 44 and 55 contain two populations that differ in GFP expression levels, 
whereas clone 59 contains primarily cells that express high GFP levels (Fig. 6B). We propose that the distinct 
progeny of clones 44 and 55 are equivalent to the hypomethylated Rec H and hypermethylated Rec L clones found 
in DRGFP HeLa cells, and that clone 59 only generated Rec H progeny. To test this hypothesis, we treated the cells 
with 5-azadC and measured GFP expression. Exposure to 5-azadC shifted Rec H cells to the right (higher expres-
sion) and reduced the number of Rec L cells in clones 44 and 55. Demethylation slightly affected GFP expression 
in derivatives of clone 59 (Fig. 6B,C).
We also determined the DNA methylation status of the CpG island at the 5′ end of the homologous targeting 
sequence with primers specific to sub-regions I and II (Fig. 6A). MEDIP analysis showed that region I in clone 44 
was hypermethylated compared to clones 55 and 59. Region II in clone 55, and to a lesser extent in clone 44, was 
hypermethylated compared to clone 59, which is not methylated (Fig. 6D). The differences in mCpG content were 
largely reversed by treatment with 5-azadC (Fig. 6D). On the basis of the I-SceI data. we hypothesize that the meth-
ylated subregion is located at the 3′ end of the DSB, which initiates HR along the direction of transcription. We pro-
pose that the DSB occurring during homologous pairing upstream of region I generated clone 44 and that a DSB 
between regions I and II generated clone 55. Clone 59 is equivalent to high expressor clones found in GFP+ cells.
These data extend the notion of HR-induced methylation and suggest a general mechanism that modifies 
expression of targeted genes by homologous recombination.
Discussion
The data reported here shed light on somatic DNA methylation and consequent histone modification induced 
by damage and homologous repair. They suggest that cell-to-cell variations in gene expression are dependent on 
the different DNA methylation profiles and chromatin structures of the expressed gene acquired during or soon 
after HR.
Transient and stable cis and trans chromatin changes induced by DNA damage and repair. Concurrent with 
DSB formation by I-SceI and repair by HR, chromatin near the lesion becomes enriched with the repressive chro-
matin mark, H3K9m2/3. This modification has been reported to be essential to recruit other histone-modifying 
enzymes and ATM to the site of damage22. The I-SceI-treated cells also transiently lose H3K4 methylation, 
but restore the H3K4m2/3 mark 2 to 7 days after exposure. The rapid appearance of H3K9me2/3 and loss of 
H3K4me3 at the DSB region after I-SceI exposure (Fig. 1B, panels 6, 10) suggest that these changes are induced 
by the formation of DSBs. Subsequent purification reveals that H3K9m2/3 is selectively retained after HR only 
in Rec L clones (Fig. 2A,B). Maintenance of H3K4m2/3 is secondary to DNA methylation. Thus, treatment of 
Rec L cells with the DNA demethylating agent, 5-azadC, significantly reduced the levels of H3K9m2/3 on GFP 
chromatin (Fig. 2C).
De novo methylation of the repaired segment was also responsible for stabilization of the chromatin loop 
specific to Rec L cells (loop C in Fig. 3). Repressive methylation H3K9m2/3 marks in Rec L cells were also present 
at sites physically distant to the repaired DSB. However, these sites were, in fact, juxtaposed and linked by loop C 
(Fig. 3). At other physically distant sites (e.g., the puromycin-resistance gene), histone marks were not modified 
by damage and repair (data not shown). Note that a similar series of events occurs during transposon integration 
and silencing. Chromatin repressive marks (H3K9me2/3) are induced early during integration of the transposable 
element (TE) followed by methylation of the integrated segment23.
We propose that the initial functionally relevant event in HR-directed gene modification is the formation of 
H3K9me3 at the DSB. This modification is induced by the DSB or by NHEJ in the majority of cells. Histone meth-
ylation is carried out by the histone methyltransferase SUV39, which is recruited to the DSB11,24,25. The increase 
of H3K9me3 contributes to the repression of local transcription induced by DNA damage26,27. The H3K9me2/3 at 
structure of the targeted locus. A segment at the 5′ end, containing a CpG island, is shown (lines). The primers 
for MEDIP analysis are located in regions I and II. Panel (B) shows the cytofluorimetric analysis of the 3 clones 
exposed or not to 0.5 μ M 5-azadC for 4 days and analyzed 48 h later. Dot Plot scans are shown to illustrate the 
composition of GFP+ or GFP− cells. The arrows indicate the shift of the L population after 5-azadC treatment. 
Differences in GFP expression between control and 5-azadC treated cells were tested for statistical significance 
using the Chi Square test, T(X), (Population Comparison module of the FlowJo software from Tree Star). Cl 
44, untreated vs 5-azadC T(X) = 460, p > 0.001; Cl 55, untreated vs 5-azadC T(X) = 246, p > 0.001; Cl 59, 
untreated vs 5-azadC T(X) = 61, p < 0.001. (C) The panel on the left shows the overlapping profiles of the three 
clones without treatment to compare the relative GFP expression levels. Cl 44 vs Cl55 T(X) = 143, p < 0.001; 
Cl 44 vs Cl59 T(X) = 658, p > 0.001; Cl 55 vs Cl59 T(X) = 255, p > 0.001. The central and the left panels show 
the quantitative analysis of GFP expression in Rec H and Rec L cells before or after 5-azadC treatment as % of 
GFP+ cells and mean of fluorescence intensity. In the left panel, Rec H and Rec L clones were analyzed together. 
Differences between treatments were tested for statistical significance using matched pairs t test: *p < 0.001. 
Panel (D) shows MEDIP analysis of region I and II, respectively in the 3 clones. *p < 0.001.
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the DSB is progressively lost after repair except in Rec L cells, and to a lesser extent in Rec H clones (see Fig. 2B, 
panel 5). Rec L and Rec H clones are characterized by discrete chromatin loops (Fig. 3) and specific H3K4me2/3 
and H3K9me2/3 profiles along the GFP gene (Fig. 2B). These marks appear very early after DSB formation in 
unsorted mass culture and precede stabilization (Fig. 3A). The most striking feature of the HR cells is the stability 
and the inheritance of the chromatin and DNA changes at the repaired locus. Our data also indicate that the ini-
tial de novo methylation of the repaired segment can be revised. Early after exposure to I-SceI, the ratio of Rec H 
to Rec L clones was approximately 1:1. After 7–14 days, the ratio changed to ≃4:1, depending on the clone8. The 
ratio was stabilized permanently by day 21. The repressive chromatin marks (H3K9me2/3) were maintained only 
in Rec L cells, suggesting that the DNA methylation profiles after repair stabilize repressive chromatin markers 
(Fig. 2C).
BER enzymes reshape stable methylation. Overall, the final methylation status of the repaired gene is poly-
morphic (Figs 4F and 5A). We find that depletion of BER enzymes two days after DSB formation modified per-
manently the expression of repaired GFP (Fig. 4 and Supplemental Figs S2 and S3). We, and others, have reported 
that recruitment of BER and NER enzymes to promoter sites of several nuclear hormones or HIF-induced genes 
is essential for transcription16–18,28,29. Additionally, the BER enzyme, TDG, which suppressed GFP DNA meth-
ylation after DSB repair (Supplemental Fig. S2B,C) is involved in active CpG de-methylation during transcrip-
tion19–21. These data and those shown in Fig. 4 and Supplemental Figs S2 and S3 indicate that other BER enzymes, 
(e.g., OGG1 and APE1), which recognize and process oxidized G, are also involved in transcription-associated 
demethylation. Indeed, although the absolute methylation levels of the repaired segments do not change dra-
matically, depletion of BER enzymes significantly changes the qualitative methylation profiles of the repaired 
segment, 3′ to the I-SceI site (Fig. 4). We propose, therefore, that BER enzymes perform transcription-associated 
demethylation at GFP at the repaired locus. This process is partly stochastic with respect to a particular CpG, 
since some CpGs are preferentially methylated (Figs 4F and 5B,C). These may seed further methylation along the 
repaired gene. Methylation revision generates polymorphic methylation profiles, which influence GFP expression 
depending on the location of the methylated CpG (Fig. 5). We wish to stress that CpG preferentially methylated 
in sorted H or L clones were also identified in mass culture sequencing (Figs 4F and 5B).
Polymorphism of somatic methylation profiles. Comparing the levels of expression of GFP with the meth-
ylation profiles of single DNA molecules, we find a relationship between the profile and the expression of the 
repaired gene. We describe clones carrying the same number of mCpGs (Fig. 5), but whose GFP enzyme levels 
vary dramatically. The differences of GFP expression between Rec H and Rec L clones are reduced or erased by 
5-azadC treatment, indicating that the variations in expression reflect the methylation status of specific CpGs.
In conclusion, we propose that the variability of GFP expression is affected by editing of local methylation by 
transcription and active demethylation (Fig. 4; ref. 19), which together with DNA damage and repair represent a 
major source of polymorphism of methylation in somatic cells.
Is DNA methylation in somatic cells deterministic or stochastic? It was recently reported that methyla-
tion of INK4-ARF suppressor gene is induced by a specific Ki-Ras oncogene transcriptional program30. This 
observation supports a general deterministic model for DNA methylation in which locus-specific targeting of 
DNMT enzymes induces and maintains DNA methylation. The choice of target is not random, but determined 
by specific affinities of transcription factors and chromatin modellers. Eventually, the preference of DNMT1 for 
hemi-methylated DNA stabilizes the methylation profiles. This deterministic model may rationalize clustering of 
methylated sites in the same DNA region, but fails short of explaining the extreme polymorphism of methylated 
alleles found with a deeper sequence coverage of the genome (Fig 5 and ref. 12).
Our data suggest that both deterministic and stochastic factors govern stable DNA methylation profiles. In 
the system described here, we can quantify the deterministic and the stochastic factors that contribute to the final 
methylation status of GFP epialleles. HR and specific factors, recruited to the DSB, establish the location and the 
strand that will be methylated (Figs 2D and 5 and refs 10,11). In contrast to this deterministic modification of the 
epigenome, stochastic editing of methylation by transcription and BER enzymes generates polymorphism of the 
methylated GFP alleles.
We propose, therefore that both mechanisms contribute to the final methylation status of DNA in each cell. 
Importantly, our work impacts in the area of genome editing, which is largely driven by HR. The final penetrance 
of a repaired gene will be directed by the events related to DNA methylation revision described here.
Methods
Cell culture, transfections and plasmids. HeLa cells lines were cultured at 37 °C in 5% CO2 in RPMI 
medium supplemented with 10% fetal bovine serum (Invitrogen), 1% penicillin-streptomycin, and 2 mM glu-
tamine. HeLa-DR-GFP cells were obtained by stable transfection of HeLa cells with the pDR-GFP plasmid as 
described in ref. 11. We used the same conditions of growth (~40% confluent cells starting from freshly frozen ali-
quots). The structure of the pDR-GFP and other plasmids is described in Supplemental Information. The expres-
sion vectors for OGG1WT and for the K338R/K341R OGG1 mutant were the FLG-Tagged vectors previously 
described in ref. 31.
DNA extraction and qRT-PCR and qPCR. Genomic DNA extraction was performed as described in 
Supplemental Information. Reverse Transcription Polymerase Chain Reactions (qRT-PCR) and Quantitative 
Polymerase Chain Reactions (qPCR) were performed on a 7500 Real Time PCR System (Applied Biosystems) 
using the SYBR Green-detection system (FS Universal SYBR Green MasterRox/Roche Applied Science). The 
complete list of oligonucleotides is reported in the Supplemental Table S1.
FACS analysis. For the FACS analysis, HeLa-DR-GFP cells were harvested and re-suspended in 500 μ l of PBS 
at density of 106 cells/ml. Cell viability was assessed by Propidium Iodide (PI) staining: before FACS analysis cells 
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were incubated with 3 μ M PI for 10 min. Cytofluorimetric analysis was performed on a 9600 Cyan System (Dako 
Cytometrix), PI positive cells were excluded from the analysis by gating the PI-negative cells on a FSC-Linear vs 
FL2H-Log plot; GFP + cells were identified with a gate (R1) on a FL1H-Log vs SS-Log plot. Rec L and Rec H cells 
were identified on a FL1H Histogram of the R1-gated cells with 2 range-gate (see Fig. 4A). The same gate was used 
for all flow cytometry experiments.
Population comparison was performed using the FlowJo software (Chi-Squared Test). Differences in fluores-
cence intensity (mean) were determined using the matched pairs Student’s t test.
Bisulfite DNA preparation, PCR, and sequence analysis. (The detailed protocol is described in the 
Supplemental Methods). A total of 2 μ g of genomic DNA was bisulfite_converted according to the EZ DNA 
Methylation Kit (Zymo Research). Methylation status was assessed through a strategy based on the locus- spe-
cific amplification of bisulfite-treated genomic DNA, amplifying each amplicon separately, followed by Illumina 
MiSeq sequencing. The sequence of the bisulfite-specific primers used for this analysis is reported Supplemental 
Table S1. The methods involved two PCR steps, following Illumina recommended procedure. The pool of ampli-
cons was subjected to sequencing using MiSeq system (V3 reagents kits). Sequencing was performed by 281 
cycles (paired-end sequencing). Sequences in FASTQ format by Illumina sequencing machine were initially pro-
cessed with Paired-End reAd mergeR (PEAR) data for an initial quality filtering and assembling (R1 plus R2). 
Only those sequences with a threshold quality score of ≥ 30 and an overlapping region within paired-end reads 
of 40 nt were processed with PReprocessing and INformation of SEQuence (Prinseq) to obtain FASTA for further 
analysis. Reads were aligned to the bisulfite converted reference sequence. Reads with ambiguous calls at the CpG 
dinucleotide were removed. After filtering, an average of 25,607.875 (range: 2,389–81,923) amplicon reads were 
obtained from each sample. Methylation states were estimated by counting the number of base calls (T/C) at CpG 
sites in the mapped reads compared to the referent on both strands (% methylation).
Chromatin Immune-Precipitation (ChIP). Cells were transfected and/or treated as indicated in the leg-
ends of the figures. The cells (~2.5 × 106 for each antibody) were fixed for 10 min at room temperature by adding 
1 volume of 2% formaldehyde to a final concentration of 1%; the reaction was quenched by addition of glycine to 
a final concentration of 125 mM. Fixed cells were harvested and the pellet was re-suspended in 1 ml of lysis Buffer 
containing 1× protease inhibitor cocktail (Roche Applied Science). The lysates were sonicated to have DNA frag-
ments 300 to 600 bp. Sonicated samples were immunoprecipitated as described in Supplemental Information and 
the DNA was recovered and subjected to qPCR using the primers indicated in the legend of the specific figures, 
primers sequences are described in Supplemental Table S1.
MeDIP. Cells were transfected and/or treated as indicated in figure legends. A total of ~5 × 106 cells were 
harvested and Genomic DNA extracted as described above. Ten micrograms of total genomic DNA was digested 
in 200 μ l for 16 h with Restriction Endonuclease mix containing 30 U each of Eco RI, Bam HI, Hind III, XbaI, 
Sal I (Roche Applied Science), phenol/chloroform extracted, ethanol precipitated and resuspended in 50 μ l of 
TE buffer. An aliquot (1/10) of digested DNA was used as input control to determine DNA concentration and 
digestion efficiency. MeDIP was performed essentially as described32 except that 2 μ g of antibody specific for 5 mC 
(Abcam) were used to precipitate methylated DNA from 5 μ g of total genomic DNA.
Chromosome conformation capture (3C). The 3C assay was performed as described previously18,33 with 
minor modifications. Briefly, the Hae III restriction enzyme, which cleaves pDR-GFP and generates 55 frag-
ments was used. Digestion was performed on formaldehyde-fixed nuclei with 150 U of restriction enzyme at 37 °C 
for 16 h. The restriction enzyme was inactivated by addition of SDS to 2% and incubation at 65 °C for 30 min. 
The reaction was diluted into 4 ml ligation buffer containing 50 U of T4 DNA Ligase and incubated at 16 °C for 
18 h. Samples were de-crosslinked by incubation at 65 °C in the presence of proteinase K for 15 min, purified by 
phenol/chloroform extraction and ethanol precipitated. Samples were re-dissolved in 20 μ l of TE buffer. Primer 
sequences are shown in Supplemental Table S1.
Statistical analysis. All data (with exception of Fig. 4E) are presented as mean ± standard deviation in at 
least three experiments in triplicate (n ≥ 9). Data sets were analyzed statistically using JMP Statistical Discovery™ 
software by SAS and tested for normality using the Shapiro-Wilks test (“normal distribution fit” tool -JMP soft-
ware). Two-tailed significance tests were performed with p < 0.05 considered significant. Non-parametric anal-
yses were done with the Mann-Whitney-U-Test (Wilcoxon rank-sum test), parametric with the t-test. Detailed 
statistical analysis of the data shown in Figs 1 and 2 is reported in Supplemental Statistical Tables 1, 2, 3 and 4.
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Chapter 5: Relationship between chromatin 
remodelling and transcriptional activation in the 
terminal differentiation cellular model Treg. 
Crucial role of ENO1/MBP1 in 
immunosuppressive activity of a-iTreg. 
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Treg cells 
Regulatory T (Treg) cells or T suppressor are a T-cell subpopulation that play a key role in 
immune suppression, in the maintenance of immunological self-tolerance and homeostasis 
(Sakaguchi S. et al., 2008) (Rudensky A.Y. et al., 2011). They represent about 5%-10% of 
CD4+ T lymphocytes and are characterized by the expression of specific surface markers as 
interleukin-2 receptor !-chain (CD25) and the transcription factor forkhead box P3 (FOXP3). 
Tregs can be divided into two sub-groups: natural regulatory T cells (nTreg) and induced 
regulatory T cells (iTreg) (Sakaguchi S. et al., 2008). The gene expression profile of iTregs 
and nTregs is significantly different (Haribhai D. et al., 2009). nTregs arise in the thymus and 
are strictly controlled by the thymus microenvironment. They are strongly stimulated by Tcell 
receptor (TCR) and CD28 co-stimulating signals from dendritic cells (Jordan M.S. et al., 
2001) ( Salamon B. et al., 2000). iTregs are derived from naïve CD4+ cells (nTreg) in the 
peripheral lymphoid tissues or in vitro when activated in the presence of TGF-% and IL-2. 
iTreg induction does not require a strong TCR stimulation but requires appropriate antigenic 
stimulation. Over-intense activation of signaling downstream of the TCR can interfere with 
iTreg development. 
CD4+CD25+ Tregs express a variety of proteins, such as cytotoxic T lymphocyte-associated 
antigen-4 (CTLA-4), tumor necrosis factor receptor (TNFR) superfamily member, Toll-like 
receptor 4, C-X-C chemokine receptor type 4 (CXCR4), programmed death-1 (PD-1), and 
lymphocyte antigen complex 6. Numerous molecular studies have identified other membrane 
antigens on Treg, such as CD103, galectin-1, LY6, OX-40, 4-IBB, TNFR2, TGF-%R1, and 
neuropilin 1. However, these proteins lack specificity because they are also commonly 
expressed by activated effector Tcells (Shu Y. et al., 2016). 
Forkhead box p3 ( FOXP3) is a member of the fork head transcription factor family and is 
exclusively expressed in CD4+CD25+ Treg cells (Walker M.R. et al., 2003). FOXP3 plays an 
important role in the growth, differentiation, and function of Tregs and is recognized as a 
marker of CD4+CD25+ Treg cells. The survival of Treg in the periphery depends critically on 
the interaction of the TCR with self antigens, and by the action of IL-2 and TGF-%. Despite 
Treg do not produce IL-2, their development depends on this cytokine in the thymus and their 
periphery in survival. Furthermore, studies conducted on knock out TGF-% mice have shown 
that the IL-2 is necessary for the maintenance of the expression of FOXP3 and for the 
regulatory function, but not for their development in the thymus (Brunkow M. E. et al., 2001). 
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In addition to natural Treg, it's possible to get in vitro another group of regulatory T cells 
(iTreg), through exposure of lymphocytes T CD4+ CD25- (Tconv) with particular stimulation 
(for istance anti-CD28 antibodies and anti-TCR, TGF- %1, vitamin D3). Inducible CD4+ 
CD25+ cells (iTreg) express FOXP3 and show the same regulatory properties of nTreg. The 
ways in which the Treg exert their action are numerous and not yet fully defined. It's been 
postulated that CD4+ CD25+ cells could directly inhibit antigen presenting cells (APC). 
However, it has been shown that Treg can also operate through direct interaction cell-cell 
independent from APC. 
Different diseases with presumed or proven immune or autoimmune pathogenesis have been 
associated with an alteration of Treg activity, such as multiple sclerosis, autoimmune 
polyglandular syndrome type 2, myasthenia gravis, psoriasis, diabetes mellitus type I and 
lupus erythematosus. In these pathologies it was proved that there is a reduction of the 
expression of FOXP3 and cytokines produced by Treg, in the absence of their depletion, 
indicating a lack of regulatory function as qualitative as quantitative. 
 FOXP3 a key gene in T regulatory cells 
 FOXP3 gene is a master regulator for the development of Tregs, and its constitutive 
expression is required for Treg-suppressive function. Mutations of  FOXP3 impair the 
development and function of nTreg cells, leading to a severe immunological disorder, called 
immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, in 
humans multiple endocrine disease, X chromosome linkage syndrome. In addition, ectopic 
expression of  FOXP3 is able to confer suppressive activity on conventional T (Tconv) cells 
(Fontenot J. D. et al., 2003) (Hori S. et al., 2003). The human  FOXP3 gene is located at the 
small arm of the X-chromosome (p11.23-13.3), with 11 different coding exons, 3 noncoding 
exons, and104 introns (Brunkow M. E. et all 2001). The 2 extreme 5*-non coding exons (.2a 
and .2b) are spliced to a second non coding exon (.1) and separated by 640bp. The .2b and 
.1 exons are separated by approximately 5000 bp and have conserved noncoding sequences 
CNS2 (+2177!+2189bp), intron CNS3 (+4393!+4506bp). Except a conserved promoter 
region, the  FOXP3 gene has three adjacent conserved non coding intronic sequences: CNS1, 
CNS2 and CNS3. These introns are highly conserved, and  FOXP3 expression is heavily 
influenced by the methylation state of certain motifs within them (Zheng Y. et al., 2010). The 
methylation status of the these conserved CpG island determines FOXP3 expression level and 
the stability of Treg cells (Toker A. et al., 2011), more specifically the CNS1 and CNS3 are 
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targets of histone modifications, while the CNS2, also known as TSDR (Treg-cell specific 
demetilated region) is a region rich in CpG whose selective demethylation is critical for the 
stability of the expression of FOXP3 in Treg cells. A detailed study of FOXP3 mRNA 
identifies two different transcription start sites, one proximal and one distal; as a result of 
alternative splicing seven different isoforms originate: "full length", two free exon 2 
(FOXP3/2), two depleted of exon 7 (FOXP3/7) and two of both exons, 2 and 7 
(FOXP3/2/7). 
The suppressive activity of i-Treg is based on the expression of FOXP3E2, the variant 
splicing form containing exon 2, which is altered in autoimmune diseases, including multiple 
sclerosis (a severe chronic inflammatory demyelinating disease that affects the central 
nervous system) and diabetes mellitus type I. 
Preliminary data 
The human FOXP3 gene encodes for at least 7 different transcript variants, 4 major forms 
have been extensively characterized. These variants differ both for the untranslated 5' end and 
for the alternative splicing of exon 2.  
We focused our attention on the differential usage of transcription start sites (TSS) of the 
FOXP3 gene and on the differential expression of FOXP3 transcripts, during the very early 
phases of activation of human nTreg and Tconv cells. In particular we evaluated the different 
transcripts originating either from the 5' distal start (DS), one containing the exon 2 (named 
DS-FOXP3E2) and the other one lacking it (named DS-FOXP3/2), or from the 5' proximal 
start (PS), one containing the exon 2 (named PS-FOXP3E2) and the other one lacking it 
(named PS-FOXP3/2) (Fig. 14). 
 
Figure 14 Schematic representation of alternative transcripts of the FOXP3 gene with the position of 
oligonucleotides used to measure the different mRNAs. Alternative mRNAs are shown aligned from 5' to 3' on a 
virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, dark 
green areas represent putative protein coding regions, light green boxes represent the 5'UTR (on the left) and 3' 
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UTR (on the right).!Flags identify validated cap site on the 5' side. Filled flags correspond to frequent events, 
while empty flags correspond to lesser frequent events.!The oligonucleotides are represented as red arrows and 
their location is shown under the mRNAs. The black brackets indicate the pairs of oligonucleotides used for each 
amplification. 
We evaluated the expression of all transcripts in basal conditions and upon TCR stimulation 
(anti-CD3/CD28) in the early phases of T cell activation. Our data show that unstimulated 
nTreg cells have very high levels of the DS-transcripts (high basal level of FOXP3) which 
were downmodulated upon 12 h of TCR stimulation; while Tconv cells, which do not express 
FOXP3 in basal conditions, increase FOXP3 mRNA levels upon T cell activation (Fig. 15 A). 
In particular, unstimulated nTreg expresses both DS-FOXP3E2 that DS-FOXP3/2 transcripts 
(generated by the activity of the transcription start 1). After 30'-60' of TCR stimulation are 
reduced both transcripts containing the DS-start, and between 6-12h the only splicing variant 
detectable is the /2. PS-transcripts are not found in unstimulated cells and are induced 
between 30' to 60' of TCR stimulation and remain stable up to 12h. In conclusion in TCR-
stimulated nTreg cells the FOXP3E2 variant derive exclusively from the PS-start site (Fig. 
15B lower panel). Tconv cells, upon TCR engagement induce the FOXP3 gene by both distal 
start 1 and proximal start 2 (Fig. 15A). After 15' of stimulation, we observed a small, but 
significant, induction of both DS- and PS-FOXP3/2 transcripts (Figure 15 B higher panel); 
the DS- rapidly subsided at 30' to reappear at 60' and further increase at 12h. Conversely, the 
PS- forms increased overtime during TCR stimulation and reached a peak at 12h. Of note, full 
length DS- and PS-transcripts were absent in unstimulated Tconv cells and were induced after 
15' of TCR stimulation from the PS-start, and only upon 12hrs from the DS-start. 
To evaluate if the differential FOXP3 gene regulation was correlated with changes histone 
chromatin modifications, we analyse the FOXP3 promoter region, the conserved non-coding 
region 3 (CNS3) and Poly_A for the presence of di- and tri-methylations of the lysin 4 and 9 
of the H3 histone (H3K4m2, H3K4m3, H3K9m2 and H3K9m3, respectively). ChIP analysis 
revel that in nTreg on CNS3 the level of di- and tri-methylations of the lysine 4 increase (this 
region is near to the putative proximal start) while it decrease on distal promoter (in fact we 
detect an enrichment of H3K9m2/m3) (Fig. 16B). TCR stimulation in Tconv cells induced a 
rapid H3K4 tri-methylation in both the promoter (within 30') and CNS3 (within 15') (Fig. 
16A). Finally, we analyzed the histone code at 3' end of the FOXP3 gene (Poly_A site) in 
both nTreg and Tconv cells. In nTreg cells we observed a rapid increase (15'-12h) in H3K4m3 
and a consequent decrease of H3K4m2 (Figure 16B higher right panel), whereas H3K9 was 
demethyled at 15 min and methylated at 30 min (Figure 16B lower right panel). In Tconv 
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cells we found a rapid increase in H3K4m3 (similar to nTreg) (Figure 16A higher right 
panel)accompanied by an early (15'-30') H3K9m2/m3 methylation (Figure 16A lower right 
panel). These preliminary data have allowed me to study the altered immunosuppressive 
activity in individuals with autoimmune disorders such as multiple sclerosis. 
During the activation of regulatory T cells of these patients, there is a compromise of the 
intermediate glycolytic metabolism. This phenomenon is associated to an alteration of 
suppressive activity of iTreg cells connected with levels of  FOXP3-E2 variants. It is known 
that glycolysis is indispensable for the suppressive function of a-iTreg (activated inducible 
Treg) cells and it is implicated in the induction of specific splicing variants of FOXP3E2. Our 
studies have demonstrated a crucial role for the glycolytic enzyme enolase-1 and its isoform 
(i.e., MBP-1) in modulating the expression of specific splicing forms of  FOXP3 that are 
indispensable for the suppressive function of iTreg cells. The treatment with a inhibitor of 
glycolysis 2DG diminishes the abundance of the  FOXP3-E2 splice forms, necessary for the 
regulatory function of iTreg cells. The splice form that accounted for the suppressive activity 
of iTreg cells was the 47-kDa form, which contains the region encoded by exon 2. Under 
conditions of inhibition of glycolysis (treatment with 2DG), there is an increase in enolase-1 
on both the  FOXP3 promoter and  FOXP3 CNS2, and this is associated with reduced 
expression of total  FOXP3 and the  FOXP3-E2 splice variant. The results obtained allowed to 
conclude that during the activation of Tconv cells enolase-1 enzyme (ENO1) is localized in 
the cytoplasm and it is engaged in the glycolytic process, when glycolysis is inhibited (in 
iTreg-2DG cells) ENO1/MBP-1 translocate to the nucleus, where it is localized on the 
regulatory elements of FOXP3 to repress and modulate the expression to total  FOXP3 and 
the  FOXP3-E2 isoform. This leads to the generation of cell-to iTreg with a low expression of 
FOXP3E2 and a reduced suppressive activity. Silencing of ENO1 in the absence of treatment 
with 2DG (in iTreg-CTR cells) lead to a reduction in  FOXP3 expression that could be 
ascribed to impairment of the glycolytic activity of enolase-1. Our data have identified a 
previously unknown molecular mechanism that links a specific glycolytic enzyme to the 
regulation of a “master gene” ( FOXP3) whose product is necessary for the induction and 
function of Treg cells. 
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Figura 15 FOXP3 mRNAs transcripts levels in CD4+ T cells. A. Total RNA was prepared from Tcov and nTreg 
1 h after culturing them in medium alone or with anti-CD3/anti-CD28 for 15, 30, 60 minutes and 12 hours and 
analyzed by RT-qPCR (Reverse Transcription, Real Time PCR) with specific primers (all transcripts) (panel A 
on the left) or specific oligonucleotides for the 5' distal start (DS-mRNAs, see Fig. 15 A on the right) normalized 
on 18s RNA levels. B. Analysis of Exon 2 alternative splicing derived from total (PS) and distal (DS) 
transcription start sites (TSS) in nTreg and Tconv cells during the early phases and after 12 h of anti anti-
CD3/anti-CD28 stimulation. Total RNA was extracted and levels of spliced mRNA forms were monitored by 
semi-quantitative RT-PCR using specific primers. All the cDNAs were tested for template amount by RT-qPCR 
for 18s RNA. The statistical analysis derived from at least 3 experiments in triplicate (n -9; Mean±SD).  
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Figura 16 Early methylation-demethylation assessed in nTreg and Tconv cells. Methylation-demethylation 
cycles of histone H3K4/K9 on FOXP3 promoter, CNS3 and Poly_A chromatin induced by anti-CD3/anti-CD28 
in Tconv and nTreg cells. Tconv and nTreg cells were isolated and cultured for 1 h in medium alone and then 
treated or not with anti-CD3/anti-CD28 for 15, 30, 60 minutes and 12 hours. qChIP was carried out using 
specific antibodies recognizing H3K4me2/me3 and H3K9me2/me3. Panel A, H3K4me2/me3 occupancy on 
FOXP3 promoter, CNS3 and Poly_A in Tconv. Middle panel A, H3K9me2/me3 occupancy on FOXP3 
promoter, CNS3 and Poly_A in same cells. Panel B, H3K4me2/me3 occupancy on FOXP3 promoter, CNS3 and 
Poly_A in Treg. Lower panel B, H3K9me2/me3 occupancy on FOXP3 promoter, CNS3 and Poly_A in same 
cells. The results were normalized on the percent of input. The statistical analysis derived from at least 3 
experiments in triplicate (n -9; Mean±SD). 
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Methods of preliminary data 
RNA extraction and qRT-PCR and qPCR. 
Total RNA was extracted using Triazol (Gibco/Invitrogen). cDNA was synthesized in a 20 µl 
reaction volume containing 1 µg of total RNA, 100 units of Superscript III Reverse 
Transcriptase (Invitrogen), and 1 µl of random primers (200 ng/µl). mRNA was reverse-
transcribed for 1 h at 50 °C, and the reaction was heat inactivated for 15 min at 70 °C. The 
products were stored at -20 °C until use. Quantitative (q)RT-PCR and qPCR were performed 
three times in six replicates on a 7500 RT-PCR System (Applied Biosystems) using the 
SYBR Green-detection system (FS Universal SYBR Green MasterRox/Roche Applied 
Science). The complete list of oligonucleotides used is reported in Table 1. 
 
Chromatin Immuno-Precipitation (ChIP). 
Cells were treated as indicated in the legends of the figures. The cells (2.5 x 106 for each 
antibody) were fixed by adding formaldehyde to a final concentration of 1% for 10 min at 
room temperature and the reaction was quenched by the addition of glycine to a final 
concentration of 125 mM. Fixed cells were harvested and the pellet was resuspended in 1 ml 
of Lysis Buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.2 % NP40) containing 1X protease 
inhibitor cocktail (Roche Applied Science). The lysates were sonicated in order to have DNA 
fragments from 300 to 600 bp. Sonicated samples were centrifuged and supernatants diluted 2 
fold in the ChIP Buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl pH 
8.0). An aliquot (1/10) of sheared chromatin was further treated with proteinase K, extracted 
with phenol/chloroform and precipitated to determine DNA concentration and shearing 
efficiency (input DNA). The sheared chromatin was precleared for 2 h with 1 µg of non-
immune IgG (Normal rabbit IgG sc-2027, Normal mouse IgG sc-2025, Santa Cruz 
Biotechnology Inc., Dallas, TX) and 20 µl of Protein A/G PLUS-Agarose (sc-2003, Santa 
Cruz Biotechnology) saturated with salmon sperm (1 mg/ml). Precleared chromatin was 
divided in aliquots and incubated at 4 °C for 16 h with 1 µg of the specific antibody (anti-
H3K4m2 ab32356, anti-H3K4m3 ab1012, anti- H3K9m2 ab1220, anti-H3K9m3 ab8898 from 
Abcam, Cambridge, MA, anti-c-Rel 4727 from Cell Signaling Technology Inc., Danvers, 
MA) and non-immune IgG (Normal rabbit IgG sc-2027, Normal mouse IgG sc-2025, Santa 
Cruz Biotechnology Inc., Dallas, TX) respectively. The immuno-complexes were recovered 
by incubation for 3h at 4 °C with 20 µl of protein-A/G agarose, beads were washed with wash 
116
buffers according to the manufacturer’s instructions and immunoprecipitated DNA was 
recovered and subjected to qPCR using the primers indicated in the legend of the specific 
figures and in Table1. 
 
Table 1 
 
Primers mRNA 
 FOXP3 mRNA Fw (All transcripts) 5’-AACATGCGACCCCCTTTCACCTAC-3’ 
 FOXP3 mRNA Rev (All transcripts) 5’- GCCCCCTTCTCGCTCTCCAC-3’ 
 FOXP3 StartI 5Fw (DS) 5’-AGCCAGGCTGATCCTTTTCTGT-3’ 
 FOXP3 StartI 5Rev (DS) 5’-ATTTGGGAAGGTGCAGAGCAGT-3’ 
 FOXP3 All Starts Fw (PS) 5’-GGACAAGGACCCGATGCCCAACC-3’ 
 FOXP3 All Starts Rev (PS) 5’-ATTTGGGAAGGTGCAGAGCAGT-3’ 
Primers ChIP 
 FOXP3 Promotor Fw  5’-GGTTGGCCCTGTGATTTATTTTAG-3’ 
 FOXP3 Promotor Rev  5’-GTGTGGAAGCCGCAGACCTC-3’ 
 FOXP3 CNS3 Fw 5’-GGACAAGGACCCGATGCCCAACC-3’ 
 FOXP3 CNS3 Rev 5’- CTCCCGCCCAGTGCCACAGTAAAG-3’ 
 FOXP3 Poly_A Fw 5’-CTGCCACTCACCTCACTCCCATTCC-3’ 
 FOXP3 Poly_A Rev 5’-GCCCACTGACCGCAACCCTTAT-3’ 
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by modulating both lineage-specific differentiation and cytokine pro-
duction20,21. Here we found that highly suppressive human iTreg cells 
were generated in the absence of exogenous regulatory-type cytokines 
(i.e., TGF-β or IL-10) following suboptimal stimulation of Tconv cells 
via the TCR. They represented the highly glycolytic and metaboli-
cally active fraction of proliferating Tconv cells and depended for their 
induction on the expression of Foxp3 splicing variants containing 
exon 2 (Foxp3-E2). Among all splicing variants of human Foxp3, the 
variant produced from Foxp3-E2 (called ‘Foxp3-E2’ here) has been 
shown to serve a major role in conferring suppressive ability onto 
Treg cells22–24. Therefore, we focused on the metabolic determinants 
that led to the induction of Foxp3-E2 in human iTreg cells and found 
that glycolysis controlled the generation of iTreg cells through locali-
zation of the glycolytic enzyme enolase-1 to the nucleus. Enolase-1 
directly affected the expression of Foxp3-E2 after binding to Foxp3 
regulatory regions, such as the promoter and conserved noncoding 
sequence 2 (CNS2). We confirmed our findings in studies of subjects 
with the autoimmune diseases relapsing-remitting multiple sclerosis 
(RRMS) or type 1 diabetes (T1D), in whom we observed impaired 
glycolysis and Foxp3-E2 expression in iTreg cells.
RESULTS
Generation of iTreg cells after suboptimal TCR stimulation
To determine whether the induction of human iTreg cells from Tconv 
cells could be achieved through weak stimulation of the TCR in the 
absence of exogenous cytokines, we obtained peripheral blood mono-
nuclear cells (PBMCs) from healthy human subjects, negatively selected 
Tconv cells (purity, >98%) from those cells and activated them (via the 
TCR) for 36 h in vitro with beads coated with monoclonal antibody 
(mAb) to the invariant signaling protein CD3 plus mAb to CD28 (at 
a density of 0.1 bead per cell) (Supplementary Fig. 1). At 24 h after 
activation, we assessed cellular metabolism (glycolysis, mitochondrial 
respiration and fatty acid oxidation (FAO)) by measuring the extracel-
lular acidification rate (ECAR) and oxygen-consumption rate (OCR). 
Tconv cells underwent an increase in their mitochondrial respiration 
rate (OCR) and used both glucose and fatty acids, as indicated by an 
increase in glycolysis and FAO (Fig. 1a,b). At 36 h after activation, we 
sorted Tconv cells by flow cytometry into three subsets on the basis of 
their cell-surface expression of the T cell–activation marker CD25. We 
subsequently assessed the proliferation marker Ki67, phosphorylation 
of S6 (a downstream target of the metabolic checkpoint kinase mTOR) 
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Figure 1 Generation of human iTreg cells from  
Tconv cells during weak stimulation of the TCR.  
(a) ECAR, as an indicator of glycolysis (left), and  
OCR, quantifying mitochondrial respiration (right),  
of Tconv cells after 24 h of in vitro stimulation with  
medium alone or with mAb to CD3 plus mAb to CD28  
(CD3+CD28) (key), in the presence of (above plots)  
glucose, the ATP-synthase inhibitor oligomycin and  
2DG (left), or oligomycin, the uncoupling reagent  
FCCP and the respiratory-chain inhibitors antimycin  
A plus rotenone (right), administered sequentially  
(dotted downward arrows). (b) OCR, quantifying  
FAO (left), of Tconv cells stimulated for 24 h in vitro  
as in a, right, in the presence of the specific FAO  
substrate palmitate alone (+ palm) or palmitate plus  
the FAO inhibitor Etx (+ palm + inh), and their  
FAO index (right), calculated as ratio of the  
FCCP-stimulated OCR in the presence of palmitate  
to the FCCP-stimulated OCR in the presence of  
palmitate plus inhibitor. (c) Flow cytometry of  
CD4+CD25+ T cells sorted by flow cytometry on the  
basis of surface CD25 expression (far left), and  
expression of Ki67, phosphorylation of S6 and  
expression of Foxp3 (right) in CD25hi, CD25int and  
CD25lo cells gated as at left. Numbers in plots  
indicate percent CD25hi cells (top), CD25int cells (middle) or CD25lo cells (bottom) or mean fluorescence intensity (MFI) (in parentheses) of CD25 in 
those cells (far left), or percent Ki67+ cells (left), cells with phosphorylated S6 (middle) or Foxp3+ cells (right), as well as the MFI (in parentheses)  
of Ki67 (left), phosphorylated (p-) S6 (middle) or Foxp3 (right). (d) Proliferation (left) of CFSE-labeled CD4+ T cells stimulated for 96 h in vitro with 
mAb to CD3 plus mAb to CD28 and cultured alone (CD4+ alone) or in the presence of flow cytometry–sorted CD25hi, CD25int or CD25lo T cells  
(above plots), and percent proliferation of CD4+ T cells in those conditions (far right). Numbers in plots (left) indicate percent CFSE dilution in  
CD4+ T cells cultured alone (top left); numbers above bracketed lines indicate percent CFSE dilution in CD4+ T cells cultured with iTreg cells.  
*P < 0.05 and **P < 0.0001 (paired two-tailed Student’s t-test (b) or Wilcoxon matched-pairs test (d)). Data are from one experiment representative  
of two experiments with technical duplicates (a; mean ± s.e.m.), three independent experiments with technical duplicates (b; mean ± s.e.m. (left) or 
mean ± s.e.m. of n = 18 (right)), one experiment representative of eight experiments (c), one experiment representative of three experiments (d, left)  
or three independent experiments with technical triplicates (d, right; mean ± s.e.m. of n = 9 replicates).
119
©
20
15
N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
nature immunology  aDVaNCE ONLINE PUBLICaTION 
A rt i c l e s
and Foxp3 in cells with high CD25 expression (CD25hi), intermedi-
ate CD25 expression (CD25int) or low CD25 expression (CD25lo) and 
found that CD25hi cells had highest levels of all these (Fig. 1c). In paral-
lel, we evaluated the ability to suppress in vitro the proliferation of CD4+ 
T cells labeled with the division-tracking dye CFSE and stimulated 
with mAb to CD3 plus mAb to CD28. We found that the subset with 
the highest expression of CD25, Ki67 and Foxp3 and greatest phos-
phorylation of S6 also had the strongest suppressive activity (Fig. 1d) 
and that the suppression was contact dependent (Supplementary 
Fig. 2a). We also evaluated the methylation status of Foxp3 CNS2 
to assess the stability of Foxp3 expression (a more highly methyl-
ated CNS2 is related to diminished stability). The frequency of CNS2 
methylation in iTreg cells was low and similar to that observed in freshly 
isolated Treg cells (Supplementary Fig. 2b). The low CNS2-methylation 
status, high suppressive activity and expression of Treg cell–characteristic 
surface markers (CTLA-4, PD-1, GITR and CD71) were retained for 
up to 10 d of culture in the presence of IL-2, at levels similar to those of 
the initially generated iTreg cells (at 36 h) (Supplementary Fig. 2b–d). 
The generation of iTreg cells did not depend on TGF-β and IL-10, since 
neutralization of these cytokines in vitro did not alter the induction 
of iTreg cells (data not shown). These results indicated that human iTreg 
cells could be induced from Tconv cells stimulated by weak engagement 
of TCR in the absence of exogenous cytokines and that they retained 
their suppressive capacity overtime.
Glycolysis and FAO in the generation and function of iTreg cells
Since the generation and function of T cells depend on underlying met-
abolic programs17–19, we evaluated the metabolic pathways involved in 
the generation of iTreg cells. We activated Tconv cells in the presence or 
absence of a specific inhibitor of glycolysis (2-deoxy-d-glucose (2DG)) 
and a specific inhibitor of FAO (etomoxir (Etx)) (Supplementary Fig. 3). 
2DG-treated Tconv cells had lower glycolysis than that of untreated 
Tconv cells and had mitochondrial respiration (Fig. 2a) and FAO (Fig. 2b) 
similar to that of untreated Tconv cells. In contrast, treatment with 
Etx affected the FAO rate (Fig. 2b) and decreased the mitochondrial 
respiration without any substantial effect on glycolysis (Fig. 2a). 
Although both compounds inhibited the upregulation of CD25 expres-
sion, Foxp3 expression was much lower in CD25hi T cells generated in 
the presence of 2DG and sorted by flow cytometry (iTreg-2DG cells) 
and was higher in sorted CD25hi T cells generated in the presence 
of Etx (iTreg-Etx cells) than in untreated (control (CTR)) CD25hi  
T cells (iTreg-CTR cells) (Fig. 2c). To determine whether the metabolic 
perturbations were associated with an altered regulatory function, we 
assessed the ability of iTreg-2DG cells and iTreg-Etx cells to suppress 
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Figure 2 Generation of human  
iTreg cells from Tconv cells  
during weak stimulation of  
the TCR in the presence of  
inhibitors of either glycolysis  
or FAO. (a) ECAR (left) and  
OCR (right) of Tconv cells  
stimulated for 24 h in vitro  
with mAb to CD3 plus mAb  
to CD28 (in conditions as  
in Fig. 1a; above plots), grown in  
the absence (control (CTR)) or  
in the presence of 2DG or Etx  
(key) (as in Supplementary  
Fig. 3). (b) OCR, quantifying  
FAO, of Tconv cells stimulated  
for 24 h in vitro with mAb to  
CD3 plus mAb to CD28 (in conditions  
as in a, right; above plots), grown in the absence of 2DG or Etx (control (CTR)) or in the  
presence of 2DG (left) or Etx (middle), and in the presence of palmitate alone or palmitate plus  
inhibitor (as in Fig. 1b), and the FAO index of those cells (right; calculated as in Fig. 1b).  
(c) Flow cytometry analyzing the expression of CD25 and CD4 (left), and of Foxp3 and CD4 (right),  
by CD4+CD25hi iTreg-CTR, iTreg-2DG and iTreg-Etx cells sorted by flow cytometry. Numbers in plots  
(top left corner) indicate percent CD25+ cells or MFI (in parentheses) of CD25 (left) or percent Foxp3+ cells or MFI (in parentheses) of Foxp3 (right); 
numbers adjacent to outlined areas (right) indicate percent Foxp3hi cells (top) or Foxp3int cells (bottom). (d) Proliferation of CFSE-labeled CD4+ T cells 
stimulated for 96 h in vitro with mAb to CD3 plus mAb to CD28 and cultured alone (filled gray curves) or in the presence of iTreg-CTR, iTreg-2DG or iTreg-
Etx cells (black lines) at various ratios (CFSE+CD4+ T cells to iTreg cells, 8:1 to 1:1; above plots). Numbers in plots indicate percent CFSE dilution  
in CD4+ T cells cultured alone (top left); numbers above bracketed lines indicate percent CFSE dilution in CD4+ T cells cultured with iTreg cells.  
Below, frequency of proliferation of CD4+ T cells in the conditions above (‘–’ indicates CD4+ T cells alone). NS, not significant (P > 0.05); *P < 0.05,  
**P < 0.001 and ***P < 0.0001, iTreg-2DG versus iTreg-CTR or iTreg-Etx versus iTreg-CTR in d (paired two-tailed Student’s t-test (b) or Wilcoxon  
matched-pairs test (d)). Data are from one experiment representative of two experiments with technical duplicates (a; mean ± s.e.m.), three 
independent experiments with technical duplicates (b; mean ± s.e.m. (left) or mean ± s.e.m. of n = 18 (right)), one experiment representative of  
eight experiments (c), one experiment representative of three (d, top), or three independent experiments with technical triplicates (d, bottom;  
mean ± s.e.m. of n = 45 (1:1 ratio, iTreg-CTR cells from five subjects), n = 36 (1:1 ratio, iTreg-2DG cells from four subjects), n = 27 (1:1 ratio,  
iTreg-Etx cells from three subjects), or n = 18 (all other conditions, cells from two subjects).
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the proliferation of CD4+ T cells in vitro. iTreg-2DG cells displayed less 
suppressive function than that of iTreg-CTR cells, whereas iTreg-Etx cells 
had higher suppressive activity than that of iTreg-CTR cells (Fig. 2d). 
Together these results indicated that glycolysis was necessary for the 
generation and suppressive function of human iTreg cells.
Biochemical signature of iTreg cells
To better understand the molecular basis of the findings reported 
above for iTreg cells, we studied cell metabolism, cytokine-related sig-
naling and Foxp3 expression during specific metabolic perturbations. 
Immunoblot analysis of iTreg cells stimulated in vitro for 1 h with mAb 
to CD3 plus mAb to CD28 showed that both 2DG and Etx reduced 
the activation of mTOR in iTreg cells, in terms of the phosphorylation 
of S6, but via different mechanisms (Fig. 3). Indeed, while 2DG abol-
ished the phosphorylation of S6, Etx increased the total amount of S6 
without increasing its activity in terms of phosphorylation. Moreover, 
iTreg-2DG cells had lower expression of enolase-1 than that of iTreg-
CTR cells, whereas iTreg-Etx cells had enolase-1 expression similar to 
that of iTreg-CTR cells. Also, iTreg-2DG cells had less phosphorylation 
of the signal transducer STAT3 than that of iTreg-CTR cells, whereas 
iTreg-Etx cells had an amount of STAT3 phosphorylation similar to 
that of iTreg-CTR cells. The IL-2–IL-2R–STAT5 signaling pathway 
has a central role in the induction of Foxp3 and in the generation and 
homeostasis of Treg cells25,26. We found profound impairment in the 
activation of STAT5 in iTreg-2DG cells following TCR stimulation, 
whereas the induction of STAT5 phosphorylation was greater in stim-
ulated iTreg-Etx cells than in their iTreg-CTR counterparts.
Human Foxp3 has various splicing variants; however, despite 
the importance of Foxp3 in Treg cells, the regulation and functional 
activity of Foxp3 isoforms remain poorly understood22–24. Since we 
observed that glycolysis was necessary for the induction of human 
iTreg cells, we evaluated the differential effects of metabolic perturba-
tions on Foxp3 isoforms. Specifically, we found that 2DG hampered 
induction of the 47-, 44- and 38-kilodalton (kDa) forms of Foxp3 
but favored expression of the 49-kDa form (Fig. 3). In contrast, 
Etx increased the expression of the 47-kDa form but did not affect 
the expression of the 49-, 44- or 38-kDa forms (Fig. 3). Of note, the 
densitometric sum of total Foxp3 forms showed no difference among 
the three iTreg cell populations (Fig. 3), which suggested differential 
metabolic regulation of the various splicing forms of Foxp3 in iTreg 
cells. We confirmed these data at the mRNA level by RT-PCR analysis 
(data not shown). Overall, these analyses revealed that glycolysis con-
trolled the generation of human iTreg cells via a specific biochemical 
machinery involving the mTOR pathway, IL-2R signaling and the 
modulation of various splicing variants of Foxp3.
Metabolic programs and phenotypical characteristics of iTreg cells
Next we evaluated the phenotype and the metabolic profile of iTreg 
cells generated in the presence of inhibitors of either glycolysis or 
FAO. Inhibition of glycolysis with 2DG diminished expression of the 
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Figure 3 Biochemical analysis of human iTreg cells. Immunoblot analysis (far left) of total and/or phosphorylated (p-) S6, enolase-1, STAT3, STAT5, 
Foxp3 and Erk1/2 in iTreg-CTR, iTreg-2DG and iTreg-Etx cells (above blots) left unstimulated (−) or stimulated (+) for 1 h with mAb to CD3 plus mAb 
to CD28 (α-CD3 + α-CD28; above lanes); total Foxp3 was assessed with mAb PCH101, which recognizes all splicing variants of Foxp3 (left margin, 
molecular sizes). Right, densitometry analysis, with each phosphorylated protein normalized to its total form (S6, STAT3 and STAT5), or total protein 
normalized to total Erk1/2 (enolase-1 and Foxp3), presented relative to results obtained for unstimulated iTreg-CTR cells. Each symbol (right) represents 
an individual data point (n = 9); small horizontal lines indicate the mean. *P < 0.0001 and **P < 0.05 (two-tailed Student’s t-test). Data are from one 
experiment representative of three independent experiments (far left) or three independent experiments with technical triplicates (right).
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Treg cell markers CTLA-4, PD-1, GITR, CD39 and CD71, as well as 
the phosphorylation of S6, whereas Etx had an effect similar to that 
of 2DG on the expression of PD-1 and CD39 and phosphorylation of 
S6, but slightly reduced the expression of CD71 and CCR7, preserved 
the expression of CTLA-4, and upregulated the expression of GITR, 
compared with results obtained with no treatment (in iTreg-CTR cells) 
(Fig. 4a). The measurement of ECAR (glycolysis) and OCR (FAO 
and oxidative phosphorylation) in iTreg cells indicated that iTreg-2DG 
cells had impaired glycolysis and mitochondrial respiration relative 
to that of iTreg-CTR cells (Fig. 4b), with FAO rates similar to those of 
iTreg-CTR cells (Fig. 4c). Etx affected FAO (Fig. 4c) and mitochon-
drial respiration (Fig. 4b) but preserved glycolysis (Fig. 4b), relative to 
results obtained with no treatment (in iTreg-CTR cells). These effects, 
secondary to the metabolic perturbations, were not associated with 
altered survival and/or viability of T cells, as indicated by staining with 
propidium iodide and annexin V, which was similar in iTreg-2DG, 
iTreg-Etx and iTreg-CTR cells (data not shown). Thus, inhibition of gly-
colysis impaired the generation and function of iTreg cells and reduced 
the induction of Foxp3 and the expression of Treg cell markers.
Glycolysis controls iTreg cells’ suppressive function via Foxp3-E2
To better understand the effects of metabolism on the expression 
of the splicing variants of Foxp3, as they were related to the regula-
tory function of iTreg cells, we analyzed, at level of both mRNA and 
protein, the expression of all Foxp3 transcripts and that of the two 
main Foxp3 spliced forms22–24,26: one containing exon 2 (Foxp3-
E2), and the other lacking it (Fig. 5a). Quantitative RT-PCR with 
primers spanning exons 9–11 (to amplify all transcripts) showed 
a 37-fold greater abundance of total Foxp3 mRNA in iTreg-CTR 
cells than in Tconv cells (Fig. 5b). iTreg-2DG cells had 50% less total 
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Figure 4 Phenotypical characterization and metabolic programs of iTreg-CTR, iTreg-2DG and iTreg-Etx cells. (a) Flow cytometry analyzing the expression 
of CD25 and CD4 in iTreg-CTR, iTreg-2DG and iTreg-Etx cells (far left) and of Treg cell–specific markers (horizontal axes) (right). Numbers adjacent to 
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Foxp3 mRNA, whereas iTreg-Etx cells had very slightly but signifi-
cantly greater levels of total Foxp3 mRNA, than iTreg-CTR cells had 
(Fig. 5b). Quantitative RT-PCR with specific primers for the ampli-
fication of transcripts containing Foxp3 exon 2 (Fig. 5a) showed 
that the expression of Foxp3-E2 mRNA was twofold lower in 
iTreg-2DG cells and 1.4-fold higher in iTreg-Etx cells than in 
iTreg-CTR cells (Fig. 5b).
To further assess whether 2DG and Etx regulated the splicing of 
exon 2 differentially, we did semiquantitative RT-PCR with primers 
spanning exons 1–3. 2DG affected only the expression of Foxp3-E2, 
whereas Etx increased the abundance of both Foxp3-E2 and Foxp3 
lacking exon 2 compared with results obtained for untreated (iTreg-
CTR) cells (Fig. 5b). Next we sought to determine whether level of 
mRNA from the Foxp3 splicing forms correlated with protein expres-
sion in iTreg cells generated in the presence of metabolic inhibitors. 
For this, we measured all splicing forms of Foxp3 protein by using two 
specific mAbs: one (PCH101) that recognizes all splicing variants of 
Foxp3 (through a common epitope of the amino terminus of Foxp3); 
the other (150D/E4) specific for the variants encoded by Foxp3-E2 
(recognized through an epitope encoded by sequence present only 
in exon 2). Immunoblot analysis with mAb PCH101 revealed that 
the amount of the 49-kDa form of Foxp3 increased after treatment 
with each metabolic inhibitor, relative to its abundance in untreated 
(iTreg-CTR) cells, with this phenomenon being more evident in 
iTreg-2DG cells (Fig. 5c). iTreg-2DG cells had substantially less of 
both the 47-kDa splicing form and 44-kDa splicing form than 
iTreg-CTR cells had, whereas the level of these forms was not altered 
in iTreg-Etx cells relative to that in iTreg-CTR cells (Fig. 5c). The 
densitometric sum of the various Foxp3 splicing forms showed no 
difference among the three iTreg cell populations (Fig. 5c), which 
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Figure 5 Glycolysis controls expression of the Foxp3-E2  
variants, which are indispensable for the suppressive  
function of iTreg cells. (a) Splicing variants of FOXP3 mRNA:  
green boxes, exons (light green, 5′ and 3′ untranslated regions  
(UTR); dark green, coding sequence; blue, poly(A) sites);  
black lines, spliced regions (∆2, deletion of exon 2); arrows,  
positions of PCR primers. (b) Real-time PCR analysis of  
all FOXP3 mRNA (left) and FOXP3-E2 mRNA (middle) in  
iTreg-CTR, iTreg-2DG and iTreg-Etx cells, and semiquantitative  
RT-PCR analysis with primers spanning exons 1–3, followed by  
quantification of densitometry of the PCR products FOXP3 and  
FOXP3 lacking exon 2 (FOXP3-∆2) after separation by  
electrophoresis through agarose gels (right). (c) Immunoblot analysis  
(far left) of Foxp3 (above) and total Erk1/2 (used for normalization)  
in iTreg-CTR, iTreg-2DG and iTreg-Etx cells, probed with mAb  
PCH101, to a common epitope of the amino terminus (as in  
Fig. 3), or mAb 150D/E4, to an epitope encoded by exon 2.  
Right, densitometry of all Foxp3 forms, normalized to total  
Erk1/2 and presented relative to results obtained for iTreg-CTR cells.  
Each symbol (right) represents an individual data point (n = 15);  
small horizontal lines indicate the mean. (d) Proliferation (left) of CFSE-labeled CD4+ T cells stimulated for 72 h in vitro with mAb to CD3 plus mAb to 
CD28 and cultured alone or in the presence of iTreg cells (key) generated in the presence of siRNA-E2, siRNA-E5 or siRNA-Scr (left margin), at a ratio 
of 1:1 or 2:1 (above plots). Numbers in plots indicate percent CFSE dilution in CD4+ T cells alone (top left); numbers above bracketed lines indicate 
percent CFSE dilution in CD4+ T cells cultured with iTreg cells. Right, percent proliferation of CD4+ T cells in the conditions at left. *P < 0.05, **P < 0.005  
and ***P < 0.001, siRNA-E2 versus siRNA-Scr or siRNA-E5 versus siRNA-Scr in d (Wilcoxon test (b), two-tailed Student’s t-test (c) or Wilcoxon 
matched-pairs test (d)). Data are from three independent experiments with technical triplicates (b; mean ± s.d. of n = 9 replicates), one experiment 
representative of five experiments (c, far left), five independent experiments with technical triplicates (c, right), one experiment representative of three 
experiments (d, left) or three independent experiments with six technical replicates in each (d, right; mean ± s.e.m. of n = 18 replicates).
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indicated that the effects induced by the metabolic inhibitors were 
specific for defined splicing variants of Foxp3.
To determine whether the lower abundance of the 44- to 47-kDa 
splicing forms had to be ascribed to a lower abundance of Foxp3-E2 
(as observed by quantitative RT-PCR), we performed immunoblot 
analysis of the same cell lysates with mAb 150D/E4 to the variants 
encoded by Foxp3-E2 (Foxp3-E2), which detects a 47-kDa product. 
iTreg-2DG cells had much less Foxp3-E2, whereas iTreg-Etx cells had 
more Foxp3-E2, than iTreg-CTR cells had (Fig. 5c). Flow cytom-
etry confirmed that treatment with 2DG led to the generation of 
iTreg cells with reduced expression of Foxp3, both as total Foxp3 and 
Foxp3-E2, whereas Etx increased both total Foxp3 and Foxp3-E2 in 
iTreg cells, relative to their expression in untreated (iTreg-CTR) cells 
(Supplementary Fig. 4a), and that these effects were dose dependent 
(Supplementary Fig. 4b,c). Thus, glycolysis and FAO controlled the 
expression of splicing variants of Foxp3 in iTreg cells differentially, at 
the level of both mRNA and protein.
Since iTreg-2DG cells displayed impaired suppressive capacity 
associated with reduced expression of Foxp3-E2, with the region of 
Foxp3 encoded by exon 2 being part of the Foxp3 transcriptional 
repressor domain22–24, we studied whether Foxp3-E2 was indispen-
sable for the regulatory function of iTreg cells by using small interfer-
ing mRNA (siRNA) specific for the Foxp3-E2 domain (siRNA-E2). 
We generated iTreg cells in the presence of siRNA-E2 and assessed 
their ability to suppress the proliferation of CD4+ T cells in vitro. 
After confirming, by immunoblot analysis, siRNA-induced silenc-
ing in Tconv cells stimulated with mAb to CD3 plus mAb to CD28 
(Supplementary Fig. 5a), we found that iTreg cells generated in the 
presence of siRNA-E2 had less suppressive ability than iTreg cells gen-
erated in the presence of control siRNA with a scrambled sequence 
(siRNA-Scr) (Fig. 5d), despite the finding that iTreg cells generated in 
the presence of siRNA-E2 expressed the other Foxp3 splice variants 
(44 kDa) (Supplementary Fig. 5a). Of note, iTreg cells generated in 
the presence of siRNA-E2 had an impaired suppressive phenotype 
(Fig. 5d) similar to that of iTreg-2DG cells (Fig. 2d). As an additional 
control, we also silenced Foxp3 exon 5, a common sequence for all 
Foxp3 transcripts, with siRNA (siRNA-E5); this reduced the abun-
dance of all the Foxp3 splicing variants (Supplementary Fig. 5a) 
and markedly hampered the generation of iTreg cells, as indicated 
by the substantial reduction in CD25 expression (data not shown). 
iTreg cells generated in the presence of siRNA-E5, sorted on the basis 
of their CD25hi phenotype, had a suppressive ability similar to that 
of iTreg cells generated in the presence of siRNA-Scr (Fig. 5d). These 
phenomena occurred because silencing of Foxp3 exon 5 reduced the 
induction of all Foxp3 splicing variants and, consequently, hampered 
the upregulation of CD25 expression and the generation of iTreg cells 
(data not shown). Since the sorting gate was on CD25hi cells, it was 
likely that CD25hi cells recovered from the silencing of Foxp3 exon 
5 were those in which the knockdown had failed, which had retained 
their suppressive ability (Fig. 5d). Overall, these analyses revealed that 
glycolysis controlled the expression of Foxp3-E2, which was necessary 
for the suppressive function of human iTreg cells.
Enolase-1 controls Foxp3-E2 expression
Several isoforms of enolase-1, a key glycolytic enzyme, can bind 
DNA27–29. Among them, the 37-kDa isoform (MBP-1) has been shown 
to regulate gene expression in various experimental systems27–29. 
Both the glycolytic enzyme enolase-1 and the transcriptional repres-
sor MBP-1 arise from the gene ENo1 through the use of alternative 
translation start sites present on ENo1 mRNA29,30. Published evidence 
suggests that enolase-1 isoforms have multifunctional roles, ranging 
from glycolytic activity in the cytoplasm to gene regulation in the 
nucleus29,30. For this reason, we evaluated whether enolase-1 isoforms 
localized in the nuclear fraction of iTreg-CTR, iTreg-2DG and iTreg-Etx 
cells to control Foxp3 expression. Immunoblot analysis revealed that 
three different products of the alternative translation start sites of the 
ENo1 transcript (48, 37 and 31 kDa in size) were selectively greater 
in abundance in iTreg-2DG cells than in iTreg-CTR cells, whereas their 
amounts were similar in iTreg-Etx cells and iTreg-CTR cells (Fig. 6a). To 
determine whether enolase-1 was involved in the regulation of Foxp3 
in iTreg cells, we first evaluated the binding of enolase-1 to the Foxp3 
regulatory elements and then assessed the effect of the silencing of 
ENo1 on Foxp3 mRNA expression. Chromatin-immunoprecipitation 
analysis revealed that the recruitment of enolase-1 to both the Foxp3 
promoter and its CNS2 regions was greater in iTreg-2DG cells than 
in iTreg-CTR cells (Fig. 6b); in contrast, the association of enolase-1 
with the Foxp3 promoter was much lower in iTreg-Etx cells than in 
iTreg-CTR cells, but its association with Foxp3 CNS2 was similar in 
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Figure 6 Recruitment of enolase-1 to FOXP3 regulatory regions controls  
Foxp3-E2 expression. (a) Immunoblot analysis (far left) of enolase-1 isoforms  
in nuclear extracts of iTreg-CTR, iTreg-2DG and iTreg-Etx cells, probed with a  
mAb (H-300) that recognizes an epitope common to all isoforms (48, 37 and  
31 kDa), and of the control protein MCM7 (bottom); gels were exposed for  
1 min (48 kDa), 5 min (37 kDa) or 20 min (31 kDa) to avoid overexposure of  
the signal. Right, densitometry of all enolase-1 forms, normalized to MCM7 and  
presented relative to results obtained for iTreg-CTR cells. Each symbol (right)  
represents an individual data point (n = 9); small horizontal lines indicate the  
mean. (b) Recruitment of enolase-1 to the promoter of FOXP3 (left) or FOXP3 CNS2 (right) in Tconv cells and iTreg-CTR, iTreg-2DG and iTreg-Etx cells 
(key), assessed by chromatin immunoprecipitation with mAb to enolase-1. (c) Quantitative real-time PCR analysis of all FOXP3 transcripts (left) 
or FOXP3-E2 mRNA (right) in iTreg-CTR and iTreg-2DG cells generated in the presence of siRNA-Scr or siRNA-ENO1 (horizontal axis); results were 
normalized to those of control 18S rRNA and are presented relative to those of iTreg-CTR cells treated with siRNA-Scr. *P < 0.05, **P < 0.01,  
***P < 0.005, †P < 0.001 and ‡P < 0.0001 (two-tailed Student’s t-test). Data are from three independent experiments with technical triplicates  
(a,c; mean ± s.e.m. of n = 9 in c) or three independent experiments (b mean ± s.d. of n = 3).
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iTreg-Etx cells and iTreg-CTR cells (Fig. 6b). Freshly isolated, unstimu-
lated Tconv cells, which did not express Foxp3, had less cytoplasmic 
enolase-1 than did iTreg-CTR cells, and the recruitment of enolase-1 
to the Foxp3 regulatory elements in these cells was similar to that in 
iTreg-2DG cells (Supplementary Fig. 5b and Fig. 6b).
To address whether enolase-1 directly controlled the splicing of 
Foxp3 mRNA, we silenced ENo1 by using ENO1-specific siRNA 
(siRNA-ENO1) during the generation of iTreg cells. After confir-
mation by quantitative RT-PCR that silencing of ENo1 occurred 
(Supplementary Fig. 5c), we found that silencing of ENo1 restored 
expression of Foxp3 mRNA in iTreg-2DG cells (Fig. 6c). Specifically, 
silencing of ENo1 in iTreg-2DG cells led to the recovery of all Foxp3 
transcripts (fourfold greater abundance than in iTreg-2DG cells 
generated with siRNA-Scr) and an even greater recovery of Foxp3-E2 
mRNA (13-fold greater abundance than in iTreg-2DG cells generated 
with siRNA-Scr) (Fig. 6c). In addition, the level of Foxp3-E2 mRNA 
was significantly higher, whereas the level of total Foxp3 mRNA was 
slightly lower, in iTreg-CTR cells generated in the presence of siRNA-
ENO1 than in those generated with siRNA-Scr (Fig. 6c). Together these 
data established that enolase-1 specifically repressed the expression of 
Foxp3-E2 in iTreg cells.
Properties of CD4+Foxp3-E2+ T cells
To investigate the physiological relevance of our findings reported 
above, we examined ex vivo CD4+Foxp3-E2+ cells and their biological 
properties. CD4+Foxp3-E2+ cells constituted (on average) 5.94% ± 2.68% 
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Figure 7 Impaired glycolysis, impaired IL-2–IL-2R–STAT5 signaling  
and altered Foxp3-E2 expression in iTreg cells from subjects with RRMS.  
(a) ECAR of Tconv cells isolated from subjects with RRMS who had not  
undergone treatment (n = 6) and healthy subjects (CTR) (n = 14), then  
stimulated for 24 h in vitro with mAb to CD3 plus mAb to CD28  
(in conditions as in Fig. 1a, left). (b) Proliferation of CFSE-labeled  
CD4+ T cells stimulated for 96 h in vitro with mAb to CD3 plus mAb to  
CD28 and cultured alone or in the presence of iTreg cells (key) from subjects as  
in a (left margin), at a ratio of 1:1 or 1:2 (above plots). Right, percent proliferation of CD4+ T cells in those conditions (far right). Numbers in  
plots (left) indicate percent CFSE dilution in CD4+ T cells cultured alone (top left); numbers above bracketed lines indicate percent of CFSE dilution  
in CD4+ T cells cultured with iTreg cells. (c) Flow cytometry analyzing the expression of CD25, Foxp3-E2 and CD4 (left) or various Treg cell markers 
(right) in iTreg cells from subjects as in a. Numbers in top left corner indicate percent CD25hi cells or MFI (in parentheses) of CD25 (left) or percent 
Foxp3-E2hi cells  or MFI (in parentheses) of Foxp3-E2 (middle); and numbers above plots (right) indicate percent or MFI (in parentheses) of each marker. 
(d) Immunoblot analysis of phosphorylated and total STAT5 (top) and of the 44- and 47-kDa forms of Foxp3 (bottom) in Tconv cells obtained from subjects 
as in a and stimulated for 24 or 36 h (above lanes) in vitro with mAb to CD3 plus mAb to CD28. Bottom, densitometry of Foxp3 normalized to total 
Erk1/2, or of phosphorylated STAT5 normalized to total STAT5, presented relative to results for Tconv cells from healthy subjects assessed after 24 h of 
stimulation. Each symbol (right) represents an individual data point; small horizontal lines indicate the mean. (e) Immunoblot analysis (left) of the  
44- and 47-kDa forms of Foxp3 in Tconv cells obtained from pairs of monozygotic twins (n = 6) discordant for RRMS and without treatment, then 
stimulated for 24 or 36 h in vitro with mAb to CD3 plus mAb to CD28 (left). Right, densitometry of Foxp3 normalized to total Erk1/2 and presented 
relative to results obtained for Tconv cells from the healthy twin, assessed after 24 h of stimulation. Each symbol (right) represents an individual data 
point (n = 27); small horizontal lines indicate the mean. *P < 0.05, ** P < 0.001 and ***P < 0.0001 (Wilcoxon matched-pairs test (b) or Wilcoxon test 
(d,e)). Data are from six (RRMS) or fourteen (CTR) independent experiments (a; mean ± s.e.m.), one experiment representative of three experiments 
(b, left), three independent experiments with technical triplicates (b, right; mean ± s.e.m. of n = 9 replicates), one experiment representative of three 
experiments (c), one experiment representative of four independent experiments (d, left), or four independent experiments (Foxp3) with technical 
triplicates from four subjects (n = 12) or three independent experiments (STAT5) with technical triplicates from three subjects (n = 9) (d, right), one 
experiment representative of three (e, left) or three independent experiments with nine technical replicates from three sets of twins (e, right; n = 27).
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of PBMCs from healthy human donors, whereas CD4+ cells 
expressing total Foxp3 represented 10.20% ± 3.97% of these cells 
(Supplementary Fig. 6a). Flow cytometry revealed that CD4+Foxp3-
E2+ cells had higher expression of Treg cell–associated markers (CD25, 
CTLA-4, GITR, CD39 and CD71) than did CD4+ cells that expressed 
total Foxp3 (Supplementary Fig. 6b,c), and they were more prolif-
erative and metabolically active than CD4+ cells that expressed total 
Foxp3, as indicated by their larger amounts of Ki67 and phospho-
rylated S6 (Supplementary Fig. 6d). These findings suggested 
that among all the peripheral human CD4+Foxp3+ T cells, those con-
taining the region encoded by exon 2 represented the fraction with 
the strongest suppressive properties, in agreement with the results we 
obtained for iTreg cells.
Defective glycolysis and function of iTreg cells in autoimmunity
We next analyzed the relevance of the findings to human autoim-
munity, in patients with RRMS who had not undergone treatment 
and in patients with T1D. Despite the evidence that the prolifera-
tion of Tconv cells obtained from subjects with RRMS and stimulated 
in vitro with mAb to CD3 plus mAb to CD28 was similar to that 
of their counterparts from healthy control subjects (Supplementary 
Fig. 7a), glycolysis was impaired in Tconv cells from subjects with 
RRMS, as indicated by their diminished basal and maximal glycolysis 
and glycolytic capacity (Fig. 7a and Supplementary Fig. 7b). iTreg cells 
generated from Tconv cells of subjects with RRMS demonstrated dimin-
ished in vitro suppressive ability relative to that of those generated from 
healthy age- and sex-matched control subjects (Fig. 7b). Moreover, 
iTreg cells from subjects with RRMS had reduced expression of 
Foxp3-E2, CTLA-4, PD-1 and CD71 and less phosphorylation of S6, 
and slightly increased expression of GITR, compared with that of 
iTreg cells from healthy control subjects (Fig. 7c). There was also 
impaired induction in expression of the 47-kDa and 44-kDa forms 
of Foxp3 in Tconv cells from subjects with RRMS at 24 and 36 h 
after stimulation with a minimal dose of mAb to CD3 plus mAb to 
CD28, together with impairment of the IL-2–IL-2R–STAT5 signaling 
pathway at 24 h (Fig. 7d). We also confirmed the specific decrease 
in Foxp3-E2 expression in Tconv cells from subjects with RRMS, 
by immunoblot analysis with mAb to Foxp3-E2 (Supplementary 
Fig. 7c). Of note, we also confirmed those findings in studies of 
monozygotic twins discordant for RRMS (one twin affected and 
one twin healthy) who had also not undergone treatment (Fig. 7e), 
as measured by the induction of Foxp3-E2 in Tconv cells stimulated 
in vitro with mAb to CD3 plus mAb to CD28 (Supplementary Fig. 1). 
Notably, we observed a profound delay in the induction of both the 
47-kDa form of Foxp3 and the 44-kDa form of Foxp3 in Tconv cells 
from the twin with RRMS at 24 h, relative to the induction in such 
cells from the healthy twin (Fig. 7e). At 36 h, the level of the 44-kDa 
form of Foxp3 was not significantly lower than its abundance in 
Tconv cells from the healthy twin, whereas the 47-kDa form of Foxp3 
was still profoundly lower in abundance (Fig. 7e).
To explore whether altered induction of Foxp3-E2 was a specific 
feature of RRMS or was instead a common phenomenon in autoim-
munity, we also evaluated the induction of Foxp3, Treg cell markers 
and IL-2–IL-2R–STAT5 signaling in Tconv cells obtained from subjects 
with early-onset T1D and stimulated in vitro with mAb to CD3 plus 
mAb to CD28 (Supplementary Fig. 1). We found that iTreg cells from 
subjects with T1D had lower expression of Foxp3-E2, CTLA-4, PD-1 
and GITR, without differences in the phosphorylation of S6 or expres-
sion of CD71, relative to that of iTreg cells from age-matched healthy 
control subjects, as assessed by flow cytometry (Fig. 8a). At both 24 h 
Figure 8 Impaired IL-2–IL-2R–STAT5  
signaling and altered Foxp3-E2 expression  
in iTreg cells from subjects with T1D. (a) Flow 
cytometry analyzing the expression of  
CD25, Foxp3-E2 and CD4 (left) or Treg cell 
markers (right) in iTreg cells from subjects  
with early-onset T1D or healthy subjects (CTR) 
(numbers in plots as in Fig. 7c). (b) Immunoblot 
analysis (far left) of phosphorylated and  
total STAT5 (top) and the 44- and 47-kDa  
forms of Foxp3 (below) in Tconv cells obtained 
from subjects as in a and stimulated for 24 or  
36 h in vitro with mAb to CD3 plus mAb to 
CD28. Right, densitometry of phosphorylated 
STAT5 normalized to total STAT5 or of all  
Foxp3 normalized to total Erk1/2, presented 
relative to results obtained for Tconv cells  
from healthy subjects, assessed after  
24 h of stimulation. Each symbol (right) 
represents an individual data point; small 
horizontal lines indicate the mean.  
(c) Immunoblot analysis of the 44- and  
47-kDa forms of Foxp3 in Tconv cells  
obtained from monozygotic twins (n = 2) 
discordant for T1D, then stimulated for  
24 or 36 h in vitro with mAb to CD3 plus  
mAb to CD28. Right, densitometry of  
Foxp3 normalized to total Erk1/2, presented 
relative to results obtained for Tconv cells 
from healthy donors, assessed after 24 h of 
stimulation. Each symbol (right) represents 
an individual data point; small horizontal lines indicate the mean. *P < 0.005 and **P < 0.001 (Wilcoxon test). Data are from one experiment 
representative of two (a), one experiment representative of three independent experiments (b, left), three independent experiments with technical 
triplicates from five healthy subjects (n = 15) or seven subjects with T1D (n = 21) (b, right), one experiment representative of three independent 
experiments (c, left) or three independent experiments with technical triplicates from one set of twins (n = 9) (c, right).
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and 36 h, there was marked impairment in induction of the 47- and 
44-kDa forms of Foxp3 in subjects with T1D relative to their induction 
in healthy control subjects (Fig. 8b). These phenomena correlated with a 
significant reduction in the phosphorylation of STAT5 observed at 24 h 
in Tconv cells from subjects with T1D, relative to its phosphorylation 
in such cells from healthy control subjects (Fig. 8b). We confirmed, 
by immunoblot analysis with mAb to Foxp3-E2, the specific decrease 
in Foxp3-E2 (Supplementary Fig. 7d). Of note, we confirmed again 
the impairment in the induction of Foxp3-E2 in monozygotic twins 
discordant for T1D. At 24 h, the level of the 47- and 44-kDa forms of 
Foxp3 in Tconv cells from the affected twin was similar to that in cells 
from the healthy twin, while at 36 h the 47-kDa form was much less 
abundant in cells from the affected twin than in cells from the healthy 
twin (Fig. 8c), which confirmed our findings for Foxp3-E2 expression 
in RRMS, another autoimmune disease. Overall, our data suggested 
that Tconv cells from healthy subjects exhibited normal glycolysis dur-
ing in vitro stimulation with mAb to CD3 plus mAb to CD28, which 
led to the generation of functional iTreg cells that expressed appropri-
ate amounts of Foxp3-E2 (Supplementary Fig. 8). In subjects with 
autoimmunity, impaired glycolysis during Tconv cell stimulation led to 
reduced expression of Foxp3-E2 that would account for the diminished 
regulatory ability of iTreg cells (Supplementary Fig. 8).
DISCUSSION
Here we found that glycolysis was indispensable for the generation of 
human iTreg cells from Tconv cells through localization of the glycolytic 
enzyme enolase-1 to the nucleus, which directly affected the induc-
tion of specific splicing variants of Foxp3-E2 after enolase-1 bound 
to the Foxp3 promoter and CNS2. We confirmed our findings in 
two different human autoimmune diseases, RRMS and T1D. This 
emphasizes the link between metabolism and immunotolerance in 
the development of autoimmunity.
Human iTreg cells can be generated anew from non-regulatory 
Tconv cells, following suboptimal stimulation of the TCR and without 
the requirement for exogenous regulatory-type cytokines or drugs; 
this provides evidence that TCR signal strength is a critical determi-
nant of the induction of Foxp3, the generation of Treg cells and the 
engagement of specific metabolic programs during the activation of 
Tconv cells11,17–19,31. In our experimental system, weak (0.1 bead per 
cell) and short (36-hour) activation of Tconv cells via the TCR gave 
rise to iTreg cells that were the highly proliferative and metabolically 
active fraction of activated T cells (whose generation closely relies 
on glycolysis). 2DG (a glycolytic inhibitor) affected the induction 
of Foxp3, reduced the expression of Treg cell markers and impaired 
the suppressive function of iTreg cells. The inhibition of FAO via Etx 
increased Foxp3 expression and induced iTreg cells with stronger 
regulatory properties. These results are in agreement with published 
reports showing that the engagement of distinct metabolic pathways 
controls the function and differentiation of T cells17–19.
Glycolysis fuels the energetic and biosynthetic demands of CD4+  
T cell growth and proliferation and represents the metabolic program 
necessary for appropriate cell activation17,21,32. Compelling experi-
mental evidence suggests that during maximal activation of CD4+  
T cells, autocrine secretion of IL-2 induces Foxp3 in a small fraction 
of cells, which leads to conversion into Foxp3+ Treg cells, whose 
stability over time has been questioned33. We observed here that weak 
stimulation of the TCR generated Foxp3+ iTreg cells that were stable 
over time. Therefore, we speculate that the activation of Tconv cells 
induces a self-limiting mechanism of activation through the genera-
tion of iTreg cells and thereby induces the maintenance of tolerance. 
This could help to explain the apparent paradox of the association 
of T cell immunodeficiency with autoimmunity34,35; i.e., a reduced 
activation rate of T cells (immunodeficiency) might diminish the 
generation of iTreg cells necessary to replenish the peripheral pool of 
Treg cells (autoimmunity).
Our study has also demonstrated a crucial role for the glycolytic 
enzyme enolase-1 and its isoform (i.e., MBP-1) in modulating the 
expression of specific splicing forms of Foxp3 that were indispensable 
for the suppressive function of iTreg cells. So far, about twelve different 
Foxp3 transcripts have been reported, as well as four to eight differ-
ent splicing forms of the protein (ranging from 18 kDa to 49 kDa), 
but their functions are not completely understood22–24,26. We found 
that treatment with 2DG was able to diminish the abundance of the 
Foxp3-E2 splice forms, which we found were necessary for the regula-
tory function of iTreg cells (as exemplified by the reduced suppressive 
ability of both iTreg-2DG cells and cells generated with siRNA-E2, 
in which Foxp3-E2 was silenced). The splice form that accounted 
for the suppressive activity of iTreg cells was the 47-kDa form, which 
contains the region encoded by exon 2. The role of that region has been 
assessed at a molecular level in various experimental systems36–38. 
Foxp3 can block the activity of RORγt, a transcription factor associated 
with the TH17 subset of helper T cells, through direct interaction 
involving the region encoded by exon 2 (ref. 36). Foxp3 interacts also 
with the transcription factor RORα, and mutations of sequence in 
exon 2 encoding the ‘LxxLL’ motif (where ‘x’ indicates any amino 
acid) hamper the interaction and repression by Foxp3 (refs. 37,38). 
In addition, CD4+CD25+ T cells containing spliced forms of Foxp3 
lacking exon 2 are less hypo-responsive and produce more IL-2 than 
are CD4+CD25+ T cells containing the Foxp3-E2 splicing form24.
The recruitment of different factors to Foxp3 regulatory elements 
can influence gene expression or alternative splicing through a com-
bination of physical mechanisms ranging from direct interaction 
to transient chromatin modification. Among those factors, MBP-1, 
which is derived from alternative translation of ENo1 transcripts, 
has been reported to bind DNA and to suppress gene expression27–30. 
We found that under conditions of inhibition of glycolysis (treatment 
with 2DG), there was an increase in enolase-1 on both the Foxp3 
promoter and Foxp3 CNS2, and this was associated with reduced 
expression of total Foxp3 and the Foxp3-E2 splicing variant. In 
addition, when glycolysis was inhibited (in iTreg-2DG cells) during 
RNA-mediated interference of ENo1, the observed recovery of total 
Foxp3 and the Foxp3-E2 isoform depended on the non-glycolytic 
activity of enolase-1. In contrast, silencing of ENo1 in the absence of 
treatment with 2DG (in iTreg-CTR cells) lead to a reduction in Foxp3 
expression that could be ascribed to impairment of the glycolytic 
activity of enolase-1. Our data have identified a previously unknown 
molecular mechanism that links a specific glycolytic enzyme to the 
regulation of a ‘master gene’ (Foxp3) whose product is necessary 
for the induction and function of Treg cells. In resting Tconv cells, 
with low glycolytic demands, enolase-1 was specifically recruited to 
Foxp3 regulatory regions, and this correlated with no Foxp3 expres-
sion. Activation of the TCR led to an increase in glucose uptake and 
glycolysis, which supported the energetic needs of Tconv cells and 
drove appropriate Foxp3 expression; impairment of the glycolytic 
pathway (with 2DG) during the activation of Tconv cells hampered 
the induction of Foxp3-E2 after accumulation of the enolase-1 iso-
forms in the nucleus on Foxp3 regulatory regions. This indicated 
that glycolysis was required for the generation of iTreg cells following 
the activation of Tconv cells. We also found that iTreg-2DG cells had 
an impairment in the IL-2–IL-2R–STAT5 signaling pathway (which 
has a pivotal role in the induction of Foxp3 and the generation and 
homeostasis of Treg cells)25,39, whereas iTreg-Etx cells exhibited more 
127
©
20
15
N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
nature immunology  aDVaNCE ONLINE PUBLICaTION 
A rt i c l e s
activation of this pathway. In Tconv cells, a major consequence of IL-2 
signaling is the phosphorylation of STAT5, which binds to the Foxp3 
promoter; this leads to Foxp3 expression and the acquisition of sup-
pressive ability by the cells40,41. This is a key event in the generation 
of Treg cells, as shown by the fact that STAT5- or IL-2Rγ-deficient 
mice have considerably fewer Foxp3+ Treg cells than their wild-type 
counterparts have42. We applied those findings to two human autoim-
mune diseases, including studies of disease-discordant monozygotic 
twins, in which a reduced suppressive function of iTreg cells was asso-
ciated specifically with impaired expression of Foxp3-E2, secondary 
to a glycolytic defect during the activation of Tconv cells. In summary, 
our data suggest that distinct metabolic pathways contribute to the 
generation of ‘waves’ of Treg cells during T cell activation to replenish 
the peripheral Treg cell pool and protect from loss of immunotoler-
ance34,35. Targeted manipulation of metabolic disturbances could be 
instrumental in modulating immunotolerance in autoimmunity.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
Subjects and iTreg cell induction. iTreg cells were induced from CD4+CD25− 
cells (Tconv cells) from healthy donors and subjects with RR-MS or T1D. The 
study was approved by the Institutional Review Board of the Università degli 
Studi di Napoli “Federico II”, and peripheral blood was obtained from subjects 
with RR-MS and healthy control subjects after they signed a written informed 
consent approved by the Institutional Review Board. Subjects with RR-MS 
(including two pairs of disease-discordant monozygotic twins) had all not 
undergone treatment and were 40 ± 20 years of age (at a female/male ratio 
of 4:1), with relapsing-remitting disease and with a Kurtzke expanded 
disability status score between 0 and 4 (ref. 43). Healthy donors were matched 
for age, body mass index and sex with the subjects with RR-MS and had no 
history of inflammatory, endocrine or autoimmune disease. All blood samples 
from patients and controls were collected at 9:00 a.m. into heparinized 
Vacutainers (BD Biosciences) and were processed within the following 4 h.
Subjects with T1D (8 ± 3 years age, at a female/male ratio of 1:1), including 
the pairs of disease-discordant monozygotic twins, were recruited after 
resolution of diabetic ketoacidosis, with blood glucose values between 
80 mg/dl and 180 mg/dl, after glycemic stabilization through the use of 
exogenous insulin, achieved in 5 d. Diabetes was defined according to 
the Global International Diabetes Federation/International Society for 
Pediatric and Adolescent Diabetes Guidelines for Diabetes in Childhood and 
Adolescence44 and included symptoms of diabetes, in addition to a random 
plasma glucose concentration of ≥11.1 mmol/l (200 mg/dl) or a fasting plasma 
glucose concentration of ≥7.0 mmol/l (≥126 mg/dl), or a glucose concentra-
tion of ≥11.1 mmol/l (≥200 mg/dl) 2 h after glucose loading during an oral 
glucose-tolerance test, and a glycated hemoglobin (HbA1c) of ≥ 6.5 (ref. 44). 
The following criteria were used for the selection of healthy control subjects 
for studies of T1D: a fasting blood glucose concentration of <5.5 mmol/l 
(<100 mg/dl), negative personal and familial history of autoimmune disorders, 
and negativity for islet autoantibodies at the 99th percentile. The children 
with T1D and control subjects (matched for age, sex and body mass index) 
were recruited at the Sezione di Pediatria, Dipartimento di Scienze Mediche 
Traslazionali, Università di Napoli ‘‘Federico II’’, after the Institutional Review 
Board of the Università degli Studi di Napoli “Federico II” approved the study 
and parents provided their written informed consent.
For the generation of iTreg cells, after Ficoll hypaque–gradient centrifu-
gation (GE-Healthcare), Tconv cells were isolated from PBMCs by negative 
selection with a human CD4+CD25+ T cell kit (Invitrogen) (cell purity >98% 
by flow cytometry), and cells were cultured (2 × 106 cells per ml) in six-well 
plates (Becton-Dickinson; Falcon) with RPMI-1640 medium supplemented 
with 100 UI/ml penicillin, 100 µg/ml streptomycin (Life Technologies) and 
either 5% autologous serum or 5% AB human serum (Invitrogen). Cells were 
stimulated for 36 h with Dynabeads coated with mAb to CD3 plus mAb to 
CD28 (Invitrogen) at a density of 0.1 bead per cell. Tconv cells were then stained 
with the following mAbs: fluorescein isothiocyanate (FITC)-conjugated 
anti–human CD4 (RPA-T4; 555346BD; PharMingen), phycoerythrin 
(PE)–indodicarbocyanine (Cy5)–conjugated anti-human CD25 (M-A251; 
555433; BD PharMingen). Cells were sorted by flow cytometry on the basis 
of their cell-surface expression of CD25 with a MoFlo high-performance 
cell sorter (Dako/Beckman-Coulter) or a BD FACSJazz (Becton-Dickinson) 
(Supplementary Fig. 1). For the generation of iTreg cells in the presence of 
inhibitors of specific metabolic pathways, Tconv cells were stimulated for 36 h 
with Dynabeads coated with mAb to CD3 plus mAb to CD28 (0.1 bead per cell) 
(Invitrogen) in the absence or presence of 1 mM 2-deoxy-d-glucose (2DG) 
(Sigma-Aldrich) or 200 µM etomoxir (Etx) (Sigma-Aldrich). Cells obtained 
from each culture were then stained with FITC-conjugated anti–human CD4 
(RPA-T4; 555346; BD PharMingen) and PE-Cy5–conjugated anti–human 
CD25 (M-A251; 555433; BD PharMingen), and iTreg cells from each experi-
mental culture were then sorted by flow cytometry (cell purity >98% by 
flow cytometry) (Supplementary Fig. 3). Cells at 36 h after sorting by 
flow cytometry are called ‘iTreg-CTR cells’, ‘iTreg-2DG cells’, ‘iTreg-Etx cells’  
and ‘Tconv cells’ here.
Molecular signaling and immunoblot analysis. iTreg-CTR, iTreg-2DG and 
iTreg-Etx cells sorted by flow cytometry were lysed after 1 h of culture with or 
without stimulation with Dynabeads coated with mAb to CD3 plus mAb to 
CD28 (0.2 bead per cell) (Invitrogen). Tconv cells from subjects with RR-MS 
or T1D and healthy subjects were lysed 24 and 36 h after stimulation with 
Dynabeads coated with mAb to CD3 plus mAb to CD28 (0.1 bead per cell) 
(Invitrogen). Subcellular fractionations were performed with a nuclear-cytosol 
fractionation kit (NE-PER Nuclear and Cytoplasmic Extraction Reagents; 
Thermo-Fisher). Total cell lysates were obtained incubation of cells for 20 min 
at 4 °C in a solution of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl and 1.0% Triton 
X-100, plus SigmaFast protease inhibitor (S8820; Sigma-Aldrich) and Sigma 
phosphatase inhibitor (P5726; Sigma-Aldrich), and immunoblot analyses were 
performed as described45. The following mAbs used were used for normaliza-
tion of nuclear extracts: antibody to S6 phosphorylated at Ser240 and Ser244 
(2215), anti-S6 (5G10, 2217), anti-enolase-1 (3810), antibody to STAT3 phos-
phorylated at Tyr705 (3E2; 9138), anti-STAT3 (79D7; 4904), antibody to STAT5 
phosphorylated at Tyr694 (9351), anti-STAT5 (9352) (all 1:1,000 dilution; 
all from Cell Signaling Technology); anti-Erk1/2 (H72, SC292838) (Santa 
Cruz Biotechnology); antibody to all Foxp3 (PCH101; 12-4776), antibody 
to Foxp3-E2 (150D/E4; 14-4774) (all 1:500 dilution; all from eBioscience); 
anti-enolase-1 (1:500 dilution; H-300; SC15343) and anti-MCM7 (1:3,000 
dilution; 141.2; SC9966) (all from Santa Cruz Biotechnology). All filters were 
quantified by densitometry as described45. Results were calculated as the 
densitometry of each phosphorylated protein normalized to that of its total 
form (S6, STAT3 and STAT5) or normalized to that of Erk1/2 (enolase-1 and 
Foxp3) or MCM7 (enolase-1 from nuclear extracts) and are presented relative 
to results obtained for control samples.
‘Seahorse’ experiments. Metabolic profiles of Tconv and iTreg cells were 
evaluated in the presence or absence of stimulation with Dynabeads coated 
with mAb to CD3 plus mAb to CD28 (0.1 bead per cell) (Invitrogen). Real-time 
measurements of oxygen consumption rate (OCR) and extracellular acidifi-
cation rate (ECAR) were made with an XF-96 Extracellular Flux Analyzer 
(Seahorse Bioscience). Tconv cells and iTreg cells were plated in XF-96 plates 
(Seahorse Bioscience) at a density of 2 × 105 cells per well and were cultured 
with RPMI-1640 medium supplemented with 5% AB human serum. OCR was 
measured in XF medium (non-buffered DMEM medium containing 10 mM 
glucose, 2 mM l-glutamine and 1 mM sodium pyruvate) under basal conditions 
and in response to 5 µM oligomycin, 1.5 µM of FCCP (carbonylcyanide-4-
(trifluoromethoxy)-phenylhydrazone) and 1 µM of antimycin and rotenone 
(Sigma-Aldrich). ECAR was measured in XF medium in basal conditions and 
in response to 10 mM glucose, 5 µM oligomycin and 100 mM of 2DG (all from 
Sigma-Aldrich). Experiments with the Seahorse system were done with the 
following assay conditions: 3 min of mixture; 3 min of waiting; and 3 min of 
measurement. For the analysis of FAO, the XF Palmitate-BSA FAO substrate 
was used (Seahorse Bioscience). FAO was measured in FAO buffer containing 
111 mM NaCl, 4.7 mM KCl, 2 mM MgSO4 and 1.2 mM Na2HPO4, supple-
mented with 2.5 mM glucose, 0.5 mM carnitine and 5 mM HEPES, pH7.4 (all 
from Sigma-Aldrich) Etomoxir (final concentration, 40 µM; Sigma-Aldrich) 
was added 15 min before the ‘XF’ assay (time 0). At time 0, cells were given 
30 µl of 1 mM palmitate conjugated to 0.17 mM BSA. FAO was calculated 
as the ratio of the FCCP-stimulated OCR in the presence of palmitate to the 
FCCP-stimulated OCR in the presence of Etx.
Flow cytometry, T cell proliferation and CFSE staining. For staining of 
PBMCs, Tconv or iTreg cells, the following mAbs were used: FITC-conju-
gated anti–human CD4 (RPA-T4; 555346; BD PharMingen), PE-conjugated 
anti–human CD25 (M-A251; 555432; BD PharMingen), PE-Cy5-conjugated 
anti–human CD25 (M-A251; 555433; BD PharMingen), allophycocyanin 
(APC)-conjugated anti–human CD39 (TU66; 560239; BD PharMingen), APC-
conjugated anti–human CD71 (M-A712; 551374; BD PharMingen), APC-
conjugated anti–human CD127 (HIL-7R-M21; 555598; BD PharMingen), 
PE-Cy5-conjugated anti–human CD152 (BNI3 555854; BD PharMingen), 
PE-conjugated anti–human GITR (DT5D3; 130-092-895; Miltenyi Biotec), 
PE-Cy5-conjugated anti–human CD45RO (UCHL1 MCA461C; Serotec), 
FITC-conjugated anti–human CCR7 (150503; FAB197F; R&D Systems), 
APC-conjugated anti–human CD62L (DREG-56 559772; BD Pharmingen) 
and peridinin chlorophyll protein (PerCP)–cyanine 5.5 (Cy5.5)–conjugated 
anti–human CD279 (PD-1; EH12.1 581273; BD Pharmingen). Thereafter cells 
were washed, fixed and permeabilized (fixation-permeabilization buffer; eBio-
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science) and were stained with the following mAbs: PE–anti-Foxp3 (PCH101; 
12-4776; eBioscience), PE–anti-Foxp3 (150D/E4; 12-4774; eBioscience), Alexa 
Fluor 647–conjugated antibody to ribosomal protein S6 phosphorylated at 
Ser235 and Ser236 (D57.2.2E; 4803S; Cell Signaling) and FITC–anti-Ki67 
(B56; 556026 BD Biosciences). Analyses were performed with Diva software 
(BD) and FlowJo software (Tree Star). For T cell–proliferation assays, purified 
T cells (5 × 104 cells per well) were cultured as described26. The fluorescent 
dye CFSE (5,6-carboxyfluorescein diacetate succinimidyl ester) was used at 
a concentration of 1 µg/ml (Invitrogen). Flow cytometry analyzing CFSE 
dilution was performed by gating on CD4+CFSE+ cells stimulated for 96 h 
with Dynabeads coated with mAb to CD3 plus mAb to CD28 (0.2 bead per 
cell) (Invitrogen) alone or cultured with iTreg cells at varous ratios (from 1:1 to 
8:1, CD4+ T cells/iTreg cells) in round-bottomed 96-well plates for cell-cell 
contact experiments or in 24-well plates for Transwell experiments (all from 
Becton-Dickinson).
RNA extraction, qRT-PCR, qPCR and siRNA. Total RNA was extracted with 
Triazol (Invitrogen). cDNA was synthesized in a 20-µl reaction volume con-
taining 1 µg of total RNA, 100 units of Superscript III Reverse Transcriptase 
(Invitrogen) and 1 µl of random primers (200 ng/µl). mRNA was reverse-
transcribed for 1 h at 50 °C, and the reaction was heat-inactivated for 15 min 
at 70 °C. The products were stored at −20 °C until use. Quantitative RT-PCR 
and quantitative PCR were performed on a 7500 RT-PCR System (Applied 
Biosystems) with a SYBR Green detection system (FS Universal SYBR Green 
MasterRox; Roche Applied Science). The Foxp3 splice variants primers used 
are in Supplementary Table 1. Primers for 18S were used as internal standard 
control for the reactions (Supplementary Table 1).
For knockdown of Foxp3 and ENo1 with siRNA, cells were transiently 
transfected, with a Neon Transfection System, with siRNA at a final con-
centration of 10 nM (in medium without serum), and incubation was 
continued for 48 h. RNA with a scrambled sequence, at the same concen-
tration, was used as negative control. siRNA was designed to target Foxp3 
exon 5 (target sequence, 5′-UCGAAGAGCCAGAGGACUU-3′) or exon 2 
(target sequence, 5′-GGCCACAUUUCAUGCACCA-3′) or with a scram-
bled sequence (target sequence, 5′-AUUGAGUGUAGAUUAAGUA-3′). 
A mixture of siRNA specific for all ENo1 isoforms was used (target sequences, 
5′-CAGUGGUGUCUAUCGAAGA-3′ and 5′-CCGUGACCGAGUCUCU 
UCA-3′) (4390821; Life Technologies). Tconv cells were transfected under 
the following conditions: pulse voltage, 2,400 V; pulse width, 20 ms; pulse 
number, 1. Then, cells were stimulated with Dynabeads coated with mAb to 
CD3 plus mAb to CD28 (0.1 beads/cell) (Invitrogen). After 36 h of stimula-
tion, immunoblot analysis or RT-PCR was performed for confirmation of 
specific silencing.
Chromatin immunoprecipitation. After the appropriate treatment, cells 
(~7 × 105 for each antibody) were fixed for 10 min at room temperature by 
the addition of 1 volume of 2% formaldehyde to a final concentration of 1%; 
the reaction was quenched by the addition of glycine to a final concentration 
of 125 mM. Fixed cells were harvested and the pellet was resuspended in 
1 ml of lysis buffer (10 mM Tris-HCl, pH 8.0, 10 mM NaCl and 0.2% NP-40) 
containing 1× protease inhibitor cocktail (Roche Applied Science). The lysates 
were sonicated to produce DNA fragments 300–600 base pairs in length. 
Sonicated samples were centrifuged and supernatants were diluted twofold 
in chromatin immunoprecipitation buffer (20 mM Tris-HCl, pH 8.0, 150 mM 
NaCl, 2 mM EDTA and 1% Triton X-100). An aliquot (1/10) of sheared chro-
matin was further treated with proteinase K, then underwent extraction with 
phenol-chloroform and precipitation for measurement of DNA concentra-
tion and shearing efficiency (input DNA). Chromatin-immunoprecipitation 
reactions were set up according to the manufacturer’s instructions (Abcam). 
The sheared chromatin was precleared by incubation for 2 h with 1 µg of 
non-immune mouse IgG (sc-2025) and rabbit IgG (sc-2027) (both from 
Santa Cruz Biotechnology) and 20 µl of Protein A/G PLUS-Agarose (Santa 
Cruz Biotechnology) saturated with salmon sperm (1 mg/ml). Precleared 
chromatin was divided in aliquots and then was incubated for 16 h 
at 4 °C with 1 µg of specific antibody (anti-enolase-1: 3810 (Cell Signaling 
Technology) or sc-15343 (Santa Cruz Biotechnology)) and non-immune IgG 
(identified above). The immunocomplexes were recovered by incubation for 
3 h at 4 °C with 20 µl of protein-A/G agarose, then beads were washed with 
wash buffers according to the manufacturer’s instructions (sc-2003; Santa Cruz 
Biotechnology), and immunoprecipitated DNA was recovered and analyzed 
by quantitative PCR (primers, Supplementary Table 1).
Methylation experiments. Methyl-sensitive PCR was used for analysis of 
the methylation status of the CpG island near the CNS2 region of Foxp3. 
Genomic DNA was prepared as described46. Genomic DNA (1 µg) isolated 
from cells was digested overnight at 37 °C with 10 U of HpaII or MspI. Two 
neighboring regions of the Foxp3 CpG island have been analyzed by real-time 
PCR with specific primers (Supplementary Table 1). H19 and UEB2B were 
used as a control for fully methylated and unmethylated regions (primers, 
Supplementary Table 1).
Statistical analysis. All statistical analyses were performed with SPSS software, 
version 16 for Mac (SPSS), and the GraphPad program (Abacus Concepts). All 
the comparisons for immunoblot, PCR, proliferation and ‘Seahorse’ analyses 
were evaluated with the nonparametric Wilcoxon/Kruskal-Wallis or the paired 
two-tailed Student’s t-test. For all analyses, we used two-sided tests, with a 
p value of <0.05 indicative of statistical significance.
43. Kurtzke, J.F. Rating neurologic impairment in multiple sclerosis: an expanded 
disability status scale (EDSS). Neurology 33, 1444–1452 (1983).
44. Craig, M.E., Hattersley, A. & Donaghue, K.C. Definition, epidemiology and 
classification of diabetes in children and adolescents. Pediatr. Diabetes 10, 3–12 
(2009).
45. De Rosa, V. et al. A key role of leptin in the control of regulatory T cell proliferation. 
Immunity 26, 241–255 (2007).
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Obtened results explain how apparently different mechanisms such as “transcription which 
induces damage” and “primarily induced DNA damage can condition transcription” are 
closely connected. This correlation translates into a change of chromatin structure (histone 
code and DNA looping) which influences transcriptional levels, preserves memory of damage 
and keeps transcriptional memory too. 
First of all, we considered transcriptional activation effects in depending nuclear receptors 
genes using a model of inducing transcription. Data shows how hormonal stimulation 
conduce to methylation-demethylation cycles (Shi L. et al., 2011) of K4 and K9 of histone H3 
and how these changes are linked to the formation of loops connecting the 5' gene ends, 
3'ends and enhancers in examined genes. The formation of the chromatin loops is facilitated 
by local DNA oxidation following demethylation by LSD1, which presumably releases 
supercoiling and rigidity of the helix to oxidized bases, in particular oxidized the G to 
produced 8-oxoG. In addition we assessed the kinetics of repair enzymes recruitment (NER 
and BER) involved in the repair of oxidative damage, underlining the foundamental role of 
these enzymes in transcriptional activation. Silencing experiments allowed us to define the 
timing of recruitment of these enzymes and their role in transcription, in fact their depletion 
reduces specific mRNA and increases basal transcription (data not shown) but we have not 
clear instructions about their role in chromatin looping formation. The oxidative burst of Gs, 
generated by estrogen stimulation, is repaired in asynchronous manner on two strands of 
different regions of PS2 gene. Our data points out that DNMT3a is essential for the correct 
repair of oxidized G, in fact it closely works with OGG1 protecting the C point in front of 8-
oxoG. We performed pull-down experiments using the deleted forms of DNMT3A (full-
lenght, C-terminal, N-terminal) which allowed us to establish that DNMT3A interacts with 
OGG1 and APE1 (data not shown). Moreover transcriptional activation induces not only the 
oxidation of G, but also the changes in methylation and hydroxymethylation of CpG, in which 
DNMT3A and TET1 are involved.  
In this first line of research, gene expression regulated by nuclear receptor, we observed that 
the transcriptional activation induces chromatin remodelling which brings to histone 
modifications, chromatin 3D structure changes and it uses oxidative damage as start. 
Otherwise we evaluated how transcriptional activation and chromatin remodelling respond to 
primarily induced DNA damage. We explored the changes of histone code that match DNA 
methylation at the site of DNA repair in a DR-GFP model. Early after DSB formation, 
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chromatin near the lesion becomes enriched with H3K9m2/3 in two recombinant cell 
populations (Rec L and Rec H cells). This repressive chromatin marker is linked to DNA 
methylation, in fact treatment of Rec L cells with DNA demethylating drug, 5-azadC, 
significantly reduces the levels of H3K9m2/3 on GFP chromatin. We evaluated the histone 
methylation changes in Rec L and Rec H cells at 14 days post-HR and the obtained results 
revealed an increase of permissive markers levels (H3K4me2/me3) while the DNA region at 
3' end of damaged site is marked by di and tri-methylation of K9. These cell populations do 
not suffer DNA damage but they are damaged cells’ daughter, therefore they have a damage 
memory. This memory is expressed as DNA methylation and histone code changes. Another 
important aspect that was analyzed is the link between de novo methylation of repaired region 
and the formation of chromatin loops. We identified two loops: loop A links a region that 
includes a GFP transcription start site driven by the chicken-actin promoter, high in Rec H 
cells, and loop C includes a more distal 3' region of the GFP coding sequence located 
downstream to the I-SceI site, high and stable in Rec L cells. The treatment with 5-aza-C 
shows that the loop C in L cells is stabilized by the local DNA methylation, while treatment 
with actinomycin D reduces the loop A in both cell populations and the loop C in the HR-L, 
suggesting that interactions are generated and maintained by the transcription. 
After repair, DNA methylation is not static but it is progressively re- modelled. 
Demethylation of DNA has recently been linked to BER enzymes, which remove mismatches. 
In mammals, DNA demethylation requires that 5mC is firstly modified by deaminases or by 
hydroxylation by TET enzymes (Tahiliani et al., 2009), and then, removed by Thymine DNA 
Glycosylase (TDG). Our data indicates that BER (TDG, APE1 and OGG1) enzymes are 
recruited on the DSB and remain on the site after repair. Silencing or inactivation of APE1 or 
OGG1 enhances methylation and reduces expression of GFP. We proposed that BER 
enzymes, loaded by the transcription machinery (Wu & Zhang, 2010) contribute to 
demethylation of Rec L cells and their conversion to Rec H cells. An aspect that could be 
interesting to investigate whether the methylation is symmetrical or not on the two strands of 
altered genes in tumors. We saw that asymmetric methylation is associated with transcription 
that induces cycles of the DNA and histone methylation/demethylation, so the asymmetric 
promoter methylation of tumor suppressor genes could be used as a prognostic parameter in 
cancer. 
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Transcriptional activation modifies chromatin structure, in this change damage is included 
and it leaves a transcriptional memory on DNA, therefore, we wondered if transcriptional 
memory works as damage memory. We studied the chromatin changes during cell 
differentiation process to understand the mechanisms of transcriptional memory that induces 
chromatin changes on gene of regulative region after the acquisition of a new phenotype. For 
this purpose we studied the relationship between chromatin remodeling of FOXP3 gene and 
immunophenotypic differentiation of human primary CD4+ T lymphocytes, in particular we 
evaluated the histone code modifications, chromatin 3D structure changes and the expression 
of all  FOXP3 transcripts in the early phases of T cell activation, in Tconv and nTreg cells, 
studing the altered immunosuppressive activity in individuals with autoimmune disorders. We 
analized the altered immunosuppressive activity in individuals with autoimmune disorders in 
which the glycolisis is compromised. This dysfunction is associated with an alteration of 
suppressive activity of iTreg cells connected with  FOXP3-E2 variants levels. It is note that 
glycolysis is indispensable for the suppressive function of a-iTreg, so we demonstrated a 
crucial role for the glycolytic enzyme enolase-1 and its isoform (i.e., MBP-1) in the 
modulation of the  FOXP3-E2 splice, indispensable for the suppressive function of iTreg 
cells. 
134
  
 
References 
135
Aguilera A., and Garcia-Muse T. (2012). R loops: from transcription byproducts to threats to 
genome stability. Mol. Cell 46, 115–124. 
Ahn S. H., Kim M., Buratowski S. (2004) Phosphorylation of serine 2 within the RNA 
polymerase II C-terminal domain couples transcription and 3* end processing. Mol. Cell 
13, 67–76. 
Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J. D. Biologia molecolare della 
cellula. Zanichelli, 1995. 
Allis C. D. and Jenuwein T. (2016) The molecular hallmarks of epigenetic control. Nat. Rev. 
Genet. 17, 487-500. 
Andrade M.J. Martin R. Juarez S.F., Lopez de L. (2009) Limited terminal transferase in 
human DNA polymerase mu defines the required balance between accuracy and efficiency 
in NHEJ. Proc. Natl. Acad. Sci. U.S.A. 106, 16203-16208. 
Banerjee S., Kumar B. R., Kundu T. K. (2004) General transcriptional coactivator PC4 
activates p53 function. Mol. Cell. Biol. 24, 2052–2062. 
Bannister A. J. , Kouzarides T. (2007) Chromatin modifications and their function. Cell 
128(4): 693-705. 
Baylin S. B. and Ohm J. E. (2006). Epigenetic gene silencing in cancer – a mechanism for 
early oncogenic pathway addiction? Nat Rev Cancer 6, 107–116. 
Bohgaki T., Bohgaki M., Hakem R. (2010) DNA double-strand break signaling and human 
disorders. Genome Integr. 1, 15. 
Brunkow M. E., Jeffery E. W., Hjerrild K. A. (2001). Disruption of a new fork head/winged-
helix protein, scurfin, results in the fatal lympho proliferative disorder of the scurfy mouse. 
Nature Genetics 27(1): 68–73. 
Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A., 
Wilkinson J. E., Galas D., Ziegler S. F., Ramsdell F. (2001)Disruption of a new 
forkhead/winged-helix protein, scurfin, results in the fatally phoproliferative disorder of 
the scurfy mouse. Nat Genet 27:68–73 
Burdett V., Baitinger C., Viswanathan M., Lovett S. T., Modrich P. (2001) In vivo 
requirement for RecJ, ExoVII, ExoI, and ExoX in methyl-directed mismatch repair. Proc 
Natl Acad Sci USA; 98, 6765-6770 
Caldecott K.W., Aoufouchi S., Johnson P. & Shall S. (1996). XRCC1 polypeptide interacts 
with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase 
III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res. 24, 4387-4394. 
Camenisch U., Dip R., Schumacher S. B., Schuler B., Naegeli H. (2006) Recognition of 
helical kinks by xeroderma pigmentosum group A protein triggers DNA excision repair. 
Nat. Struct. Mol. Biol. 13, 278–284. 
Cheng K. C., Cahill D. S., Kasai H., Nishimura S., Loeb L. A. (1992) 8- Hydroxyguanine, an 
abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 
267: 166–172. 
Cho Y. H., Yazici H., Wu H. C., Terry M. B., Gonzalez K., Qu M., Dalay N. and Santella R. 
M. (2010). Aberrant promoter hypermethylation and genomic hypomethylation in tumor, 
136
adjacent normal tissues and blood from breast cancer patients. Anticancer Res. 30, 2489-
2496. 
Coin F., Oksenych V., Egly J. M. (2007) Distinct roles for the XPB/p52 and XPD/p44 
subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair. Mol. 
Cell 26, 245–256. 
Compe E. and Egly J. M. (2012). TFIIH: when transcription met DNA repair. Nat Rev Mol 
Cell Biol. 13, 343-354. Erratum in: Nat Rev Mol Cell Biol. 2012; 13, 476. 
Cortazar, D., Kunz, C., Saito, Y., Steinacher, R., and Schar, P. (2007). The enigmatic thymine 
DNA glycosylase. DNA Repair (Amst.) 6, 489–504. 
Cortellino S., Xu J., Sannai M., Moore R., Caretti E., Cigliano A., Le Coz M., Devarajan K., 
Wessels A., Soprano D. (2011). Thymine DNA glycosylase is essential for active DNA 
demethylation by linked deamination-base excision repair. Cell 146, 67–79. 
Cuozzo C., Porcellini A., Angrisano T., Morano A., Lee B., Di Pardo A., Messina S., Iuliano 
R., Fusco A., Santillo M. R., Muller M. T., Chiariotti L., Gottesman M. E. & Avvedimento 
E. V. (2007). DNA damage, homology-directed repair, and DNA methylation. PLoS 
Genet. 3, e110. 
Dantzer F., de La Rubia G., Ménissier-De Murcia J., Hostomsky Z., de Murcia G. & 
Schreiber V. (2000). Base excision repair is impaired in mammalian cells lacking 
Poly(ADP-ribose) polymerase-1. Biochemistry 39, 7559-7569. 
Deaton, A. M. and Bird A., A. CpG islands and the regulation of transcription. Genes Dev. 
25, 1010–1022 (2011). 
Devadas S., Zaritskaya L., Rhee S. G., Oberley L., Williams M. S. (2002). Discrete 
generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective 
regulation of mitogenactivated protein kinase activation and fas ligand expression. J Exp 
Med, 10, 59-70. 
Dichtl B., Blank D., Ohnacker M., Friedlein A., Roeder D., Langen H. & Keller W. (2002). A 
role for SSU72 in balancing RNA polymerase II transcription elongation and termination. 
Mol. Cell 10, 1139–1150. 
Diderich K., Alanazi M., Hoeijmakers J. H. (2011) Premature aging and cancer in nucleotide 
excision repair-disorders. DNA Repair (Amst) 10, 772–780. 
Egger G., Jeong S., Escobar S. G., Cortez C. C., Li T. W., Saito Y., Yoo C. B., Jones P. A., 
Liang G. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic 
knockouts suggests an essential role for DNMT1 in cell survival. (2006) Proc Natl Acad 
Sci USA. 103(38):14080-5.  
Fagbemi A. F., Orelli B., Scharer O. D. (2010) Regulation of endonuclease activity in human 
nucleotide excision repair. DNA Repair (Amst) 10, 722–729. 
Fagbemi A. F., Orelli B., Scharer O. D. (2011) Regulation of endonuclease activity in human 
nucleotide excision repair. DNA Repair (Amst) 10 722–729. 
Fontenot J. D., Gavin M. A., Rudensky A. Y. (2003)  FOXP3 programs the development and 
function of CD4+CD25+ regulatory T cells. Nat Immunol;4:330–336.  
Franchini D. M., Schmitz K. M., and Petersen-Mahrt S. K. (2012). 5-Methylcytosine DNA 
demethylation: more than losing a methyl group. Annu. Rev. Genet. 46, 419–441. 
137
Frit P., Kwon K., Coin F., Auriol J., Dubaele S., Salles B., Jean-Marc Egly J. M. 
(2002)Transcriptional activators stimulate DNA repair. Mol. Cell 10, 1391–1401. 
Fuda N. J., Ardehali M. B., Lis J. T. (2009) Defining mechanisms that regulate RNA 
polymerase II transcription in vivo, Nature 461, 186–192. 
Fuks F., Burgers W. A., Brehm A., Hughes-Davies L., Kouzarides T. (2000). DNA 
methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 24: 88–
91.  
Fuks F., Hurd P. J., Deplus R., Kouzarides T. (2003). The DNA methyltransferases associate 
with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31: 2305–2312. 
Geiman T. M., Sankpal U. T., Robertson A. K., Zhao Y., Zhao Y., Robertson K. D. (2004). 
DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and 
components of the histone methylation system. Biochem Biophys Res Commun 318: 544–
555. 
Getts R. C, Stamato T. D. (1994) Absence of a Ku-like DNA end binding activity in the xrs 
double-strand DNA repair-deficient mutant. J. Biol. Chem. 269, 15981-15984. 
Gillet L. C., Scharer O. D.. (2006) Molecular mechanisms of mammalian global genome 
nucleotide excision repair. Chem. Rev. 106, 253–276. 
Gloire G., Legrand-Poels S., Piette J. (2006). NF-kappaB activation by reactive oxygen 
species: fifteen years later. Biochem Pharmacol, 10, 1493-505. 
Goto K., Numata M., Komura J. I, Ono T., Bestor T. H., Kondo H. (1994). Expression of 
DNA methyltransferase gene in mature and immature neurons as well as proliferating cells 
in mice. Differentiation 56: 39–44. 
Greer, E. L. and Shi, Y. (2012) Histone methylation: a dynamic mark in health, disease and 
inheritance. Nat. Rev. Genet. 13 (5), 343-57. 
Gu L., Hong Y., McCulloch S., Watanabe H., Li G. M. (1998) ATP-dependent interaction of 
human mismatch repair proteins and dual role of PCNA in mismatch repair. Nucleic Acids; 
26:1173-1178. 
Harper, J. W. and Elledge, S. J. (2007) The DNA damage response: ten years after. Mol. Cell 
28, 739–745. 
Hegde M. L., Theriot C. A., Das A., Hegde P. M., Guo Z., Gary R. K., Hazra T. K., Shen B., 
Mitra S. (2008b). Physical and functional interaction between human oxidized base-
specific DNA glycosylase NEIL1 and flap endonuclease 1. J Biol Chem 283, 27028–
27037. 
Hermann A., Goyal R., Jeltsch A. (2004). The Dnmt1 DNA-(cytosine-C5)-methyltransferase 
methylates DNA processively with high preference for hemimethylated target sites. J Biol 
Chem 279: 48350–48359. 
Hildeman D. A. (2004). Regulation of T-cell apoptosis by reactive oxygen species. Free 
Radic Biol Med, 10, 1496-504. 
Hori S., Nomura T., Sakaguchi S. (2003) Control of regulatory T cell development by the 
transcription factor  FOXP3. Science;299:1057–1061. 
138
Ito S., Shen L., Dai D., Wu S. C., Collins L. B., Swenberg J. A., Egli C., Zhang Y. (2011).Tet 
proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. 
Science, 333, pp. 1300–1303. 
 Jasin M. (1996) Genetic manipulation of genomes with rare-cutting endonucleases. Trends 
Genet 12: 224-228. 
Jensen R. B., Carreira A., Kowalczykowski S. C. (2010) Purified human BRCA2 stimulates 
RAD51-mediated recombination, Nature 467, 678-683. 
Jones D. P. (2006). Redefining oxidative stress. Antioxid Redox Signal, 10, 1865-79. 
Junop M. S. , Obmolova G., Rausch K., Hsieh P., Yang W. (2001) Composite active site of an 
ABC ATPase: MutS uses ATP to verify mismatch recognition and authorize DNA repair. 
Mol Cell; 7:1-12. 
Kadyrov F. A., Dzantiev L., Constantin N., Modrich P. (2006) Endonucleolytic function of 
MutLalpha in human mismatch repair. Cell; 126, 297-308 
Kareta M. S., Botello Z. M., Ennis J. J., Chou C., Chedin F. (2006) Reconstitution and 
mechanism of the stimulation of de novo methylation by human DNMT3L. J Biol Chem. 
281(36):25893 
Kim N., and Jinks-Robertson, S. (2012). Transcription as a source of genome instability. Nat. 
Rev. 13, 204–214. 
Klungland, A. and Lindahl, T. (1997) Second pathway for completion of human DNA base 
excision-repair: ReconstituCell. Mol. Life Sci. Vol. 66, 2009  
Koch C. A., Agyei R., Galicia S., Metalnikov P., O’Donnell P., Starostine A., Weinfeld M., 
Durocher D. (2004) Xrcc4 physically links DNA end processing by polynucleotide kinase 
to DNA ligation by DNA ligase IV. EMBO J. 23, 3874-3885. 
Kraemer K. H., Patronas N. J., Schiffmann R., Brooks B. P., Tamura D., Di Giovanna J. J. 
(2007) Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex 
genotype–phenotype relationship. Neuroscience 145, 1388–1396. 
Krishnamurthy S., He X., Reyes-Reyes M., Moore C. & Hampsey M. (2004). Ssu72 is an 
RNA polymerase II CTD phosphatase. Mol. Cell 14, 387–394. 
Kuehner J. N., Pearson E. L., Moore C. (2011) Unravelling themeans to an end: RNA 
polymerase II transcription termination. Nat. Rev. Mol. Cell Biol. 12, 283–294. 
Laird P. W., Jackson-Grusby L., Fazeli A., Dickinson S. L., Jung W. E., Li E., Weinberg R. 
A. and Jaenisch R. (1995). Suppression of intestinal neoplasia by DNA hypomethylation. 
Cell 81, 197–205 
Larrea A. A., Lujan S. A., Kunkel T. A.(2010) Snap Shot: DNA mismatch repair. Cell 141, 
730. 
Le May N., Mota-Fernandes D., Vélez-Cruz R., Iltis I., Biard D., Egly J. M. (2010) NER 
factors are recruited to active promoters and facilitate chromatin modification for 
transcription in the absence of exogenous genotoxic attack. Mol. Cell 38, 54–66. 
Leonhardt H., Page A. W., Weier H. U., Bestor T. H. (1992). A targeting sequence directs 
DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865–
873. 
139
Li B., Carey M., Workman J. L. (2007) The role of chromatin during transcription, Cell 128, 
707–719. 
Li E., Beard C. and Jaenisch R. (1993). Role for DNA methylation in genomic imprinting. 
Nature 366, 362–365. 
Li E., Bestor T. H. and Jaenisch R. (1992). Targeted mutation of the DNA methyltransferase 
gene results in embryonic lethality. Cell 69, 915–926. 
Lieber M. R. (2010) The mechanism of double-strand DNA break repair by the 
nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 79, 181–211. 
Lindahl T. et Wood R. D. (1999). Quality control by DNA repair. Science 286, 1897-1905. 
Lindahl T., Instability and decay of the primary structure of DNA. (1993) Nature 362, 709–
715. 
Ljungman M. (2005) Activation of DNA damage signaling. Mutat. Res. 577, 203–216. 
Mathieu N., Kaczmarek N., Naegeli H. (2010) Strand- and site-specific DNA lesion 
demarcation by the xeroderma pigmentosum group D helicase. Proc. Natl. Acad. Sci. 
U.S.A. 107, 17545–17550. 
Mellon, I., Spivak, G., and Hanawalt, P. C. (1987). Selective removal of transcription-
blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51, 
241–249. 
Min J. H., Pavletich N. P. (2007) Recognition of DNA damage by the Rad4 nucleotide 
excision repair protein. Nature 449, 570–575. 
Missura M., Buterin T., Hindges T., Hubscher U., Kasparkova J., Brabec V., Naegeli H. 
(2001) Double-check probing of DNA bending and unwinding by XPA-RPA: an 
architectural function in DNA repair, EMBO J. 20, 3554–3564. 
Mittler R., Vanderauwera S., Suzuki N., Miller G, Tognetti V. B., Vandepoele K., Gollery M., 
Shulaev V., Van Breusegem F. (2011). ROS signaling: the new wave? Trends Plant Sci, 
10, 300-9.  
Mocquet V., Laine J. P., Riedl T., Yajin Z., Lee M. Y., Egly M. J. (2008) Sequential 
recruitment of the repair factors during NER: the role of XPG in initiating the resynthesis 
step. EMBO J. 27, 155–167. 
Modrich P., Lahue R. (1996) Mismatch repair in replication fidelity, genetic recombination, 
and cancer biology. Annu Rev Biochem; 65, 101-133. 
Morano A., Angrisano T., Russo G., Landi R., Pezone A., Bartollino S., Zuchegna C., Babbio 
F., Bonapace I. M., Allen B., Muller M. T., Chiariotti L., Gottesman M. E., Porcellini A. 
and Avvedimento E. V. (2014). Targeted DNA methylation by homology-directed repair in 
mammalian cells. Transcription reshapes methylation on the repaired gene. Nucleic Acids 
Res. 42, 804-821. 
Morano A., Angrisano T., Russo G., Landi R., Pezone A., Bartollino S., Zuchegna C., Babbio 
F., Bonapace I. M., Allen B., Muller M. T ., Chiariotti L., Gottesman M. E., Porcellini A. 
and Avvedimento E. V.(2014) Targeted DNA methylation by homology-directed repair in 
mammalian cells. Transcription reshapes methylation on the repaired gene. Nucleic Acids 
Research, 42, 2 
140
Moser J., Kool H., Giakzidis I., Caldecott K., Mullenders L. H., Fousteri M. I. (2007) Sealing 
of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA 
ligase III alpha in a cell-cycle-specific manner. Mol. Cell 27, 311–323. 
Nag K., Narsinh H. G., Martinson H. G. (2007) The poly(A)-dependent transcriptional pause 
is mediated by CPSF acting on the body of the polymerase, Nat. Struct. Mol. Biol.14, 662-
669. 
Napolitano G., Amente S., Lavadera M. L., Di Palo G., Ambrosio S., Lania L., Dellino G. I., 
Pelicci P. G., Majello B. (2013) Sequence-specific double strand breaks trigger P-TEFb-
dependent Rpb1-CTD hyperphosphorylation. Mutation Research 749, 21-27. 
Orelli B., McClendon T. B., Tsodikov O. V., Ellenberger T., Niedernhofer L. J., Scharer O. 
D. (2010) The XPA-binding domain of ERCC1 is required for nucleotide excision repair 
but not other DNA repair pathways, J. Biol. Chem. 285, 3705–3712. 
Otterlei M., Warbrick E., Nagelhus T. A., Haug T., Slupphaug G., Akbari M., Aas P. A., 
Steinsbekk K., Bakke O., Krokan H. E. (1999). Post-replicative base excision repair in 
replication foci. EMBO J 18, 3834–3844. 
Pappas D. L. Jr and Hampsey M. (2000). Functional interaction between Ssu72 and the Rpb2 
subunit of RNA polymerase II in Saccharomyces cerevisiae. Mol Cell Biol. 20, 8343-8351. 
Pasini D., Malatesta M., Jung H. R., Walfridsson J., Willer A., Olsson L., Skotte J., Wutz A., 
Porse B., Jensen O. N., Helin K. (2010) Characterization of an antagonistic switch between 
histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of 
Polycomb group target genes. Nucleic Acids Res 38(15): 4958-4969.  
Perillo B., Ombra, M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., Chiariotti L., Malorni 
A., Abbondanza C., and Avvedimento E. V. (2008). DNA oxidation as triggered by 
H3K9me2 demethylation drives estrogen induced gene expression. Science 319, 202–206. 
Petermann, E., Ziegler M. and Oei S. L. (2003) ATP-dependent selection between single 
nucleotide and long patch base excision repair. DNA Repair (Amst) 2, 1101-1114. 
Phillips T. (2008). Regulation of transcription and gene expression in eukaryotes. Nature 
Education 1 (1):199. 
Pradhan S., Bacolla A., Wells R. D., Roberts R. J. (1999). Recombinant human DNA 
(cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and 
maintenance methylation. J Biol Chem 274: 33002–33010. 
Ramsahoye B. H., Biniszkiewicz D., Lyko F., Clark V., Bird A. P., Jaenisch R. (2000). Non-
CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA 
methyltransferase 3a. Proc Natl Acad Sci USA 97: 5237–5242. 
Rao K.S. (2007). Mechanisms of disease: DNA repair defects and neurological disease. 
Nature clinical practice 3, 162-172. 
Rice J. C., Nishioka K., Sarma K., Steward R., Reinberg D., (2002) Mitotic-specific 
methylation of histone H4 Lys 20 follows increased PR-Set7 expression and its 
localization to mitotic chromosomes. Genes Dev 16(17): 2225-2230.  
Riggs A. D., Xiong Z. Methylation and epigenetic fidelity. (2004) Proc Natl Acad Sci USA. 
2004;101(1)4-5. 
Rudensky A. Y. (2011) Regulatory T cells and  FOXP3. Immunol Rev;241:260–268. 
141
Sakaguchi S., Yamaguchi T., Nomura T., Ono M. (2008) Regulatory T cells and immune 
tolerance. Cell 2008;133:775–787.  
Salomon B., Lenschow D. J. Rhee L., (2000) B7/CD28 cosimulation is essential for the 
homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune 
diabetes. Immunity 12(4), 431-440. 
Santos-Rosa H., Schneider R., Bannister A. J., Sherriff J., Bernstein B. E., Emre N. C., 
Schreiber S. L., Mellor J., Kouzarides T. (2002) Active genes are tri-methylated at K4 of 
histone H3. Nature 419(6905): 407-411.  
Scharer O. D. (2007). Achieving broad substrate specificity in damage recognition by binding 
accessible nondamaged DNA. Mol. Cell 28,184–186. 
Sentenac A. (1985). Eukaryotic RNA polymerases. CRC Crit Rev Biochem. 18, 31-90. 
Shandilya J., Roberts S. G. E. (2012) The transcription cycle in eukaryotes: From productive 
initiation to RNA polymerase II recycling. Biochimica et Biophysica Acta 1819, 391-400. 
Shen L., Wu H., Diep D., Yamaguchi S., D’Alessio A. C., Fung H.L., Zhang K., and Zhang 
Y. (2013). Genome-wide analysis reveals TET- and TDG dependent 5-methylcytosine 
oxidation dynamics. Cell 153, 692–706. 
Shi Y., Lan F., Matson C., Mulligan P., Whetstine J. R., Cole P. A., Casero R. A., Shi Y. 
(2004) Histone demethylation mediated by the nuclear amine oxidase homologue LSD1. 
Cell 119, 941–953. 
Shu Y., Hu Q., Long H., Chang C., Lu Q., Xiao R. (2016) Epigenetic variability of 
CD4+CD25+ Treg contributes to the pathogenesis of autoimmune disease. Clinic Rev 
Allerg Immunol. 
Stracker T. H., Petrini J. H. (2011) The MRE11 complex: starting from the ends. Nat. Rev. 
Mol. Cell Biol. 12, 90-103. 
Strahl B. .D, Allis C. D. (2000) The language of covalent histone modifications. Nature 
403(6765): 41-45.  
Sugasawa K., Akagi J., Nishi R., Iwai S., Hanaoka F. (2009) Two-step recognition of DNA 
damage for mammalian nucleotide excision repair: directional binding of the XPC 
complex and DNA strand scanning. Mol. Cell 36, 642–653. 
Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer 
L.M., Liu D.R., Aravind L., Rao A. Conversion of 5methylcytosine to 5-
hydroxymethylcytosine in mammalian DNA by MLL partner TET1. (2009). Science. 15; 
324 (5929) :930-5. 
Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer 
L.M., Liu D.R., Aravind L., Rao A. Conversion of 5methylcytosine to 5-
hydroxymethylcytosine in mammalian DNA by MLL partner TET1. (2009). Science. 15; 
324 (5929) :930-5. 
Takahashia S., Suetakea I., Engelhardtc J., Tajima S. (2015) A novel method to analyze 5-
hydroxymethylcytosine in CpG sequences using maintenance DNA methyltransferase, 
DNMT1. FEBS Open Bio. Volume 5, 2015, Pages 741–747. 
142
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., Patel, D. J. (2007) How chromatin-
binding modules interpret histone modifications: lessons from professional pocket pickers. 
Nature Struct. Mol. Biol. 14, 1025–1040. 
Toker A., Huehn J. (2011) To be or not to be a Treg cell: lineage decisions controlled by 
epigenetic mechanisms. Sci Signal 4:pe4 
Tsodikov O. V., Ivanov D., Orelli B., Staresincic L., Shoshani I., Oberman R., Scharer O. D., 
Wagner G., Ellenberger T. (2007) Structural basis for the recruitment of ERCC1-XPF to 
nucleotide excision repair complexes by XPA, EMBO J. 26, 4768–4776. 
Tsukada Y., Fang J., Erdjument-Bromage H., Warren M. E., Borchers C. H., Tempst P. & 
Zhang Y. (2006) Histone demethylation by a family of JmjC domain-containing proteins. 
Nature 439, 811–81. 
Turner B. M. (1993) Decoding the nucleosome. Cell 75(1): 5-8.  
Um S., Harbers M., Benecke A., Pierrat B., Losson R., and Chambon P. (1998). Retinoic acid 
receptors interact physically and functionally with the T:G mismatch-specific thymine-
DNA glycosylase. J. Biol. Chem. 273, 20728-20736. 
Walker M. R., Kasprowicz D. J., Gersuk V. H., Benard A., Van Landeghen M., Buckner J. H, 
Ziegler SF (2003) Induction of  FOXP3 and acquisition of T regulatory activity by 
stimulated human CD4+CD25. Tcells. J Clin Invest 112:1437–1443. 
Wang Y., Fairley J. A., Roberts S. G. (2010) Phosphorylation of TFIIB links transcription 
initiation and termination. Curr. Biol. 20, 548–553. 
Wang Z., Zang C., Rosenfeld J. A., Schones D. E., Barski A., Cuddapah S., Cui K., Roh T. 
Y., Peng W., Zhang M. Q., Zhao K. (2008) Combinatorial patterns of histone acetylations 
and methylations in the human genome. Nat Genet 40(7): 897-903.  
Whetstine J. R., Nottke A., Lan F., Huarte M., Smolikov S., Chen Z., Spooner E., Li E., 
Zhang G., Colaiacovo M., Shi Y. (2006). Reversal of histone lysine trimethylation by the 
JMJD2 family of histone demethylases. Cell 125, 467–481. 
Williamson L. M. and Lees-Miller S. P. (2011) Estrogen receptor a-mediated transcription 
induces cell cycle-dependent DNA double-strand breaks. Carcinogenesis 32 (3) 279–285. 
Wilson III D. M., Bohr V. A., (2007) The mechanics of base excision repair and its 
relationship to aging and disease, DNA Repair (Amst) 6, 544–559. 
Winterbourn C. C. (2008) Reconciling the chemistry and biology of reactive oxygen species. 
Nat Chem Biol 4: 278–286. 
Wu C. and Morris J. R. (2001). Genes, genetics, and epigenetics: a correspondence. Science 
293, 1103-1105. 
Wu, S. C., and Zhang, Y. (2010). Active DNA demethylation: many roads lead to Rome. Nat. 
Rev. Mol. Cell Biol. 11, 607–620. 
Xu W., Cho H., Evans R. M. (2003). Acetylation and methylation in nuclear receptor gene 
activation. Methods Enzymol. 364, 205-23. 
Yamaguchi S., Hong K., Liu R., Inoue A., Shen L., Zhang K. and Zhang Y. (2013) Dynamics 
of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell 
Research 23, 329–339. 
143
Yudkovsky N., Ranish J. A. & Hahn S. (2000). A transcription reinitiation intermediate that is 
stabilized by activator. Nature 408, 225-229. 
Zhang Y., Jurkowska R., Soeroes S., Rajavelu A., Dhayalan A., Bock I. (2010).Chromatin 
methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD 
domain with the histone H3 tail. Nucleic Acids Res 38: 4246–4253902. 
Zhang Y., Yuan F., Presnell S. R. (2005) Reconstitution of 5*-directed human mismatch repair 
in a purified system. Cell; 122, 693- 705. 
Zheng Y., Josefowicz S., Chaudhry A. ( 2010). Role of conserved non-coding DNA elements 
in the  FOXP3 gene in regulatory T-cell fate. Nature 463 (7282): 808–812. 
144
List of publications 
 
1. Di Zazzo E., Feola A., Zuchegna C., Romano A., Donini C. F., Bartollino S., Costagliola 
C., Frunzio R., Laccetti P., Di Domenico M., Porcellini A. The p85 regulatory subunit of 
PI3K mediates cAMP-PKA and insulin biological effects on MCF7 cell growth and 
motility. The Scientific World Journal 2014: 1-11. ISSN 2356-6140 DOI 
10.1155/2014/565839.  
  
2. Zuchegna C., Aceto F., Bertoni A., Romano A., Perillo B., Laccetti P., Gottesman M. E., 
Avvedimento E. V., Porcellini A. Mechanism of Retinoic acid-induced transcription: 
histone code, DNA oxidation and formation of chromatin loops. Nucleic Acids Research 
2015 Jan 1;42(17): 11040-11055. ISSN 1362-4962 DOI 10.1093/nar/gku823.  
  
3. De Rosa V., Galgani M., Porcellini A., Colamatteo A., Santopaolo M., Zuchegna C., 
Romano A., De Simone S., Procaccini C., La Rocca C., Carrieri P. B., Maniscalco G. T., 
Salvetti M., Buscarinu M. C., Franzese A., Mozzillo E., La Cava A., Matarese G. Glycolysis 
controls the induction of human regulatory T cells by modulating the expression of FOXP3 
exon 2 splicing variants. Nat Immunol. 2015 Nov;16(11):1174-84. DOI 10.1038/ni.3269. 
 
4. Russo G., Landi R., Pezone A., Morano A., Zuchegna C., Romano A., Muller M. T., 
Gottesman M. E., Porcellini A., Avvedimento E. V. DNA damage and repair modify DNA 
methylation and chromatin domain of the targeted locus: mechanism of allele methylation 
polymorphism. Scientific reports. 2016 Sept; 6:33222. DOI: 10.1038/srep33222. 
 
5. Pezone A., Russo G., Tramontan A., Florio E., Scala G., Landi R., Zuchegna C., Romano 
A., Chiariotti L., Muller M. T., Gottesman M. E., Porcellini A., Avvedimento E. V. High-
coverage methylation data of a gene model before and after DNA damage and homologous 
repair. Sci Data (In Press). 
 
6. Histone and DNA methylation cycles are coupled by DNA oxidation to induce 
transcription by nuclear receptors (Manuscript in preparation). 
 
145
